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 During animal development, cells are born with the potential to adopt different 
cell fates.  Many of the mechanisms that control cell fate choice are highly conserved.  
Here I study how the fates of two important cell types, the Anchor Cell (AC) and the 
Distal Tip Cell (DTC), are specified during C. elegans gonadogenesis.  The AC is an 
important signaling hub that directs uterine and vulval development.  Its specification and 
function require the E protein HLH-2/Da/E2A, an essential basic Helix-Loop-Helix 
transcription factor.  In the developing gonad, two cells Z1.ppp and Z4.aaa have naturally 
variable fates.  They require hlh-2 for the potential to adopt AC fate, for the AC/VU 
decision to specify one AC and one ventral uterine precursor cell (VU), and for execution 
of AC fate.  hlh-2 has been shown to be post-transcriptionally regulated during the 
AC/VU decision:  HLH-2 protein is observed in the AC and not in the VU, though hlh-2 
is transcribed in both cells.  Until this work, little was known about how hlh-2 is post-
transcriptionally regulated in C. elegans.  Understanding how E proteins are regulated is 
also important in other contexts, because increased E protein activity has been associated 
with developmental defects and lymphoma.  
 Here, a novel dimerization-dependent mechanism for HLH-2 down-regulation is 
	  
	  
identified in the VU.  I provide evidence that HLH-2 homodimers promote AC 
competence, the AC/VU decision, and AC function, and that HLH-2 homodimers are 
recognized in the VU and targeted for degradation.  The human ortholog E2A is found to 
be regulated similarly, raising the possibility that the mechanism for negative regulation 
of HLH-2 and E2A is conserved.  A simple model could explain the difference in 
stability of HLH-2 homodimers:  lin-12/Notch activity is low in the AC but high in the 
VU, where it promotes the turnover of HLH-2 homodimers. 
The C. elegans gonad also contains two distal tip cells (DTC), which direct the 
shape of the developing gonad and promote germline proliferation.  In addition to AC 
fate, HLH-2 is required for the specification and function of the DTCs.  However, it was 
not known what dimerizes with HLH-2 to promote DTC specification.  Here, LIN-
32/Atonal and HLH-12 are identified as two functionally redundant partners for HLH-2 
in promoting DTC fate and function.  Loss of both lin-32 and hlh-12 causes a complete 
failure of DTC migration, which likely reflects a highly penetrant failure of DTC 
specification.  lin-32 and hlh-12 are both expressed in the DTC around the time of 
specification, consistent with a cell-autonomous role.  These results suggest that LIN-32 
and HLH-12 can heterodimerize with HLH-2 in the DTC to specify fate and promote 
migration.   
This work advances our understanding of how HLH-2 is regulated and how it 
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1. Introduction to C. elegans gonadogenesis 
How cell fates are specified and executed during development is a fundamental 
question in biology.  Every animal, from nematodes to humans, must precisely regulate 
when and where cell fates are specified as the organism grows and develops.  The 
nematode Caenorhabditis elegans serves as an exceptional model organism for studying 
very basic questions, due to its relatively simple anatomy and its nearly invariant lineage, 
or pattern of cell division and fate.  In addition, its small size and transparency allow for 
direct observation of developmental events in live animals.  Here I investigate how cell 
fates are specified in two contexts during C. elegans gonad development:  the naturally 
variable specification of the anchor cell, an exception to the invariant lineage; and the 
specification of the distal tip cell. 
 
1.1 Early larval gonad development 
The adult gonad in C. elegans is one of its largest organs.  The somatic gonad in 
hermaphrodites is comprised of 143 cells, and it holds approximately 1000 germ cells 
(Kimble and Hirsh 1979; Kimble and White 1981).  However, C. elegans larvae hatch 
with just four cells in the gonad:  Z1, Z2, Z3, and Z4.  The two cells Z1 and Z4 are 
positioned at the distal ends of the gonad, and they must undergo a very specific pattern 
and number of divisions to produce the entire somatic gonad structure by the end of 
larval development (Fig. 1A).  The position of Z2 and Z3 is more proximal, and they 
proliferate to produce the germline (Fig. 1A).  Here I focus on gonad development of the 
hermaphrodite, with emphasis on the anchor cell and distal tip cells. 
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In the middle of the L1, the first of four larval stages, Z1 and Z4 begin to divide.  
The pattern of divisions of Z1 and Z4 is identical and creates a total of twelve somatic 
cells at the end of the L1 stage (Fig. 1B).  The two sets of descendants are arranged 
mirror symmetrically, with the six Z1 descendants in the anterior half of the gonad and 
the six Z4 descendants in the posterior half.   
During the L2, the germ cells proliferate, but the somatic cells stop dividing 
(Kimble and Hirsh 1979).  The two cells Z1.aa and Z4.pp are located at the distal ends of 
the gonad (anterior and posterior ends, respectively), and they become specified as distal 
tip cells (DTCs).  The DTCs are essential for guiding gonad extension and shape, as well 
as for maintaining the germline.  The proximal cells in the gonad are Z1.ppp and Z4.aaa, 
and they become the anchor cell (AC) and the ventral uterine precursor cell (VU).  The 
AC is an important signaling hub; it is required to induce vulval development and to 
promote uterine development (Kimble 1981).  The VU goes on to proliferate further and 
contribute to the developing uterus. 
 
1.2 The Anchor Cell / Ventral Uterine precursor cell (AC/VU) decision 
Specification of the anchor cell fate is quite exceptional.  Unlike most other cells 
in the developing worm, the anchor cell is specified as the result of a naturally variable 
cell fate decision between Z1.ppp and Z4.aaa.  A stochastic difference between the cells 
causes one to be specified as the AC and the other as a VU.  This is called the AC/VU 
decision. 
The natural lineage variability was first identified through lineage analysis 
(Kimble and Hirsh 1979).  Later ablation studies indicated that specification of the AC 
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and VU fate is the result of a decision.  During the L2, somatic gonad cells begin to 
rearrange to form the somatic gonad primordium (Kimble and Hirsh 1979).  Among other 
cell movements, the presumptive AC occupies a central position, while the presumptive 
VU moves either to the left or to the right (Kimble and Hirsh 1979).  If the presumptive 
AC is killed through laser ablation while the rearrangement of cells is still occurring, then 
the presumptive VU can change course and adopt the AC fate instead, replacing the AC 
(Kimble 1981).  However, once the formation of the primordium is complete, Z1.ppp and 
Z4.aaa have both committed to their respective fates.  If the AC is ablated at this point, 
the VU will not adopt the AC fate to replace it (Kimble 1981).   
These experiments have important implications regarding the nature of the 
AC/VU decision.  They show that after Z1.ppp and Z4.aaa are born, they remain 
competent to adopt either the AC or VU fate for several hours (before and during 
primordium formation).  During this competent period, cell-cell interactions determine 
the fates of each cell:  the presence of the presumptive AC influences the fate of the 
presumptive VU.   
The AC/VU decision is thus a beautiful paradigm for investigating how 
unspecified cells communicate through cell-cell interactions in order to commit to 
specific cell fates.  The biological system could not be simpler: just two cells making a 
stochastic cell fate decision that is independent of the presence of other gonadal cells 
(Seydoux and Greenwald 1989).  The two cells are born with equal potential to adopt 
either the AC fate or the VU fate.  Half of the time, Z1.ppp becomes the AC and Z4.aaa 
becomes the VU.  And the other half of the time, the opposite occurs (Kimble and Hirsh 
1979).  Each cell must commit to one of the two fates, and the cells must commit to 
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different fates from each other.  In wild-type animals, the AC/VU decision always results 
in one AC and one VU.   
 
1.3 LIN-12/Notch signaling in the AC/VU decision 
The molecular mechanism mediating the AC/VU decision was unknown, until a 
genetic screen for mutations that caused lineage defects resulted in the discovery of lin-
12 (Horvitz et al. 1983), a Notch ortholog in the worm (Yochem et al. 1988).  Analysis of 
both gain-of-function and null lin-12 alleles revealed that lin-12 plays a crucial role 
during the AC/VU decision (Greenwald et al. 1983).  In lin-12(+) animals, Z1.ppp or 
Z4.aaa adopts the AC fate and the other adopts the VU fate (“1AC”).  lin-12(d) alleles 
result in elevated LIN-12 activity, which causes both Z1.ppp and Z4.aaa to adopt the VU 
fate (the “0AC” defect).  Conversely, lin-12(0) alleles result in complete loss of LIN-12 
activity, which causes both Z1.ppp and Z4.aaa to adopt the AC fate (the “2AC” defect).  
In addition, temperature-sensitive lin-12 alleles were isolated and used to show that lin-
12 is required during the time of the decision (Greenwald et al. 1983).  This shows that 
lin-12 is required and sufficient to promote VU fate and that it acts as a “binary switch” 
during the AC/VU decision to regulate its outcome (Greenwald et al. 1983). 
Further studies revealed how LIN-12/Notch functions during the AC/VU decision 
to promote VU fate.  When all somatic gonad cells except either Z1.ppp or Z4.aaa are 
ablated, the remaining cell adopts the AC fate (Seydoux and Greenwald 1989).  However, 
when all somatic cells except Z1.ppp and Z4.aaa are ablated, one becomes the AC and 
the other becomes the VU (Seydoux and Greenwald 1989).  This suggests that (1) the 
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AC/VU decision does not depend on signals from other gonad cells; (2) the specification 
of AC fate does not depend on a signal; and (3) an AC-to-VU signal promotes VU fate.   
lin-12 could potentially act either on the signal-sending side or on the receiving 
side of the AC-to-VU signal to specify VU fate.  Mosaic analysis of lin-12(0) animals 
revealed that lin-12 functions on the receiving side.  Mosaic lin-12(0) animals were 
obtained, in which a free chromosomal duplication carrying lin-12(+) was retained in the 
lineage of either Z1.ppp or Z4.aaa and lost in the other lineage.  This results in a lin-
12(+) cell next to a lin-12(0) cell during the AC/VU decision.  The lin-12(0) cell always 
becomes the AC,  demonstrating that lin-12 acts cell-autonomously to promote VU fate 
(Seydoux and Greenwald 1989). 
We now know that lag-2 encodes the DSL (Delta/Serrate/LAG-2) ligand that is 
expressed in the AC and activates LIN-12/Notch, the transmembrane 
receptor/transcription factor, in the neighboring VU (Wilkinson et al. 1994).  Ligand-
dependent activation of Notch results in its cleavage, releasing the Notch intracellular 
domain to translocate to the nucleus and activate transcription of specific target genes 
(Struhl et al. 1993; Struhl and Adachi 1998).  Loss of lin-12 or lag-2 disrupts the AC/VU 
decision and specification of the VU fate, causing both Z1.ppp and Z4.aaa to adopt the 
AC fate (Greenwald et al. 1983; Lambie and Kimble 1991).  
Z1.ppp and Z4.aaa are initially competent to adopt either fate, so our lab was also 
interested in understanding how lin-12 and lag-2 are regulated during the AC/VU 
decision (Fig. 2).  Looking early, both Z1.ppp and Z4.aaa are competent to adopt either 
the AC fate or the VU fate.  Z1.ppp and Z4.aaa both express lag-2 and lin-12 (Fig, 2A, 
Wilkinson et al. 1994).  A stochastic difference in levels of LIN-12 activity is amplified 
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through positive feedback loops (Fig. 2B,C).  Activated LIN-12 directly promotes and 
increases lin-12 transcription, among other target genes (Wilkinson et al. 1994).  In the 
presumptive VU, higher LIN-12 activity results in higher lin-12 expression.  In the 
presumptive AC, however, less LIN-12 activity over time results in reduced lin-12 
expression until its expression is no longer detectable.   
The DSL ligand lag-2 is also regulated at the transcriptional level, but with the 
opposite pattern as lin-12 (Fig. 2B,C).  lag-2 is initially expressed in both Z1.ppp and 
Z4.aaa.  As the decision progresses, lag-2 transcription decreases over time in the 
presumptive VU until it is no longer detected; it remains high in the presumptive AC 
(Wilkinson et al. 1994).  Thus, transcriptional regulation during the AC/VU decision 
causes expression of lag-2 to become restricted to the AC and expression of lin-12 to 
become restricted to the VU.   
LIN-12 drives lin-12 expression, but what causes lag-2 transcription to become 
restricted to the AC? Or more broadly:   
How is the fate of the AC specified, and how is AC fate prevented in the VU? 
  hlh-2 is known to be required for AC fate and is eliminated post-transcriptionally 
from the VU (Karp and Greenwald 2003).  How hlh-2 is functioning in the AC and 
down-regulated in the VU was unknown, and is the subject of Chapter 2. 
 
2. Function and regulation of HLH-2/Daughterless/E2A in the AC 
2.1 Requirements for HLH-2 in specification and function of the AC 
The basic Helix-Loop-Helix transcription factor HLH-2 is an essential gene, due 
in part to its critical activity during embryogenesis (Krause et al. 1997).  HLH-2 is also 
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required later during gonadogenesis (Karp and Greenwald 2003; 2004).  Timed reduction 
of hlh-2 by RNA-mediated interference (RNAi) has revealed the three roles for HLH-2 in 
the anchor cell:  (1) AC competence, (2) AC specification, and (3) AC function.   
Initially, HLH-2 is required for the AC and VU precursors to be competent to 
adopt the AC fate.  L1 larvae treated with hlh-2(RNAi) develop with a 0AC defect, as 
Z1.ppp and Z4.aaa never had the choice to become an AC (Karp and Greenwald 2004).  
The 0AC defect is even observed in a lin-12(0) background, which normally has 2ACs.  
Thus hlh-2 acts upstream of lin-12 in promoting AC competence, as loss of hlh-2 causes 
lin-12-independent specification of VU fate (Karp and Greenwald 2004).  
HLH-2 is also required in the L2 larval stage for the AC/VU decision to occur and 
specify one AC and one VU.  Loss of hlh-2 in L2 larvae results in the failure of the 
AC/VU decision, giving a 2AC defect (Karp and Greenwald 2003).  This is (at least in 
part) due to the loss of expression of the DSL ligand lag-2, which is a direct 
transcriptional target of HLH-2 (Karp and Greenwald 2003).  Without expression of the 
ligand lag-2, LIN-12/Notch cannot be activated in the adjacent cell.  Since neither cell 
receives LIN-12 activity, neither adopts the VU fate, resulting in the 2AC defect.  
Lastly, HLH-2 is required in the specified AC for execution of its function.  After 
specification, the AC has several roles: inducing vulval development, inducing further 
ventral uterine development, invading the basement membrane to allow vulval-uterine 
connection to form, and fusing with the uterine seam to finish the connection between the 
gonad and the vulva.  Thus far, HLH-2 activity has been implicated in all of these 
functions (Hwang and Sternberg 2004; Karp and Greenwald 2004; Schindler and 
Sherwood 2011).  For vulval induction, HLH-2 directly activates transcription of lin-
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3/EGF.  lin-3/EGF encodes the inductive signal secreted by the AC, and it is required for 
activation of the EGFR-Ras pathway in the nearest vulval precursor cell, thus initiating 
vulval development (Hill and Sternberg 1992).   
 
2.2 Regulation of HLH-2 during the AC/VU decision 
I am interested in understanding how HLH-2 is regulated during the AC/VU 
decision.  It is clear that HLH-2 is essential for the decision to be resolved, and that HLH-
2 directly promotes the transcription of lag-2/DSL and other target genes in the AC (Fig. 
2B,C).  Previous work from our lab demonstrated that HLH-2 protein is observed only in 
the AC precursor and in the specified AC (both by antibody staining and by an hlh-2 
translational fusion reporter), but it is not observed in the VU (Karp and Greenwald 
2003).  Surprisingly, hlh-2 is transcribed in both the AC and the VU before, during, and 
after the AC/VU decision (Fig. 2C,D; Karp and Greenwald 2003).  Our lab thus 
demonstrated that hlh-2 is regulated post-transcriptionally (Karp and Greenwald 2003).  
This leads to a specific question investigated in chapter 2:  How is HLH-2 regulated 
during the AC/VU decision? 
HLH-2 could be regulated at the level of mRNA transcript stability, translation, or 
protein stability.  Chapter 2 details the progress made on this question.  Briefly, I find that 
HLH-2 is regulated post-translationally in the AC/VU decision.  It is down-regulated in 
the VU via a novel dimerization-dependent mechanism, which I expect to only be active 
in the presumptive VU.  These results indicate that HLH-2 homodimers act to promote 
AC competence, the AC/VU decision, and execution of AC fate.  Conversely, in the VU, 
HLH-2 homodimers are recognized and targeted for degradation.  This provides the 
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presumptive VU with a mechanism for eliminating HLH-2, the transcription factor that 
promotes AC fate. 
 
3. The basic Helix-Loop-Helix (bHLH) transcription factors 
3.1 Characteristics and classification of bHLH transcription factors 
 The basic Helix-Loop-Helix (bHLH) proteins form a family of 
transcription factors that are essential during the development of organisms ranging from 
plants to sponges to humans (Murre et al. 1989).  bHLH proteins have been shown to be 
required for cell fate specification and differentiation in many processes, including 
neurogenesis (Jarman et al. 1995), myogenesis (Harfe et al. 1998a), and hematopoiesis 
(Bain et al. 1994).  bHLH proteins have also been implicated in several diseases, 
including Burkitt’s lymphoma (Schmitz et al. 2012), kidney disease (Slattery et al. 2008), 
medulloblastoma (Roussel and Hatten 2011), and several carcinomas (Ruzinova and 
Benezra 2003).   
The defining feature of the family is the presence of a basic Helix-Loop-Helix 
domain, which is required for dimerization and DNA-binding (Murre et al. 1989).  The 
basic region contains several highly conserved lysines and arginines (Murre et al. 1989).  
These basic residues are required for DNA binding in vitro, but not for dimerization, as 
shown by mutation analysis of the bHLH protein E47 (Voronova and Baltimore 1990).  
The HLH region consists of two amphipathic helices connected by a loop.  Two bHLH 
proteins interact through the hydrophobic sides of their helices to form a dimer 
(Ellenberger et al. 1994).  The HLH region is required for both DNA-binding and 
dimerization, because mutation of hydrophobic residues in the HLH region disrupt 
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dimerization and DNA binding (Voronova and Baltimore 1990).  This leads to a model 
for how bHLH proteins function:  two proteins interact through their HLH regions, 
forming a dimer.  Dimerization is essential because it brings together the basic DNA-
binding regions and allows the dimer to bind to specific E box DNA target sequences, 
CANNTG (Fig. 3A; Murre et al. 1989). 
HLH proteins are generally categorized into classes, based on their dimerization 
partners, expression patterns, and bHLH protein sequences.  Class I HLH proteins are the 
E proteins (Murre et al. 1994).  They are very broadly expressed, and they can form 
heterodimers or homodimers to function (Murre et al. 1994).   
Class II HLH proteins are expressed in fewer tissues than Class I HLH proteins, 
and they are obligate heterodimers, dimerizing with E proteins to function (Murre et al. 
1994).  Examples of Class II HLH proteins include Neurogenin, Atonal, and Achaete-
scute (Massari and Murre 2000).  Class III HLH proteins are the Myc family, and Class 
IV HLH proteins can dimerize with Myc (Murre et al. 1994).  Class V HLH proteins 
negatively regulate Class I and II proteins.  These include Extramacrochaete and ID, 
which have the HLH region but lack the basic region (Benezra et al. 1990; Ellis et al. 
1990; Garrell and Modolell 1990; Murre et al. 1994).  They act dominantly, binding 
Class I and II HLH proteins thereby blocking their activity, though no class V bHLH 
proteins appear to be present in C. elegans.  Class VI HLH proteins are defined by the 
presence of a proline in their basic region, and they include Hairy and Enhancer of split 
(Murre et al. 1994).  Class VII HLH proteins are grouped based on a shared bHLH-PAS 
domain (Massari and Murre 2000). 
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The C. elegans genome has 42 genes with predicted bHLH domains.  Sequence 
homology and in vitro dimerization assays have been used to group the 42 bHLH proteins 
into the classes described above (Grove et al. 2009).  In several cases, previous studies 
had shown in vitro evidence for bHLH protein dimerization. HLH-2, the only Class I 
bHLH protein in C. elegans, is of particular interest in the AC and VU.  
 
3.2 The Class I “E proteins”:  homodimer or heterodimer 
In humans, there are four E proteins: HEB, two E2A isoforms (E12 and E47), and 
E2-2.  The only E protein in Drosophila is Daughterless, and the only E protein in C. 
elegans is HLH-2 (Fig. 3B).  Alignment of the bHLH domains of these proteins shows an 
extremely high degree of conservation.  For example, 63% of the amino acids in the 
bHLH domains of E47 and HLH-2 are identical, and several of the differences are 
conservative (Fig. 3C).  Mutational analysis and the crystal structure of the E47 
homodimer reveal several crucial residues for homodimer formation 	  
(Voronova and Baltimore 1990; Ellenberger et al. 1994), that are conserved in HLH-2. 
The human E2A gene expresses two isoforms, E12 and E47, which are identical 
except for a single alternatively spliced exon (Murre et al. 1989; Sun and Baltimore 
1991).  The different exon creates differences between the two isoforms in a short stretch 
of residues just before the bHLH domain, as well as in part of the bHLH domain.  The 
E12 isoform primarily forms heterodimers in vitro, while the E47 isoform is able to either 
homodimerize or heterodimerize.  This difference is due to the presence of an inhibitory 
domain prior to the bHLH domain in E12 that is absent from E47 (Sun and Baltimore 
1991).   
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A disulfide bond can also regulate homodimer stability.  E proteins contain a 
single cysteine in helix 1, which is conserved in HLH-2 (Fig. 3C).  E protein 
homodimerization brings the cysteine residues in each E protein close together.  A 
disulfide bond is able to spontaneously form and stabilize the homodimer (Benezra 1994).  
Surprisingly, this disulfide bond even stabilizes E12 homodimers, which are generally 
not observed in vitro.  When the cysteine is mutated, E12 can still heterodimerize, but it 
can no longer homodimerize (Benezra 1994).   
Both HLH-2 and E47 lack the E12 inhibitory domain that prevents 
homodimerization (Fig. 3C).  Additionally, previous groups have used in vitro 
electrophoretic mobility shift assays (EMSAs) to show that HLH-2 can form a 
heterodimer with various Class II partners or a homodimer (Krause et al. 1997; Harfe et 
al. 1998b; Zhang et al. 1999; Portman and Emmons 2000; Hwang and Sternberg 2004; 
Hwang et al. 2007).  Class II partners that have been shown to dimerize with HLH-2 and 
bind DNA in vitro include LIN-32/Atonal (Portman and Emmons 2000), HLH-12/TCF15 
(Tamai and Nishiwaki 2007), HLH-8/Twist (Harfe et al. 1998b), HLH-3/Achaete-Scute 
(Krause et al. 1997), and NGN-1/Neurogenin (Nakano et al. 2010).  Taken together, these 
findings suggest that HLH-2 may be more similar to E47 in its dimerization capabilities 
than to E12. 
The overall structure of the E proteins is also conserved.  They all have a long N-
terminus, with the bHLH domain toward the C-terminal end of the protein (Fig. 3B).  
Structure/function studies have identified two activation domains in the E2A N-terminus 
that are important for promoting transcription (Aronheim et al. 1993; Bain et al. 1994).  
Dimerization of the E protein E2-2 requires an additional domain that is C-terminal to the 
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bHLH domain (Goldfarb et al. 1998).  This C-terminal sequence is conserved in human E 
proteins and in HLH-2 (Fig. 3C), though it has never been functionally tested in C. 
elegans. 
 
3.3 Roles for Class I and II bHLH transcription factors during development 
bHLH proteins are essential transcription factors for many developmental 
processes in a wide array of organisms.  They are required for the specification of many 
different cell fates, as well as for the function of many specified cells.  In C. elegans, loss 
of the Class I bHLH protein HLH-2 leads to embryonic lethality (Krause et al. 1997), 
demonstrating its importance during development.  The role of HLH-2 is best 
characterized in neuronal development and in somatic gonad development.  
Several studies in C. elegans have investigated the role of some of the eighteen 
putative Class II partners of HLH-2, though much remains unknown.  See Table 1 for a 
summary of what is currently known about the Class II bHLH proteins, including their 
homologs, their biological roles, and whether they genetically or physically interact with 
hlh-2.  Of the eleven that have been studied, seven Class II bHLH genes have been shown 
to be important for the specification and / or differentiation of different types of neurons 
(Way and Chalfie 1989; Zhao and Emmons 1995; Hallam et al. 2000; Portman and 
Emmons 2000; Thellmann et al. 2003; Frank et al. 2003; Doonan et al. 2008; Nakano et 
al. 2010; Poole et al. 2011; Bertrand et al. 2011; Felton and Johnson 2014).  hlh-12 is 
required in the somatic gonad for migration of the distal tip cell (Tamai and Nishiwaki 
2007).  None have been implicated in the specification or function of the AC, though hlh-
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2 is required for the specification and function of both the AC and the distal tip cell in the 
somatic gonad (Karp and Greenwald 2003; 2004).  
Much work has been done in other model systems to understand the 
developmental role of bHLH proteins.  bHLH proteins are crucial for neural progenitor 
cell self-renewal and for their differentiation into many different cell types, including 
GABAergic neurons, glutamatergic neurons, astrocytes, and oligodendrocytes (Imayoshi 
and Kageyama 2014).  In Xenopus, Neurogenin and NeuroD promote neuronal fates 
(Hindley et al. 2012).  In mice, Neurogenin3 has been shown to regulate the specification 
of endocrine cells in the pancreas (Rukstalis and Habener 2009).  In mammalian systems, 
E proteins are required for specification of B cells (Murre 2005).   
bHLH genes are clearly important for cell fate specification during development.  
In many cases, their expression and/or activity must be coordinated with other 
developmentally important genes and signaling pathways.  I am interested in the context 
of the AC/VU decision, where high HLH-2 and low LIN-12/Notch activity promotes AC 
fate and the converse promotes VU fate.  There are several other developmental contexts 
in which bHLH proteins and Notch activity promote opposite outcomes.  Specification of 
the sensory organ precursor cells in Drosophila is one particularly interesting example, 
due to its similarity to the AC/VU decision.  
 
Specification of the Sensory Organ Precursor in Drosophila 
One particularly well-known role for bHLH proteins and Notch is in the 
development of the Drosophila peripheral nervous system (PNS).  The PNS gives rise to 
four different sensory structures: external organs, chordotonal organs, multidendritic 
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neurons, and photoreceptors.  The external sensory organs are the bristles (macrochaetae 
and microchaetae), which act as chemoreceptors and mechanoreceptors.  The chordotonal 
sensory organs are interior and act as stretch receptors. (summarized in Dambly-
Chaudière and Ghysen 1987) 
In the imaginal wing disc, the neuroectoderm will give rise to both the external 
sensory organs and the epidermis.  The spacing of these organs is highly regulated, which 
is the consequence of regulating which cells are specified as sensory organ precursors, or 
SOPs.  Each individual sensory organ consists of a neuron and support cells that derive 
from a single SOP (Ghysen and Dambly-Chaudière 1988).   
 In Drosophila, the sole Class I bHLH protein Daughterless (Da) is required for 
development of PNS sensory organs (Caudy et al. 1988).  Interestingly, multiple Class II 
partners are required for the development of specific types of sensory organs.  The bHLH 
proteins of the Achaete-Scute complex are required for the development of external 
organs, where achaete and scute are required to specify the SOP (Ghysen and Dambly-
Chaudière 1988).  The bHLH gene atonal is required to specify the cells that give rise to 
chordotonal organs, photoreceptors, and some multiple dendritic neurons (Jarman et al. 
1993; 1994).  
 The role of the Achaete-Scute Complex (AS-C) in specification of SOPs for the 
external sensory organs has been well studied.  achaete and scute are important for both 
SOP competence and SOP specification.  In the developing wing disc, small “proneural 
clusters” of cells begin to express ac and sc, giving them the competence to adopt the 
SOP fate (Romani et al. 1989; Cubas et al. 1991).  Through Notch-mediated interactions, 
only one cell in the proneural cluster is specified as the SOP, and the other cells adopt the 
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epidermal fate.  The presumptive SOP in the cluster accumulates higher levels of Ac and 
Sc (Cubas et al. 1991).  ac and sc expression is further increased through “self-
stimulation,” and ac and sc, along with EGFR/Ras activity, specifies the SOP of each 
proneural cluster (Culí and Modolell 1998; Culí et al. 2001).  Ac and Sc also promote 
delta expression in the presumptive SOP (Haenlin et al. 1994; Kunisch et al. 1994).  
Delta expression activates Notch in the neighboring cells; higher Notch activity acts cell-
autonomously to bias a cell toward epidermal fate and against SOP fate (Heitzler and 
Simpson 1991), in part by driving expression of the Class VI bHLH gene e(spl) to repress 
ac and sc expression (Bailey and Posakony 1995; Heitzler et al. 1996).  Low Notch 
activity fails to activate expression of e(spl), allowing ac and sc expression to remain 
high in the presumptive SOP.   
 The parallels between the SOP specification and the AC/VU decision are quite 
striking.  HLH-2 confers AC competence to a group of cells prior to the decision, like 
Ac-Sc promote SOP competence in the proneural cluster.  High LIN-12/Notch activity 
promotes VU fate, while high HLH-2 activity promotes AC fate.  In the fly, high Notch 
activity promotes epidermal fate and represses SOP fate, while high AS-C expression 
specifies the SOP.  HLH-2 promotes expression of lag-2/DSL, which activates LIN-12 in 
the presumptive VU.  Ac and Sc promote delta transcription, which activates Notch in the 
presumptive epidermal cells.   
 There are also interesting differences in the regulation of gene expression.  In the 
presumptive epidermal cells, Notch activity leads to a decrease in ac and sc transcription, 
thus allowing AS-C to be down-regulated in presumptive epidermal cells.  An additional 
mechanism exists to decrease Sc activity through shaggy (Yang et al. 2011), but a Sgg 
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binding site is not present in HLH-2.  By contrast, hlh-2 transcription remains in the VU 
despite high LIN-12 activity (Karp and Greenwald 2003).  However, HLH-2 protein is 
not observed in the VU and is only seen in the AC (Karp and Greenwald 2003).  This 
indicates that even though these two developmental processes show very strong 
similarities, they likely rely on different mechanisms to regulate bHLH protein 
expression in the different cell types. 
  
3.4 Post-transcriptional regulation of Class I and II bHLH proteins  
I am interested in understanding how HLH-2 is regulated during the AC/VU 
decision and, more broadly, in understanding how bHLH proteins function and are 
regulated during development.  Above, I described an example of bHLH gene regulation 
downstream of Notch activity that involved transcriptional repression of bHLH genes.  
However, bHLH genes can be regulated in many other ways as well.  HLH-2 is regulated 
post-transcriptionally during the AC/VU decision, so I focus below on post-
transcriptional mechanisms that regulate bHLH gene expression. 
In principle, there are multiple levels at which post-transcriptional regulation of 
bHLH genes can occur.  Several studies have shown that dimerization partner choice can 
alter the activity of bHLH proteins, and that post-translational modifications can alter 
their activity and/or stability.  One mechanism for negatively regulating E protein activity 
is through dimerization with the Class V HLH proteins, Id/Emc.  These proteins contain 
the HLH region but lack the basic DNA binding region.  They can dimerize with E 
proteins, and the missing basic region prevents DNA binding, thus dominantly inhibiting 
transcriptional activity of E proteins (Ellis et al. 1990; Garrell and Modolell 1990; 
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Benezra et al. 1990).  Analysis of the C. elegans genome does not reveal an HLH 
domain-containing gene without a basic region (Grove et al. 2009), indicating that worms 
likely rely on other mechanisms to regulate bHLH protein expression and activity.   
The activity of a Class II / E heterodimer can be regulated via post-translational 
modifications of the E or the Class II protein.  For example, phosphorylation of Class II 
partners has been shown to modulate the activity of the Class II / E heterodimers in flies, 
frogs, and mice (Yang et al. 2011; Hindley et al. 2012; Li et al. 2012).  Different 
phosphorylation sites on E47 can also alter its dimerization preference – heterodimer 
versus homodimer (Sloan et al. 1996; Lluís et al. 2005).   
Protein stability of E and its Class II partner can also be regulated.  In frogs, mice, 
and human cell culture, Class II proteins can be ubiquitinated and degraded (Sriuranpong 
et al. 2002; Viñals et al. 2004; Vosper et al. 2007; 2009; Nie et al. 2010; Qu et al. 2013).  
E47 protein stability is also known to be regulated in human cell culture and in mouse B 
cell precursors (Huggins et al. 1999; Nie et al. 2003; King et al. 2007). 
Until this work, no examples of differential bHLH protein stability have been 
described in C. elegans.  I find that HLH-2 protein stability is differentially regulated in 
the AC/VU decision, such that HLH-2 protein is not observed in the cell with high Notch 
activity.  Below, I describe two well-studied developmental contexts in which bHLH 
protein stability is regulated: mouse pancreas development, and B cell differentiation.  
These two examples are particularly interesting, due to the role for Notch in regulating 





Specification of endocrine cells in the mouse pancreas 
 The mouse pancreas is composed of exocrine cells and endocrine cells.  There are 
five different types of endocrine cells that are necessary for the secretion of different 
hormones, including insulin and glucagon (Rukstalis and Habener 2009).  During mouse 
pancreas development, precise regulation of Neurogenin3 (Ngn3) is essential for 
specification of the endocrine cells.  Loss of Ngn3 results in the failure to specify 
endocrine cells (Rukstalis and Habener 2009).  Overexpression of Ngn3 results in a 
reduction in endocrine cell count due to premature differentiation of endocrine precursor 
cells before they have proliferated sufficiently (Rukstalis and Habener 2009).  This 
implies that precise regulation of Ngn3 is required, as too much and too little Ngn3 both 
result in few or no endocrine cells. 
 The role for Notch is very dynamic over the course of pancreas development.  
Notch activity opposes Ngn3 and promotes maintenance and proliferation of the 
pancreatic precursor cells (Afelik and Jensen 2013).  In the early developing exocrine 
duct system, low Notch activity in the tips causes the precursors to differentiate into 
acinar cells (Afelik and Jensen 2013).  In the trunk region, high Notch / low Ngn3 
specifies the exocrine duct cells and high Ngn3 / low Notch specifies the endocrine cells.  
Dll1 (Delta-like ligand 1) transcription is driven by Ngn3 (Qu et al. 2013), and expression 
of the ligand Dll1 activates Notch in neighboring progenitors, driving them toward duct 
cell fate.  This model is supported by two additional observations:  loss of Notch activity 
or overexpression of Ngn3 leads to premature endocrine cell specification, and 
constitutive Notch activity leads to excess duct cells at the expense of endocrine and 
acinar cells (Afelik and Jensen 2013).   
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 As in SOP specification in Drosophila, Notch activity drives Hes expression, and 
Hes represses Ngn3 transcription.  However, an additional mechanism exists to regulate 
Ngn3 expression.  Ngn3 protein stability is also regulated in duct cells where Notch 
activity is high (Qu et al. 2013).  In vitro experiments show that Ngn3 protein is unstable 
and that it can be stabilized by inhibiting the proteasome (Qu et al. 2013).  Their results 
also suggest that Ngn3 protein turnover is promoted downstream of Notch transcriptional 
activity (Qu et al. 2013).  Ngn3 turnover downstream of Notch in the duct cells requires 
Fbw7, a component of an E3 ligase complex that binds Ngn3 and promotes is 
ubiquitination and turnover (Sancho et al. 2014).  It is unknown if the mechanisms 
regulating Ngn3 protein stability in the pancreas and regulating HLH-2 stability in the 
AC/VU are similar.  
 
E protein turnover in senescent B cells 
 Hematopoiesis in mammals requires precise regulation of E2A and Notch activity 
to correctly specify different cell types: B cells, T cells, natural killer cells, etc.  E2A is 
required for development of B cells and T cells (Kee 2009).  B cell precursors are 
specified in the bone marrow, while T cell precursors are specified in the thymus.  Notch 
ligands are expressed in the thymus, and they activate Notch in early T cell precursors 
(Ikawa et al. 2006).  Notch and E2A act synergistically to commit the precursors to the T-
cell lineage and to promote their differentiation (Ikawa et al. 2006).  By contrast, B cell 
precursors do not have active Notch signaling.  E2A is required for their differentiation 
from pro-B cells into pre-B cells, and then into mature B cells (Kee 2009).  Active Notch 
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in aging B cell precursors promotes E2A protein turnover and opposes B cell 
specification (Van der Put et al. 2004).   
 B cell production declines as mice age.  A comparison of young vs. aged B cell 
precursor cells revealed that young precursors have higher E2A protein levels than aged 
precursors (Van der Put et al. 2004).  This difference is due to E2A protein ubiquitination 
and degradation, and not due to transcriptional changes (Van der Put et al. 2004).  Later 
work revealed that Notch activity promotes ERK activation (Nie et al. 2003; King et al. 
2007).  ERK phosphorylates E47, which promotes its turnover by Skp2 (Nie et al. 2003; 
King et al. 2007).  In cell culture, Notch can promote Asb2 expression, and a dimeric E3 
complex consisting of Skp1/Cul1 and Asb2/Cul5 promotes E47 turnover (Nie et al. 2010).  
It is unknown if this mechanism is also relevant in vivo during B cell development.   
 Increased Notch activity promotes E protein turnover without affecting E2A 
transcription.  This is potentially quite similar to the AC/VU, where only post-
transcriptional mechanisms appear to regulate HLH-2 protein levels.  I have described 
three examples of bHLH gene regulation downstream of Notch activity:  SOP 
specification, pancreas development, and B cell precursor differentiation. 
In each of these three examples, the bHLH genes are regulated downstream of Notch 
activity through different mechanisms.  This suggests that many different mechanisms 
exist that result in a similar outcome:  high Notch activity leading to low bHLH 
expression.  Studying bHLH genes in normal developmental contexts will lead to a more 
complete understanding of the range of mechanisms that regulate bHLH genes. 
In chapter 3, I investigate how HLH-2 is differentially regulated during the 
AC/VU decision.  Briefly, I find identify a novel dimerization-dependent mechanism that 
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is required for HLH-2 to be recognized and targeted for degradation in the VU.  Thus, 
HLH-2 protein is observed in the AC and not in the VU.  This mechanism is able to 
regulate E47 stability in the VU as well, raising the possibility that this mechanism is 
conserved. 
 
4. Investigating the mechanism of HLH-2 function in Distal Tip Cells 
In addition to its role in the AC, HLH-2 is essential for the fate and function of the 
distal tip cell, or DTC.  The DTC plays critical roles in promoting gonad elongation and 
fertility.  While investigating a possible role for other bHLH proteins in the AC, I 
serendipitously discovered a novel role for the bHLH protein LIN-32 in the DTC.  Below, 
I describe what is currently known about the specification and function of DTCs in 
hermaphrodites, and about the role of bHLH proteins in these processes. 
 
4.1 Lineage and Function of the Distal Tip Cell 
 During the first larval stage, the two somatic gonad precursor cells Z1 and Z4 
undergo asymmetric divisions that give rise to Z1.aa and Z4.pp, which become the distal 
tip cells (Fig. 1; Kimble and Hirsh 1979).  As their name implies, the distal tip cells 
(DTCs) occupy the two distal ends of the gonad, with Z1.aa being anterior and Z4.pp 
being posterior (Kimble and Hirsh 1979).  The Wnt signaling pathway is required for the 
asymmetry of these early divisions.  Loss of lin-17/Frz, pop-1/TCF, or other Wnt 
pathway components causes the distal tip cells to be lost (Sternberg and Horvitz 1988; 
Siegfried and Kimble 2002; Siegfried et al. 2004).  The proximal lineage seems to be 
duplicated at the expense of the distal lineage (Siegfried and Kimble 2002; Siegfried et al. 
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2004).  Thus the Wnt pathway is required for the distal lineage to be formed and possibly 
for cells to be competent to adopt the DTC fate.  When the lineage forms normally, Z1.aa 
and Z4.pp are specified as DTCs, and they begin to carry out their leader and niche 
functions.  
The adult gonad of C. elegans hermaphrodites has a very distinctive morphology: 
two large U-shaped gonad arms, with one looping into the anterior half of the worm and 
the other looping into the posterior half (Fig. 1A).  The morphology of the gonad is 
entirely dependent upon the migration and extension that is guided by the distal tip cells 
(DTCs).  This is known as the “leader function” of the DTCs (Kimble and Hirsh 1979).  
DTC migration determines the length and shape of the gonad and the DTCs navigate the 
two sequential changes in the direction of migration:  (1) the turn from distal to dorsal, 
and then (2) the turn from dorsal to proximal (Fig. 4A; Kimble and Hirsh 1979).  Loss of 
the DTCs either genetically or by ablation causes gonad elongation to fail and the U-
shaped arms do not form (Kimble 1981).  
The DTCs are also required for the fertility of the adult.  The DTCs express the 
DSL ligand lag-2 (Henderson et al. 1994), which activates GLP-1/Notch activity in the 
adjacent germ cells (Austin and Kimble 1987).  GLP-1 is the other worm ortholog of 
Notch (Yochem and Greenwald 1989).  The DTCs have long processes that can contact 
many germ cells (Fitzgerald and Greenwald 1995).  LAG-2 in the DTCs activates GLP-1 
in germ cells, promoting mitosis and thus driving germline proliferation (Austin and 
Kimble 1987).  This role in promoting germline proliferation is referred to as the “niche 
function” of the DTCs (Lam et al. 2006).  Loss of DTCs results in loss of germline 
proliferation, which causes hermaphrodites to be sterile (Kimble 1981).  
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4.2 basic Helix-Loop-Helix proteins in the Distal Tip Cell 
Karp and Greenwald first established the importance of HLH-2 in specification of 
hermaphrodite DTCs (Karp and Greenwald 2004).  hlh-2 is required for embryonic 
development (Krause et al. 1997), so RNA-mediated interference (RNAi) was used to 
knock down hlh-2 post-embryonically in L1 larvae.  The hlh-2(L1-RNAi) hermaphrodites 
are able to develop to adulthood, but they are sterile because DTC specification fails 
(Karp and Greenwald 2004).  Unlike the Wnt pathway mutants, the lineage of hlh-
2(RNAi) larvae is normal.  Z1 and Z4 divide asymmetrically in the normal pattern (Fig. 
1B; Karp and Greenwald 2004).  This indicates that hlh-2 is required for DTC 
specification, rather than for formation of the DTC lineage.  In addition, ectopic 
expression of HLH-2 causes additional DTCs to be specified (Karp and Greenwald 2004).  
Thus hlh-2 is required and sufficient to specify DTC fate.  The dimerization partner(s) of 
HLH-2 in DTC specification has not been identified. 
The bHLH protein HLH-12 (also called MIG-24) promotes the leader function in 
DTCs and in male LCs.  HLH-12 is an ortholog of TCF15, and as a Class II bHLH 
protein, it forms a heterodimer with HLH-2 in order to bind DNA (Tamai and Nishiwaki 
2007).  Either loss of hlh-12 or loss of hlh-2 results in a highly penetrant migration defect 
in DTCs (Karp and Greenwald 2004; Tamai and Nishiwaki 2007).  Rescue experiments 
show that hlh-12 functions cell-autonomously in the DTC, and that it functions in part by 
directly promoting the expression of the ADAMTS metalloprotease gon-1 (Tamai and 
Nishiwaki 2007).  Surprisingly, a hypomorphic hlh-2 allele is able to enhance the 
migration defect of hlh-12(0) (Tamai and Nishiwaki 2007).  This indicates that HLH-2 
may have additional partners in promoting DTC leader function. 
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hlh-2 has also been implicated in promoting the niche function of the DTC.  Both 
lag-2 expression in the DTC and the number of mitotic germ cells are dependent on hlh-2 
(Chesney et al. 2009).  There are 18 potential Class II HLH partners with which HLH-2 
could heterodimerize, or HLH-2 could homodimerize (Krause et al. 1997; Harfe et al. 
1998b; Zhang et al. 1999; Portman and Emmons 2000; Hwang and Sternberg 2004; 
Hwang et al. 2007; Grove et al. 2009).  However, it is not known how HLH-2 promotes 
the specification and the niche function of DTCs.  In chapter 3, I address the following 
question:  How does HLH-2 specify the fate of the distal tip cell? 
Briefly, I uncovered a role for lin-32/atonal and hlh-12 in DTC specification, and 
a later role for lin-32 in DTC migration.  An RNAi screen identified lin-32 as important 
for DTC specification.  lin-32(0) hermaphrodites have a partially penetrant DTC turning 
defect.  hlh-12(0) hermaphrodites fail to elongate the gonad (Tamai and Nishiwaki 2007).  
Loss of lin-32 or hlh-12 alone shows no DTC specification defect.  However, I show that 
hlh-12(0); lin-32(0) hermaphrodites have a highly penetrant DTC specification defect.  
Both lin-32 and hlh-12 are expressed in DTCs around the time that they are specified, 
consistent with a cell-autonomous role for lin-32 in DTC specification.  These results 
suggest that HLH-12 and LIN-32 are functionally redundant partners of HLH-2 to specify 



















Figure 1.  The hermaphrodite gonad develops over the course of four larval stages.  (A) 
The timing of different developmental events is indicated (left).  The axes of the gonad 
(proximal/distal, anterior/posterior, dorsal/ventral) are indicated with arrows.  L1 larvae 
hatch with two somatic cells, Z1 and Z4.  During the L1, those cells begin dividing and 
give rise to 12 somatic cells around the L1 molt.  The somatic cells rearrange and the α 
cells (green) undergo the AC/VU decision during the L2, while the germ cells (white) 
proliferate and the distal tip cells (DTCs, red) guide distal gonad elongation.  After the 
anchor cell (AC, yellow) is specified, it induces vulval development in the early L3 stage 
and uterine cells divide and develop.  The DTCs make two turns to create two U-shaped 
gonad arms, and vulval invagination begins soon after the DTCs turn.  (B) The lineage of 
the α cells and β cells (the sisters of the α cells) is shown from Z1 and Z4.  All of these 
divisions occur between the mid-L1 stage and early L2 stage.  Branch points in the 
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Figure 2.  hlh-2 is required during the lin-12/Notch-mediated AC/VU decision.  (A) The 
two α cells Z1.ppp and Z4.aaa are depicted.  They are initially both competent to adopt 
either the anchor cell (AC) or the ventral uterine precursor (VU) fate, and both express 
lin-12/Notch, lag-2/DSL, and hlh-2/E2A transcripts and protein.  (B) A stochastic 
difference causes one cell to have higher LIN-12 activity.  Positive lin-12 auto-regulation 
amplifies the difference (Wilkinson et al. 1994), promoting lin-12 expression and VU fate 
in the presumptive VU.  In the presumptive AC, HLH-2 protein promotes AC fate, in part 
by driving expression of lag-2, the ligand for LIN-12.  The lack of HLH-2 protein leads 
to loss of lag-2 expression in the presumptive VU.  (C) These feedback loops lead to the 
cells being committed to their fates.  (D) Surprisingly, HLH-2 protein is only observed in 
the (presumptive) AC, though its transcription remains high in the VU (Karp and 
Greenwald 2003). 











































Figure 3.  Class I bHLH proteins are conserved and function as dimers.  (A) basic Helix-
Loop-Helix (bHLH) proteins are obligate dimers.  Class I bHLH proteins, or “E” proteins, 
homodimerize or heterodimerize with Class II bHLH proteins through the HLH region 
(half circle).  This brings together the basic DNA-binding regions (black L-shaped hooks).  
The dimer can then bind to E box target DNA sequences (CANNTG) and activate gene 
expression.  (B) A stick-figure representation of HLH-2 protein shows the bHLH domain 
is close to the C-terminus.  The basic region (black) is required for DNA-binding and the 
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Hsa-E12   522 KAPRARTSPDEDEDDLLPPEQKAERE!
Hsa-E47   522 KAPRARTSS---TDEVLSLEEKDLRD!





Hsa-E12   KERRVANNARERLRVRDINEAFKELGRMCQLHLN-SEKPQTKLLILHQAVSVILNLEQQ!
Hsa-E47   RERRMANNARERVRVRDINEAFRELGRMCQMHLK-SDKAQTKLLILQQAVQVILGLEQQ!
           :**  ******:******.**:******  * : ::: **** **::** **  **:*   !
!
Cel-HLH-2 VRQRNMNPKVMAGMKRKPDDDKMKMLDDNAPSAQFGHPRF---------- 399 !
Cbn-HLH-2 VRQRNMNPKAMVGMKRKTESDK---LEEN---AQFGHPRFQ--------- 401 !
Cre-HLH-2 VRQRNMNPKAMVGMKRKTEAEK---IEENAAAAQFGHPRF---------- 394 !
Hsa-E12   VRERNLNPKAAC-LKRREEEKVSGVVGDPQMVLSAPHPGLSEAHNPAGHM 654 !
Hsa-E47   VRERNLNPKAAC-LKRREEEKVSGVVGDPQMVLSAPHPGLSEAHNPAGHM 651                 !
          **:**:***.   :**: : .    : :     .  ** :          !
!
Helix 1 Loop Helix 2 basic 







HLH region (tan) is required for dimerization.  (C) An alignment of the bHLH domain 
and flanking sequences of C. elegans HLH-2 with two other nematode HLH-2 sequences 
and the two isoforms (E12, E47) of the human ortholog E2A shows a high degree of 
conservation.  Asterisks mark identical residues, a colon marks strongly similar residues, 
and a period marks similar residues, as assigned by EMBL-EBI ClustalW2 alignment 
analysis.  The white box marks the basic region, the two gold boxes mark the helices, and 
the pale gold box marks the loop.  The blue box marks Domain C (Goldfarb et al. 1998) 


















Figure 4.  Distal tip cells (DTCs) have two key functions during gonadogenesis.  (A) The 
leader function of the DTC is to promote and direct gonad elongation.  The DTC (red 
moon shape) promotes outward growth of the gonad and guides its elongation path.  First, 
there is outward extension.  Then, the DTCs turn and migrate to the dorsal side (first turn).  
They then make a second proximal turn and migrate toward the middle of the worm 
along the dorsal side.  This creates two U-shaped gonad arms, one anterior and one 
posterior to the developing vulva (marked by asterisk).  (B) The niche function of the 
DTC is to promote germline mitosis.  DTCs (red) express the DSL ligand lag-2.  LAG-2 
protein is localized to the long DTC processes that extend along much of the mitotic zone.  
LAG-2 activates GLP-1/Notch in the germ cells (white), and GLP-1 activity promotes 
mitosis.  (C) A wider view of the distal gonad shows that once germ cells exit the mitotic 
zone, they lose contact with the LAG-2-expressing DTC.  GLP-1 is no longer activated 
and the cells begin to undergo meiosis.  This is called the niche function of the DTC, 
where the DTC promotes germ cell proliferation through activating GLP-1 to promote 

























Table 1.  Class II bHLH transcription factors in C. elegans 
 
a   The bHLH family or ortholog is based on bHLH domain sequence (Grove et al., 2009). 
b  The hlh-10 ortholog is unclear. 
c  I looked for genetic evidence that hlh-2 is also required for the same biological role as the class II gene.  
In many cases, a role for hlh-2 was not determined (n.d., gray text). 
d  I looked for in vitro evidence for bHLH protein binding HLH-2.  Assays for binding include an 
electrophoretic mobility shift assay (EMSA), a protein binding microarray (PBM), and a yeast two-hybrid 




1 (Krause et al. 1997)   9 (Tamai and Nishiwaki 2007)  17 (Hallam et al. 2000)    
2 (Thellmann et al. 2003)  10 (Simmer et al. 2003)  18 (Zhao and Emmons 1995)   
3 (Doonan et al. 2008)  11 (Frank et al. 2003)   19 (Portman and Emmons 2000) 
4 (Grove et al. 2009)   12 (Poole et al. 2011)   20 (Nakano et al. 2010) 
5 (Smit et al. 2008)   13 (Bertrand et al. 2011)   
6 (Harfe et al. 1998b)   14 (Felton and Johnson 2014)   
7 (Corsi et al. 2000)   15 (Yoshimura et al. 2008) 
8 (Nguyen et al. 2001)  16 (Mathies et al. 2003) 







cnd-1 NeuroD VNC motor neuron specification and differentiation no Y2H, PBM 
yes            
(gk718) 4, 17 
hlh-3 Ac-Sc NSM sister apoptosis, HSN differentiation yes EMSA 
yes       
(tm1688) 1, 2, 3 
hlh-4 Ac-Sc unknown n.d. Y2H, PBM yes             (tm604) 4 
hlh-6 Ac-Sc pharyngeal glands no Y2H yes         (tm299) 4, 5 
hlh-8 Twist vulval, anal depressor muscles indirect EMSA yes         (nr2061) 6, 7 
hlh-10 Atonal, ABF1b unknown n.d. Y2H, PBM, EMSA 
yes                 
(ok516) 4, 8 
hlh-12 TCF15 DTC migration yes EMSA yes           (tk68) 9 
hlh-13 Fer2 Unc, Larval arrest - GW screen no none (Y2H) yes      (tm2279) 10 
hlh-14 Ac-Sc neuroblast specification yes PBM no           (tm295) 4, 11, 12 
hlh-15 NHLH1 unknown n.d. Y2H, PBM yes      (tm1824) 4 
hlh-16 Olig-related AIY axon outgrowth indirect none (Y2H) no         (tm3612) 13 
hlh-17 Olig-related Regulation of dopamine-related behavior no none (Y2H) 
yes         
(ns204) 14 
hlh-19 Hand unknown n.d. Y2H, PBM yes        (tm3105) 4 
hlh-31 Olig-related unknown n.d. none (Y2H) yes            (ns217) 15 
hlh-32 Olig-related unknown n.d. none (Y2H) yes            (ns223) 15 
hnd-1 Hand SGP maintenance no Y2H yes          (tm280) 4, 16 
lin-32 Atonal male ray development (ray precursor specification) yes EMSA 
yes        
(tm1446) 18, 19 



























 The bHLH transcription factor HLH-2/E2A has distinct roles during somatic 
gonad development.  hlh-2 is required to endow two α cells with the potential to become 
an Anchor Cell (AC), for the cell-cell interactions that specify the two α cells as an AC 
and a Ventral Uterine precursor cell (VU), and for the function of the specified AC.  
Previous work has shown that hlh-2 is post-transcriptionally regulated during the 
specification of the α cells, called the “AC/VU decision.”  HLH-2 protein is observed 
solely in the AC, though hlh-2 transcription is observed in the AC and VU (Karp and 
Greenwald 2003).  Here, I find that HLH-2 protein stability is differentially regulated in 
the AC and VU.  Structure/function analysis of HLH-2 reveals that dimerization is 
required for its down-regulation in the VU.  Phenotypic and expression analysis suggests 
that HLH-2 homodimers function in the AC, and are targeted for degradation in the VU.  
The human ortholog E2A can rescue an hlh-2 mutant and is also down-regulated in the 
VU through dimerization.  Since E2A and HLH-2 seem to be regulated by the same 
mechanism, I propose that dimerization-dependent mechanism for HLH-2 degradation 
may be a conserved mode of bHLH protein regulation. 
 
INTRODUCTION 
Basic Helix-Loop-Helix (bHLH) proteins comprise a highly conserved family of 
transcription factors that is essential during metazoan development (Massari and Murre 
2000; Ledent et al. 2002).  E proteins, or Class I bHLH proteins, are a subset of this 
family, and loss of E proteins is lethal in C. elegans (Krause et al. 1997), in Drosophila 
(Cronmiller and Cline 1987), and in mammals (Zhuang et al. 1996).  They are obligate 
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dimers, forming either homodimers or heterodimers with Class II bHLH proteins in order 
to bind DNA (Voronova and Baltimore 1990; Massari and Murre 2000).  The dimer 
composition provides DNA binding specificity for the transcriptional activation of target 
genes (Chien et al. 1996; Grove et al. 2009). 
E proteins and their dimerization partners are required for specification and 
function of many cell types in a wide array of animals.  They are required for 
hematopoiesis, as no B cells are produced in E2A(-/-) mice (Bain et al. 1994; Zhuang et al. 
1994).  Heart and pancreatic development also depend on the activity of Class II bHLH 
proteins:  Hand for proper development of the heart (Srivastava et al. 1995), and NeuroD 
and Neurogenin3 for the specification of endocrine cells in the pancreas (Naya et al. 
1997; Gradwohl et al. 2000).  E proteins also regulate neurogenesis; for example, in 
Drosophila, specification of neural progenitor cells requires the E protein Daughterless 
(Da) and the Da dimerization partners Achaete, Scute, and Atonal (Caudy et al. 1988; 
Ghysen and Dambly-Chaudière 1988; Jarman et al. 1993). 
Ectopic expression of bHLH proteins is frequently sufficient to change cell fates 
as well.  Ectopic Ngn3 expression promotes ductal fate in the mouse pancreas by 
promoting Dll1/DSL expression, which constitutively activates Notch (Qu et al. 2013).  
In flies, overexpression of Twist leads to ectopic muscle formation (Castanon et al. 2001).  
Ectopic HLH-1/MyoD expression promotes ectopic muscle cell fate in C. elegans 
(Fukushige and Krause 2005).  Loss of ID proteins, which are negative regulators of E 
protein activity, can also cause defects in cell fate specification, presumably due to 
aberrant elevated E protein activity.  For example, loss of Id2 leads to a lack of natural 
killer cells and loss of Id3 perturbs thymocyte development in mammals (Murre 2005).  
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Dysregulation of E proteins has been implicated in disease as well. High E47 
activity has been associated with Burkitt’s lymphoma (Schmitz et al. 2012).  Conversely, 
low E protein activity is found in astrocytic tumors (Ruzinova and Benezra 2003) and in 
colorectal cancer (Zhao et al. 2013; Huang et al. 2014).  In the mouse model, loss of E47 
causes T cell lymphomas to develop (Murre 2005).  This demonstrates the importance of 
understanding the many mechanisms cells use to regulate E protein expression and 
activity.  Here, I investigate how the C. elegans E protein HLH-2 is down-regulated 
during a classic cell fate decision, the AC/VU decision. 
The nematode C. elegans has a single E protein ortholog, HLH-2, and it is 
essential for embryogenesis (Krause et al. 1997), neuroblast specification (Frank et al. 
2003; Nakano et al. 2010; Poole et al. 2011), execution of neuronal fate (Doonan et al. 
2008), and male ray development (Portman and Emmons 2000).  During somatic gonad 
development, HLH-2 is also required to specify the anchor cell (Karp and Greenwald 
2003; 2004), a signaling hub that directs vulval and uterine development (Kimble 1981).  
HLH-2 has previously been shown to be post-transcriptionally regulated in 
gonadogenesis during the naturally variable Anchor Cell / Ventral Uterine precursor cell 
(AC/VU) decision (Karp and Greenwald 2003).  Around the time of the first larval molt, 
four somatic cells are born and HLH-2 endows them with the potential to adopt either of 
two fates:  AC or VU (Kimble and Hirsh 1979; Kimble 1981; Seydoux et al. 1990; Karp 
and Greenwald 2004).  The distal sisters Z1.ppa and Z4.aap become committed to the VU 
fate very quickly. These “β cells” always become VUs, which distinguishes them from 
their sisters, the “α cells” Z1.ppp and Z4.aaa.  The α cells can remain competent to adopt 
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either fate through much of the second larval stage, and their fates are specified by the 
AC/VU decision.  
LIN-12/Notch activity mediates the AC/VU decision, a classic example of lateral 
specification.  The α cells initially both express lin-12/Notch, lag-2/DSL, and hlh-2/E2A 
(Fig. 1A).  A stochastic difference between the α cells creates a difference in levels of 
LIN-12 activity.  This difference is amplified through positive feedback loops, resulting 
in one AC and a VU (Fig. 1A) (Kimble 1981; Greenwald et al. 1983; Seydoux and 
Greenwald 1989).  Higher LIN-12 activity in the presumptive VU results in higher lin-12 
transcription through positive auto-regulation.  Conversely, lin-12 expression decreases 
as LIN-12 activity in the presumptive AC decreases.  In the presumptive AC, HLH-2 
drives transcription of lag-2 and promotes AC fate.  HLH-2 is down-regulated in the VU, 
which leads to the loss of lag-2 expression (Karp and Greenwald 2003).  
HLH-2 is required for the AC/VU decision, because loss of hlh-2 leads to the loss 
of lag-2 expression, its direct transcriptional target (Karp and Greenwald 2003).  Like 
loss of lag-2 or lin-12, loss of hlh-2 causes LIN-12/Notch signaling between the α cells to 
be disrupted and the decision fails, resulting in the specification of two ACs (Karp and 
Greenwald 2003).  Unlike lin-12 and lag-2, HLH-2 is post-transcriptionally regulated 
during the AC/VU decision.  hlh-2 transcription remains high in both the AC and in the 
VU after the decision, but HLH-2 protein is only observed in the AC, by antibody 
staining and transgenic reporters (Karp and Greenwald 2003).  An unknown mechanism 
regulates the differential expression of HLH-2 in the AC and VU.  
Here I investigate the function and regulation of HLH-2 during the AC/VU 
decision.  I find that HLH-2 protein is post-translationally down-regulated in the VU, and 
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that this occurs through a novel dimerization-dependent mechanism.  Additionally, these 
data suggest that HLH-2 homodimerizes in the AC to promote AC competence, the 
AC/VU decision, and AC function, and that HLH-2 homodimers are recognized and 
targeted for down-regulation in the VU.  E47, a human homolog of HLH-2, rescues the 
gonad defects of an hlh-2 hypomorphic allele and is also subject to post-translational 
down-regulation in the VU.  The dimerization-dependent down-regulation of E47 
indicates that the protein sequence or structure required for HLH-2 down-regulation in 
the VU is conserved in the human ortholog.  This allows the speculation that the 
mechanism for E protein down-regulation may be conserved. 
 
MATERIALS AND METHODS 
C. elegans Genetics 
Strains were grown and maintained under standard conditions at 15°C or 20°C (Brenner 
1974), unless otherwise stated.  All strains carrying extrachromosomal arrays rescuing 
pha-1(e2123ts) were maintained at 20°C and shifted to 25°C for experiments.  The 
following alleles and transgenes were used in this study:  LGI: hlh-2(bx108ts), hlh-
2(tm1768); LGIII: pha-1(e2123ts); LGIV: arIs51[cdh-3p::gfp]; LGV: arIs222[lag-
2p::2xnls-tagrfp]; LGX: nre-1(hd20) lin-15b(hd126).  The transgene arIs51 is described 
(Karp and Greenwald 2003), and the transgene arIs222 is described below.  See 







hlh-2(5.2kb)p::gfp::unc-54 3’UTR (pMS2):  The 5.2kb hlh-2 promoter contains the 
5253bp directly upstream of the translational ATG start site of hlh-2.  This promoter was 
subcloned from GS#p683 into pPD95.75 using BamHI and KpnI to create pMS2.  
hlh-2prox::gfp::unc-54 UTR (pMS80):  The hlh-2prox enhancer element was subcloned 
from pMS2 and inserted into pPD95.75 using HindIII, creating pMS80. 
hlh-2prox::gfp-hlh-2::unc-54 UTR (pMS84):  I used Accuprime Pfx DNA Polymerase 
(Invitrogen) to PCR amplify GFP from pPD95.75 and hlh-2 cDNA from GS#p683, and I 
used PCR fusion to create KpnI-gfp-hlh-2 cDNA-BsiWI (Hobert 2002).  This was 
subcloned into pMS80 using KpnI and BsiWI sites.  The unc-54 3’UTR was amplified 
from pMS80 with BsiWI sites and subcloned into the BsiWI site at the 3’ end of the hlh-2 
cDNA, creating pMS84. 
hlh-2prox::gfp::hlh-2 cDNA (variations)::unc-54 UTR:  I made several variations of this 
plasmid, and of a second version of this plasmid with the BsiWI site that sits 3’ to the 
unc-54 UTR mutated (pMS111).  I used PCR fusion to create GFP-tagged, truncated 
forms of hlh-2 cDNA.  These PCRs were subcloned into either pMS80 or pMS111 to 
generate plasmids used for injection.  HLH-2 point mutations were generated in pMS111 
using the QuikChange II XL Site-Directed Mutagenesis kit (Agilent). 
hlh-2prox::gfp::e47 cDNA::unc-54 UTR (pMS130): E2A (E47 isoform) cDNA was 
amplified from pCR4-TCF3_5 ( a generous gift from David Dominguez-Sola).  Cloning 
involved two steps due to the presence of a BsiWI restriction site in E47 cDNA.  I used 
PCR fusion to create GFP-tagged 5’E47 cDNA fusion, and this was subcloned into 
pMS111 with KpnI and the E47 BsiWI site to make an intermediate plasmid.  The 3’E47 
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cDNA fragment was PCR amplified and subcloned into the intermediate plasmid using 
BsiWI, creating pMS130.  Mutated versions were made using site-directed mutagenesis, 
as described above. 
lin-3(ACEL)::4xnls-gfp (pMS177):  The lin-3(ACEL) was identified by Hwang and 
Sternberg (2004), and it contains two CAGGTG E-boxes.  I designate the wild-type 
ACEL as lin-3(ACEL[GG]) to emphasize that the variable “NN” position in the 
CANNTG E box is “GG.”  I designed complementary oligomers that contained the wild-
type lin-3(ACEL[GG]) sequence and created HindIII and XbaI sites when annealed.  This 
was then cloned into the pPD122.53 Fire vector.  I used different oligomers to create lin-
3(ACEL[TA])::4xnls-gfp (pMS179), which has the E boxes mutated from CAGGTG to 
CATATG, using the same strategy to generate pMS179. 
 lag-2(7.2kb)p::2xnls-tagrfp::unc-54 UTR (pMS102): GS#p847 contains the 7162 bp lag-
2 promoter immediately upstream of the lag-2 translational start site.  I used KpnI and 
BsiWI sites to subclone 2xnls-tagrfp::unc-54 3’UTR from pMS35 into GS#p847, creating 
pMS102. 
hlh-2prox::gfp-hlh-2 cDNA::unc-54 UTR (pMS175):  gfp-hlh-2 cDNA::unc-54 UTR was 
PCR amplified from pMS111 with AflII and SpeI restriction sites added.  The digested 
PCR product was inserted into pCFJ910.  hlh-2prox was PCR-amplified from pMS111 
with SbfI restriction sites flanking it and added into the intermediate plasmid pCFJ910 + 
gfp-hlh-2 cDNA::unc-54 UTR (pMS174).  This generated the final product hlh-
2prox::gfp-hlh-2 cDNA::unc-54 UTR (pMS175).  All PCR-amplified regions were 
sequenced to ensure that no mutations were introduced.  




Generation of hlh-2prox::[cDNA insert]::unc-54 UTR transgenic lines: I injected three 
linearized plasmids - a pMS plasmid, pBX (pha-1(+)), and pCW2.1 (ceh-22::gfp) - at 1 
ng/µL, along with PvuII-digested N2 genomic DNA at 50 ng/µL into pha-1(e2123ts) P0 
adults.  Injected P0 worms were kept at 15°C for three days before shifting them to 22°C, 
the restrictive temperature for embryonic lethality of pha-1(e2123ts).  F2 worms were 
picked to establish multiple independent transgenic lines (a maximum of one transgenic 
line per injected P0).  All extrachromosomal arrays that rescue pha-1(e2123ts) were 
isolated and maintained in this way. 
Generation of bHLH translational reporter lines:  These lines were generated similarly, 
but with different linearized DNAs.  GFP-tagged fosmids were received from the 
TransgeneOme project (Sarov et al. 2012).  YFP-tagged fosmids were generous gifts 
from the Hobert lab.  Linearized fosmids were injected at 15 ng/µL with pBX (pha-1(+)) 
at 1 ng/µL, pJL17 (ttx-3p::mCherry) at 2 ng/µL, and sheared genomic OP50 DNA at 75 
ng/µL into pha-1(e2123ts).  The plasmid pSN349 (ngn-1p::ngn-1-gfp) from Nakano and 
Horvitz (2010) is smaller than the fosmids, so it was injected at 7.5 ng/µL with pBX 
(pha-1(+)) at 1 ng/µL, pJL17 (ttx-3p::mCherry) at 2 ng/µL, and sheared genomic OP50 
DNA at 75 ng/µL into pha-1(e2123ts).  
Generation of lin-3(ACEL)::4xnls-gfp lines:  The wild-type lin-3(ACEL[GG]) and 
mutant lin-3(ACEL[TA]) constructs were injected as previously described (Hwang and 
Sternberg 2004).  Briefly, we generated simple arrays, injecting lin-3(ACEL) plasmids at 
100 ng/µL and pBX at 50 ng/µL into pha-1(e2123ts). 
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Generation of arIs222[lag-2p::tagRFP]:  The plasmid pMS102(lag-2(7.2kb)p::2xnls-
tagRFP::unc-54 UTR) was injected at 2 ng/µL along with pCW2.1(ceh-22p::gfp) and 
pMH86(dpy-20(+)) at 1 ng/µL into dpy-20(e1282ts) to generate the extrachromosomal 
array arEx1777.  The arIs222 integrant was generated after gamma irradiation of 
arEx1777 in the dpy-20(e1282ts) background, using standard procedures (Mello and Fire 
1995).  arIs222 was outcrossed to N2 six times prior to its use in strain construction. 
Generation of arTi3[hlh-2prox::gfp-hlh-2 cDNA]:  The injection protocol followed is 
based on the published protocol (Frøkjær-Jensen et al. 2014).  Plasmids were injected as 
follows: pMS175(hlh-2prox::gfp-hlh-2 cDNA) at 10 ng/µL, pGH8 (rab-
3p::mCherry::unc-54 UTR) at ng/µL, pCFJ90 (myo-2p::mCherry::unc-54 UTR) at ng/µL, 
pCFJ104 (myo-3p::mCherry::unc-54 UTR) at ng/µL, pCFJ601 (eft-3p::mos1 
transposase::tbb-2 UTR) at ng/µL, and pMA122 (hsp16.41p::peel-1::tbb-2 UTR) at 
ng/µL.  Plasmids were injected into 20 N2 hermaphrodites.  After four hours at room 
temperature, hermaphrodites were shifted to 25°C for three days.  G418 was added to 
NGM plates with a final concentration of 0.78 mg/mL as a selection for NeoR resistance, 
which would be conferred by pMS175.  This differs from the standard protocol (Frøkjær-
Jensen et al. 2014), but has been shown to be a high enough concentration to cause 
lethality (Giordano-Santini et al. 2010).  Once starved, plates were heat-shocked in a 
33°C water bath for two hours and allowed to recover at 20°C.  One plate showed a 
successful insertion of the miniMos transgene, as assessed by survival on G418 antibiotic 





Scoring of Transgene Expression 
Gravid adults were transferred to plates and kept at 25°C.  Two days later, mid-L2 to 
early L3 worms were scored for GFP expression in the AC and VU.  Worms were 
mounted on 2% agarose pads on a slide and immobilized with 10 mM levamisole in M9.  
GFP expression was analyzed using the 63X objective of a Zeiss Axio Imager D1 
microscope and a Zeiss AxioCam MRm camera.  Expression at a 400 ms GFP exposure 
time was scored as “ON.” 
 
Scoring rescue of hlh-2(bx108ts) 
To test the function of different transgenic HLH-2 constructs, I assess their ability to 
rescue the abnormally everted vulva (Evl) and AC number defects of hlh-2(bx108ts).  I 
selected for retention of extrachromosomal arrays by keeping pha-1(e2123ts) in the 
background.  Worm embryos were collected by treating gravid hermaphrodites with a 
bleach / sodium hydroxide solution, washed with M9, and placed on NGM plates with 
OP50.  The plates were kept at 25°C for four days, and adult hermaphrodites were scored 
for the Evl defect on a dissecting microscope.  At 25°C, the Evl defect is highly penetrant.  
 
RNA interference 
RNA interference (RNAi) was administered through feeding worms bacteria expressing 
double-stranded RNA specific to a single gene.  RNAi clones for 30 of the 41 bHLH 
genes (excluding hlh-2) were obtained from the Ahringer RNAi library (Kamath et al. 
2003), and verified by sequencing.  The remaining 11 RNAi clones were made by PCR-
amplifying either the complete or partial genomic locus and subcloning it into L4440.  
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See Suppl. Table 2 for the plasmids made and used.  Plasmids were then transformed into 
HT115 bacteria for RNAi feeding. 
Bacterial cultures were grown overnight at 37°C in 2xYT with ampicillin at 50 µg/mL.  I 
added 75 µL of bacterial culture to RNAi feeding plates, which are NGM plates prepared 
with 6 mM IPTG and 100 µg/mL carbenicillin.  Worm embryos were collected by 
treating gravid hermaphrodites with a bleach / sodium hydroxide solution, washed with 
M9, and distributed to RNAi plates 4-6 hours later.  The plates were placed at 22°C (for 
scoring AC number) or 25°C (for scoring vulval induction) for approximately 40 hours, 
allowing worms to hatch and reach the L3 and L4 larval stage.  Animals were mounted 
on slides and examined using the 63x objective of the same microscope as above.  RNAi 
targeting lacZ was used as a negative control and RNAi targeting either lin-12 (for 
scoring AC number) or lin-3 (for scoring vulval induction) was used as a positive control 
for every experiment.  
AC number defects were scored by morphology and expression of the AC marker 
arIs51[cdh-3p::gfp].  Vulval induction defects were scored by morphology and by 
expression of arIs222[lag-2p::rfp], a marker of primary vulval fate.  Induction was 
scored as “failed” when the distal tip cells had reflexed but there was no evidence of 
vulval invagination or lag-2p::rfp expression.  The hypomorphic hlh-2(bx108ts) allele 
was used to sensitize the strain to possible redundancy of HLH-2 dimerization partners in 
AC competence, the AC/VU decision, and AC function.  nre-1(hd20), lin-15b(hd126) 
was used to increase the sensitivity of somatic tissues to RNAi. 
I counted the number of cells expressing arTi3[hlh-2prox::gfp-hlh-2], with cells scored as 
“GFP+” or “GFP-” by eye.  Eggs were placed on RNAi plates at 25°C, and The number 
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of GFP+ cells was assessed approximately 30 hours later in mid-L2 larvae.  Animals 
were mounted on slides and examined using the 40x objective of the same microscope as 
above.  RNAi targeting lacZ was used as a negative control and RNAi targeting lin-12 
(for scoring AC number) was used as a positive control.  nre-1(hd20), lin-15b(hd126) 
was used to increase the sensitivity of somatic tissues to RNAi. 
 
RESULTS 
HLH-2 protein stability is differentially regulated in the AC and the VU. 
 hlh-2 is post-transcriptionally regulated, such that HLH-2 protein is stably 
expressed in the presumptive AC, but not in the VU where it is also transcribed (Karp 
and Greenwald 2003).  To assess whether this regulation occurs at the level of the hlh-2 
transcript or HLH-2 protein, a translational GFP-HLH-2(cDNA) reporter was compared 
to a GFP transcriptional reporter.  
To find an appropriate promoter for this assay, I first performed a deletion 
analysis of the hlh-2 promoter and identified an element approximately five kilobases 
upstream of the hlh-2 transcriptional start site (from -5253 to -4927, relative to the 
translational start site) that is required and sufficient for expression in the α cells (the 
AC/VU precursor cells) and the β cells from their birth through the AC/VU decision 
(Suppl. Fig. 1; Appendix section 2).  This small hlh-2 enhancer element is very specific 
and does not show obvious expression elsewhere, thus avoiding potential pleiotropic 
effects from HLH-2 overexpression while still using part of its endogenous promoter to 
drive expression of the GFP-tagged proteins (Fig. 1B).  
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I used this specific enhancer element, hereafter called hlh-2prox, to drive 
expression of GFP and GFP-HLH-2, and then examined the pattern of expression of 
several independent transgenic lines.  Both the transcriptional reporter and the 
translational reporter are expressed in the late L1 / early L2 in the α cells (Fig. 1C, D).  
The transcriptional GFP reporter is also brightly expressed later in the AC and the VU 
(Fig. 1E).  The VUs derived from the β cells also express GFP (Fig. 1E, gray arrows), but 
I focus here on the αVU (white arrow).  Expression in the βVU cells was also scored, and 
the data is shown in supplementary figures (Suppl. Fig. 3,4).  The translational GFP-
HLH-2 cDNA reporter, however, is only observed in the AC (Fig. 1F).  This recapitulates 
the expression pattern of endogenous HLH-2 as previously determined by antibody 
staining (Karp and Greenwald 2003), and suggests that the difference between hlh-2 
transcription and protein expression is due to differential stability of HLH-2 protein.  
Further supporting this interpretation, I find that knocking down components of the 
proteasome by RNAi causes GFP-HLH-2 to be stabilized in the VUs (Suppl. Fig. 2).  
This result does not show that HLH-2 is directly turned over by the proteasome, but it is 
consistent with HLH-2 protein stability being differentially regulated in the AC and VU. 
 
The bHLH domain is required for HLH-2 down-regulation in the VU. 
 Next, I performed a structure/function analysis of HLH-2 to determine which 
domain or protein sequence is responsible for the differential regulation of HLH-2 
stability in the AC and VU.  EMBOSS:epestfind (http://emboss.bioinformatics.nl/cgi-
bin/emboss/epestfind) identified two putative PEST sequences: one from H73 to K93, 
and the other from H96 to K122.  These are obvious candidates to test for regulating 
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HLH-2 stability, as PEST sequences are well-characterized protein degradation signal 
sequences (Rogers et al. 1986).  However, GFP-HLH-2(ΔPESTs) has the putative PEST 
sequences deleted and it is still regulated in the same pattern as full-length HLH-2 (Fig. 
2A row 1).  This indicates that the PEST sequences are not required for differential 
regulation of HLH-2, though those sequences are functional as “PEST” protein 
degradation sequences (Suppl. Fig. 5).  
This deletion analysis is done in an hlh-2(+) background.  If HLH-2 functions as 
a homodimer in the AC/VU, then endogenous HLH-2 may affect the stability of the GFP-
HLH-2 constructs.  To determine if the PEST sequences are required for HLH-2 turnover, 
I looked at GFP-HLH-2(ΔPEST) stability in an hlh-2(tm1768) background.  This 
mutation does not affect viability or the AC/VU decision (100% 1AC), and it encodes an 
in-frame insertion/deletion that removes the two PEST sequences.  I examined the 
stability of GFP-HLH-2(ΔPEST) in the hlh-2(tm1768) background so that both 
endogenous and transgenic HLH-2 lack the PEST sequences.  HLH-2(ΔPEST) is still 
turned over in the VU (Fig. 2A row 1), confirming that the PEST sequences are not 
required for HLH-2 turnover in the VU. 
I next deleted the entire N-terminus of HLH-2, leaving the bHLH domain and the 
C-terminus (bHLH+C), and this shows the same pattern as full-length HLH-2 (Fig. 2A 
row 2).  However, when the bHLH domain is deleted, leaving only the C-terminus (C), 
expression is observed in the VU as well as in the AC (Fig. 2A row 3).  This indicates 





Residues required for HLH-2 dimerization are also required for HLH-2 down-
regulation in the VU. 
 The basic Helix-Loop-Helix (bHLH) domain is responsible for DNA-binding 
activity and dimerization activity of bHLH-containing transcription factors (Murre et al. 
1989).  The human ortholog of HLH-2 dimerizes with a bHLH partner through highly 
conserved hydrophobic residues on the helices, forming a stable hydrophobic interface 
between the HLH regions of two bHLH proteins.  The dimer is then able to bind specific 
“E box” DNA sequences (CANNTG) through the basic regions N-terminal to the HLH, 
thus allowing it to activate transcription of specific target genes (Murre et al. 1989; 
Voronova and Baltimore 1990; Ellenberger et al. 1994). 
Our HLH-2 deletion analysis indicates that the bHLH domain of HLH-2 is 
required for its down-regulation in the VU.  To test whether dimerization is required for 
HLH-2 down-regulation, I mutated conserved residues predicted to be required for 
dimerization (Fig. 2C; Voronova and Baltimore 1990), and I assessed the effect of those 
mutations on GFP-HLH-2 stability in the AC and VU.  If HLH-2 dimerization 
specifically stabilizes HLH-2 in the AC, then the dimerization-defective forms of HLH-2 
should be degraded in the AC as well as in the VU.  Conversely, if HLH-2 dimerization 
promotes HLH-2 instability in the VU, then dimerization-defective forms of HLH-2 
should be stabilized in the AC and VU.  I find that GFP-HLH-2[I345E, L346D] and 
GFP-HLH-2[I353D], two forms of HLH-2 with mutations predicted to disrupt 
dimerization, both show complete stabilization in the AC and VU (Fig. 2B rows 2 and 3).  
Additionally, deletion of the C-terminus of HLH-2 stabilizes GFP-HLH-2 in the VU 
(Suppl. Fig. 6).  The C-terminus is highly conserved, and has been shown in the human E 
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protein E2-2 to be required for dimerization (Goldfarb et al. 1998).  The stabilization of 
GFP-HLH-2(ΔC) supports the interpretation that dimerization is required for HLH-2 
turnover in the VU. 
A weak hypomorphic allele of hlh-2 is bx108. This allele encodes an R316H 
mutation, which does not prevent HLH-2 dimerization in vitro (Portman and Emmons 
2000).  This mutant form of HLH-2 can still dimerize, so it would be predicted to be 
unstable in the VU; this is exactly what is observed (Fig. 2B row 1).  Taken together, the 
deletion analysis and mutational analysis of GFP-HLH-2 indicates that dimerization is 
required for HLH-2 down-regulation in the VU. 
 The bHLH domain of HLH-2 shows a high degree of conservation with its human 
ortholog E47 (Fig. 2C).  In B cells, E47 homodimers form and are stabilized by a 
disulfide bond between their respective Helix 1 Cys573 residues (Benezra 1994).  It is 
required for stable homodimer formation but not heterodimer formation in vitro (Benezra 
1994).  This cysteine residue is conserved specifically in E proteins, including Cys329 in 
HLH-2 (Fig. 2C).  If HLH-2 forms a homodimer in the AC, then Cys329 in Helix 1 of 
HLH-2 would be important for HLH-2 turnover and function in the AC.  When the 
conserved cysteine is mutated to a serine, GFP-HLH-2[C329S] is strongly stabilized in 
the VU (Fig. 2B row 4).  This result suggests that the cysteine residue, and possibly a 






Rescue of an hlh-2 hypomorph serves as an assay for activity of wild-type and 
mutant forms of GFP-HLH-2. 
Since these mutations have never been tested in vivo before, I developed a rescue 
assay to determine if the transgenic proteins are functional or not.  I tested the function of 
GFP-HLH-2, using rescue of the hypomorphic hlh-2 allele bx108ts as an activity assay.  
The hlh-2(bx108) mutants have a partially penetrant 2AC defect (Fig. 3A left, Fig. 3B 
left), as determined by the AC marker arIs51[cdh-3p::gfp].  Additionally, they show a 
highly penetrant abnormally everted vulva (Evl) defect (Fig. 3A right, Fig. 3B right).  
With the transcriptional GFP transgene in the background at 25°C, 84% (68/81) of hlh-
2(bx108ts) adults show the Evl defect (Fig. 3C row 1).  However, I tested two 
translational GFP-HLH-2 transgenes for rescue, and find only 2% (2/84) and 3% (4/122) 
of adults show the Evl defect (Fig. 3C rows 2 and 3).  This indicates that GFP-HLH-2 is 
functional and able to rescue the Evl defect of hlh-2(bx108) adults.  Also, it shows that 
this is a robust rescue assay for HLH-2 function.  Incidentally, hlh-2prox promotes tissue-
specific expression of these proteins, which indicates that the focus of the Evl defect of 
hlh-2(bx108) is the proximal somatic gonad. 
With this assay, I was able to test the activity of the mutant forms of GFP-HLH-2.  
GFP-HLH-2(ΔPESTs) is able to rescue as well as GFP-HLH-2, with only 5% (6/131) of 
adults showing the Evl defect (Fig. 3C row 4).  The GFP-HLH-2[R316H] protein carries 
the same mutation as hlh-2(bx108) and is able to partially rescue the Evl defect (85/302, 
28% Evl), as predicted of a hypomorphic mutation.  Also as expected, the mutations 
predicted to disrupt HLH-2 dimerization abolish the rescuing activity of HLH-2.  hlh-
2(bx108) adults carrying GFP-HLH-2(ΔC), GFP-HLH-2[I345D,L346E], or GFP-HLH-
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2[I353D] showed highly penetrant Evl defects that were not significantly different from 
GFP alone: 98/129 (76%), 128/178 (72%), and 69/92 (75%), respectively (Fig. 3C rows 
6-8).  This suggests that the mutations successfully disrupt HLH-2 activity, presumably 
through disrupting its dimerization and/or DNA-binding activities, and that dimerization 
is an essential step for HLH-2 down-regulation in VU.  Intriguingly, neither of two GFP-
HLH-2[C329S] transgenes rescues the Evl defect:  107/129, 83% Evl; and 106/134, 79% 
Evl, respectively (Fig. 3C, rows 9 and 10)).  This raises the possibility that HLH-2 
homodimerization specifically is important for HLH-2 function in the AC and for HLH-2 
down-regulation in the VU. 
 
No Class II bHLH genes show expression in the AC or VU. 
Mutational analysis of HLH-2 shows that dimerization is essential for HLH-2 
turnover in the VU.  Previous in vitro electrophoretic mobility shift assays have shown 
that HLH-2 can bind to DNA as a homodimer or as a heterodimer (Krause et al. 1997; 
Harfe et al. 1998b; Zhang et al. 1999; Portman and Emmons 2000; Hwang and Sternberg 
2004; Hwang et al. 2007).  Both expression analysis and AC defects due to hlh-2(RNAi) 
reveal the role for HLH-2 in the AC (Karp and Greenwald 2003; 2004).  I therefore 
looked for evidence of a heterodimer partner for HLH-2 in the AC/VU in the same two 
ways:  expression analysis and phenotype.  
 I obtained the best available translational reporter constructs for the previously 
defined class II bHLH genes, which are considered the potential dimerization partners of 
HLH-2 (Grove et al. 2009).  All reporters are either recombineered fosmids or plasmids 
with full gene-to-gene sequences (Nakano et al. 2010; Bertrand et al. 2011; Sarov et al. 
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2012).  We made transgenic lines using conditions that show strong hlh-2 expression in 
the AC, and I looked for expression of the Class II bHLH reporters in the AC and/or VU.  
It could be that HLH-2 has one or multiple heterodimer partners that help carry out its 
multiple roles in the AC.  Those partners or a different partner could be expressed in the 
VU for the separate function of promoting HLH-2 down-regulation.  
Only HLH-2-GFP showed evidence of expression in the AC, though all reporters 
showed expression in other tissues (Table 1).  Thus, expression analysis did not implicate 
any candidate heterodimer partners for HLH-2.  This could be due to technical issues that 
arise when using transgenic arrays.  Alternatively, it could indicate that HLH-2 functions 
as a homodimer in the AC/VU. 
 
hlh-2 is the only bHLH-domain containing gene that shows phenotypic evidence for 
a role in the AC. 
 A complementary approach to expression analysis is testing candidate 
heterodimer partners for function in the AC.  HLH-2 plays three temporally distinct roles 
in promoting the fate and function of the developing AC.  It is required (1) for AC 
competence, (2) for the AC/VU decision, and (3) for execution of AC fate, including 
vulval induction.  Loss of hlh-2 during these processes by stage-specific RNAi results in 
three distinct defects, respectively: failure to specify an AC (0AC, Karp and Greenwald 
2004), failure of the AC/VU decision (2AC, Karp and Greenwald 2003), and failure of 
the AC to induce vulval development (Hwang and Sternberg 2004).  I would predict that 
loss of the heterodimer partner or partners of HLH-2 would cause the same AC and/or 
vulval induction defects as the loss of hlh-2. 
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To be as comprehensive as possible, I tested all 41 other bHLH-domain-
containing C. elegans genes for all three HLH-2-related AC defects: 0AC, 2AC, and 
failed vulval induction.  I used the hypomorphic hlh-2(bx108) allele to genetically 
sensitize the worms in case of dimerization partner redundancy, and I used nre-1(hd20) 
lin-15b(hd126) to sensitize the somatic gonad to RNA-mediated interference (RNAi).  
The number of ACs was scored by expression of the AC marker cdh-3p::gfp; vulval 
induction was scored based on both morphology (vulval invagination in the late L3 / 
early L4) and expression of the primary vulval fate marker lag-2p::tagrfp.  I performed 
RNAi by feeding L1 larvae in order to individually knock down each bHLH gene.  Under 
optimized RNAi conditions (Suppl. Fig. 7), none of the 41 bHLH genes showed an AC 
defect for any of the three HLH-2-dependent activities (Table 2, Table 3), though this 
assay was able to identify a novel partner for HLH-2 in another cell context (see Chapter 
3).  Thus, by phenotypic tests for three different functions of HLH-2 and by expression 
analysis, I find no evidence for a heterodimer partner for HLH-2 in the AC. This further 
suggests that HLH-2 functions as a homodimer in the AC. 
 
In the AC, expression of lin-3/EGF, a direct transcriptional target of HLH-2, 
requires a specific type of E box that HLH-2 homodimers can bind in vitro. 
 Our results thus far point toward HLH-2 acting as a homodimer in the AC/VU 
decision.  If this is correct, then HLH-2 homodimers should be able to bind directly to E 
box DNA sequences (CANNTG) in the promoters of AC-specific target genes.  Several 
in vitro studies have shown that HLH-2 homodimers can bind to CAGGTG-type E boxes 
(Krause et al. 1997; Harfe et al. 1998b; Zhang et al. 1999; Portman and Emmons 2000; 
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Hwang and Sternberg 2004; Hwang et al. 2007).  In one study, when the E box was 
changed from CAGGTG to CATATG, HLH-2 homodimers no longer bind (Harfe et al. 
1998b).  However, HLH-8--HLH-2 heterodimers and several other HLH-2 heterodimer 
combinations are able to bind to CATATG E box sequences in vitro (Harfe et al. 1998b; 
Grove et al. 2009).  This suggests that the binding of HLH-2 homodimers may require a 
more specific type of E box than HLH-2 heterodimers. 
With this knowledge, I investigated a direct transcriptional target of HLH-2 in the 
AC, lin-3.  lin-3/EGF is the signaling molecule secreted by the AC to induce vulval 
development.  HLH-2 homodimers can bind in vitro to the minimal lin-3 ACEL (Anchor 
Cell-specific Enhancer of lin-3) element through its two conserved CAGGTG E boxes 
(Hwang and Sternberg 2004).  This lin-3(ACEL) element drives expression in the AC 
(Fig. 4A top; Hwang and Sternberg 2004).  When both E boxes are destroyed (CAGGaa), 
HLH-2 can no longer bind in vitro and no expression is observed in the AC, showing that 
the E boxes are required for HLH-2 binding in vitro and for expression in the AC in vivo 
(Hwang and Sternberg 2004).  I predicted that if HLH-2 functions as a homodimer, then 
it should not be able to bind to the lin-3(ACEL) element if the E boxes remain intact but 
are mutated from CAGGTG to CATATG, and there should be no AC expression.  All 
three transgenic lines with wild-type lin-3(ACEL[GG])::gfp show strong expression in 
the AC (Fig. 4A top, 4B).  As the homodimer model predicts, the lin-3(ACEL[TA])::gfp 
transgene contained intact but altered E boxes is not expressed in the AC (Fig. 4A bottom, 
4C).  
Is the specific type of E box is important for HLH-2 target genes in the AC, or 
does the general presence or absence of an E box govern HLH-2 binding?  If the 
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CAGGTG sequence is important, then I would expect it to be conserved.  I chose the 
ACELs of lin-3 and egl-43, two well-characterized targets of HLH-2 in the AC (Hwang 
and Sternberg 2004; Hwang et al. 2007), and looked for conservation in three other 
nematode species.  Sequence alignments reveal that in addition to the NHR binding site 
of the ACEL, all four nematode species have two CAGGTG-type E-boxes for both lin-3 
and egl-43 (Fig. 4D).  This high degree or conservation suggests that the specific E box 
sequence is important for expression in the AC. 
 
The human homolog E47 can rescue hlh-2(h) AC defects and is down-regulated in 
the VU through dimerization. 
 HLH-2 is well conserved, from Daughterless in fruit flies to E47 in humans.  
HLH-2 shares very high protein sequence identity with the HLH domain of Daughterless 
(64% identical) and of E47 (59% identical) (Fig. 2C).  The high degree of conservation in 
the HLH domain is particularly intriguing, since dimerization activity of the HLH region 
is required for HLH-2 down-regulation.  An obvious question is whether the mechanism 
for HLH-2 down-regulation is conserved between worm and human.  As a first step to 
address this, I expressed a GFP-tagged form of E47 cDNA to see if it is down-regulated 
in the VU like HLH-2.  GFP-E47 is observed in the AC but not in the VU (Fig. 5A row 
1), showing that E47 is also down-regulated in the VU like HLH-2 (see Suppl. Fig. 8 for 
GFP expression in βVUs).  Two different transgenic arrays carrying GFP-E47 are 
capable of rescuing the Evl defect of hlh-2(bx108): 12/131 (9%) and 7/97 (7%) adults 
with Evl defects, respectively (Fig. 5B rows 3 and 4).  
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 I next asked whether the down-regulation of the human homolog is also 
dimerization-dependent.  I observed stabilization in the VU of the dimerization mutant 
GFP-E47[I588D,L589E] (Fig. 5A row 2), but the effect on stability was not nearly as 
strong as the analogous mutation GFP-HLH-2[I345D,L346E] has on HLH-2 stability.  In 
a hlh-2(bx108) background, 107/144 (74%) of adults carrying GFP-E47[I588D,L589E] 
show Evl defects (Fig. 5B row 5), indicating that the mutation does abolish the activity of 
E47.  In addition, GFP-E47 can rescue the 0AC defect caused by hlh-2(RNAi), while 
GFP-E47[I588D,L589E] cannot (Suppl. Table 3). 
Previous work showed that E47 is degraded downstream of Notch activity in 
mammalian culture and B cells through an ERK site that is not present in HLH-2 (Nie et 
al. 2003; King et al. 2007).  To determine if this site is also involved in E47 down-
regulation in the VU, where Notch activity is high, I mutated the ERK site in otherwise 
wild-type GFP-E47 and in GFP-E47[I588D,L589E].  The ERK site mutation 
[S352A,T355A,S359A] alone has no effect on GFP-E47 down-regulation in the VU (Fig. 
5A row 3). When the ERK site is mutated in combination with the dimerization mutant 
GFP-E47[I588D,L589E], E47 is stabilized in the VU (Fig. 5A row 5).  Thus disrupting 
the ERK site reveals that dimerization-mediated down-regulation is important for E47 
regulation in the VU.  I tested a role for the E3 ligase complexes involved in E47 
turnover in B cells (Nie et al. 2010), and find no evidence that Cul5/Asb2 and 
Cul1/Skp1/Skp2 are involved (Suppl. Fig. 9A,B).  Therefore, I suggest that GFP-E47 






 The bHLH proteins are transcription factors essential for the proper development 
of multicellular organisms.  Developmental defects and diseases can arise as a result of 
either reduced or excessive bHLH protein activity, thus demonstrating the importance of 
precise regulation of bHLH protein expression and activity.  Here, I have investigated the 
function and regulation of the E protein HLH-2 in the context of the AC/VU decision.  
These studies have revealed that HLH-2 protein is post-translationally down-regulated in 
the VU, via a novel dimerization-dependent mechanism.  These data suggest that HLH-2 
functions as a homodimer in the AC, and that HLH-2 homodimers are recognized and 
turned over in the VU (Fig. 6).  Here I discuss the contribution of this work to our 
understanding of the AC/VU decision, of the regulation of bHLH proteins, and potential 
implications for disease. 
 
Implications for the AC/VU decision 
The simplicity of the AC/VU decision is ideal for investigating how cell fates are 
specified.  Two cells are born with equal potential to adopt one of two fates: the anchor 
cell (AC) fate or the ventral uterine precursor cell (VU) fate.  To resolve the AC/VU 
decision, these two cells must both regulate and respond to several processes, including 
cell cycle, LIN-12/Notch activity, and HLH-2 stability, as they coordinate with each 
other to adopt alternate fates.  
HLH-2 is crucial for AC competence, for the AC/VU decision, and for the 
differentiated AC fate, and this work suggests that HLH-2 homodimerizes to carry out 
these functions.  In addition, HLH-2 homodimers may preferentially bind CAGGTG E 
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boxes in the promoters of direct targets in the AC.  Given the importance of HLH-2 and 
the number of roles it has in the gonad, there is broad interest in understanding the targets 
that act downstream of HLH-2 to carry out its different activities.  Further analysis of 
HLH-2 targets in the AC will be necessary to confirm this, but the specific E box 
sequence may prove to be a very useful criterion in searching for and identifying new 
targets of HLH-2 in the AC.  It would also simplify the mutational analysis to confirm 
novel HLH-2 targets, if only the CAGGTG E boxes must be mutated rather than all of 
them.  
Since HLH-2 promotes AC fate and function, its elimination from non-AC cells is 
likely important as well.  In this study, I investigate how HLH-2 is eliminated from the 
presumptive VU.  hlh-2 transcription remains high in the VU, though HLH-2 protein is 
normally never observed there due to post-transcriptional regulation (Karp and 
Greenwald 2003; this study).  I have shown that HLH-2 protein is post-translationally 
down-regulated in the VU.  I speculate that this down-regulation may be downstream of 
activation of LIN-12/Notch (Karp and Greenwald 2003).  This could be through 
expression of a LIN-12 target gene, which would negatively regulate HLH-2 protein.  Or, 
it could be through non-transcriptional Notch activity, as has been shown in cell culture 
with the Notch intracellular domain can regulate the activity of kinase ASK1 (Mo et al. 
2013).  When the trans acting factor that regulates HLH-2 is identified, it will be 
interesting to look for LAG-1 binding sites and see if it is a direct transcriptional target of 
LIN-12. 
This work also reveals that HLH-2 down-regulation depends on its ability to 
dimerize.  I propose that HLH-2 dimerization is necessary for its recognition as a 
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substrate in the VU.  Recognition of HLH-2 as a target substrate likely depends on a 
specific protein sequence, a specific post-translational modification, or a particular 
secondary protein structure.  In vitro studies have shown that the affinity of the E3 ligase 
Fbw7 for its substrates depends on both the Fbw7 binding site (CPD) composition and on 
Fbw7 dimerization.  Fbw7 monomers and dimers can bind to high-affinity CPDs equally 
well (Welcker et al. 2013).  However, suboptimal CPDs are bound more strongly by 
Fbw7 dimers than monomers (Welcker et al. 2013).  Of particular interest is the finding 
that substrate dimers can be bound with higher affinity that substrate monomers, when 
the CPD is suboptimal (Welcker et al. 2013).  While loss of sel-10, the Fbw7 ortholog, 
has no effect on HLH-2 turnover in the VU (unpublished observations), the same 
principle may be functioning:  perhaps HLH-2 homodimerization brings together two 
suboptimal binding sites, allowing for higher affinity binding by the trans factor that 
regulates HLH-2 stability in the VU.  If this is correct, then the trans factor should be 
specifically expressed in the VU and not in the AC. 
Thus far, I have only been able to stabilize HLH-2 protein in cis by disrupting its 
ability to dimerize.  These mutations abolish HLH-2 activity, so the consequence of 
stabilizing active HLH-2 in a VU is still unknown.  One might expect loss of the trans-
acting factor to stabilize HLH-2 and cause a 2AC defect, since HLH-2 activity promotes 
AC fate.  Alternatively, since one of the key downstream targets of HLH-2 is lag-2/DSL, 
stabilizing HLH-2 could result in high LIN-12/Notch activity in both cells, resulting in a 
0AC (or 2VU) defect.  Identifying the trans-acting factor will be very important to 




Broader implications for development and disease 
 I find that E47 is a functional ortholog of HLH-2, because it can rescue a mutant 
form of hlh-2 and it is susceptible to the same dimerization-dependent mechanism that 
negatively regulates HLH-2 in the VU.  This allows the possibility that these 
investigations of HLH-2 regulation in the worm could contribute to our understanding of 
E protein regulation in general. 
Here, I present the first direct evidence that dimerization through a bHLH domain 
can promote protein turnover.  Several studies have shown that bHLH protein stability 
can be regulated.  Class II proteins can be ubiquitinated and degraded, which has been 
observed for Mash1 in cell culture and for Ngn3 in mouse pancreas and Xenopus (Viñals 
et al. 2004; Vosper et al. 2007; Qu et al. 2013).  E47 has also been shown to be 
ubiquitinated and degraded in cell culture downstream of mUbc9 (Huggins et al. 1999), 
and downstream of Notch activity via ERK-dependent phosphorylation in B cells (Nie et 
al. 2003; King et al. 2007).  However, I do not find examples in which dimerization was 
specifically tested for a role in regulating bHLH protein stability.  
 In a recent study (Schmitz et al. 2012), mutations in E47 were found to be 
associated with Burkitt’s lymphoma (BL).  Increased E47 activity was implicated in 70% 
of BL cases through either E47 mutation or through loss-of-function mutations in ID3, a 
dominant negative regulator of E protein activity.  All of the E47 mutations affected eight 
residues in the bHLH domain specifically, and 38 out of the 39 E47(mut) cases had a 
mutation in residues conserved in HLH-2.  These mutations appear to function to increase 
E47 activity in different ways, including through decreased binding affinity for ID3 and 
altering DNA binding specificity.  Not all of the identified mutations were characterized, 
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and given that the E47 can rescue hlh-2 defects and is regulated through dimerization like 
HLH-2, perhaps the effect of these mutations could be assessed in the worm.  Also, while 
increase E47 activity is clearly implicated in BL, E47 protein stability in primary tumors 
remains uncharacterized, so it is possible that some of the mutations (or that other 
mutations in trans-acting factors) increase E47 activity in part by stabilizing E47 protein.  
 
Studying gene regulation in vivo 
Regulation of bHLH gene expression and activity is clearly important in the 
development of many different tissues in a wide array of organism, from worms to flies 
to mammals.  An excellent example of this is from a study of Notch-dependent E47 
turnover.  Activated Notch promotes E47 ubiquitination and degradation in vitro in B cell 
lines and in vivo in aging mouse B cells (Nie et al. 2003; King et al. 2007), though RNAi 
experiments and E47 mutational analysis suggests that a different mechanism recognizes 
and down-regulates bHLH proteins in the VU (Fig. 5, Suppl. Fig. 9).  However, the same 
experiment performed in T cell lines does not show Notch-dependent E47 turnover.  This 
indicates that cell context is important in studying regulation of bHLH proteins.  This 
study finds evidence that E proteins are also regulated in C. elegans, and the powerful 
genetics and live imaging of C. elegans make it an excellent system to further investigate 
mechanisms of bHLH regulation.  The biochemical work done in vitro combined with 
genetic work done in vivo will likely be key complementary approaches to capturing the 
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Figure 1. Post-translational regulation of HLH-2 protein causes its differential expression 
in the AC and VU. (A) A model depicting the AC/VU decision. The anchor cell / ventral 
uterine precursor cell (AC/VU) decision begins with the birth of two α cells with equal 
potential to adopt AC or VU fate. Both express lin-12/Notch, lag-2/DSL, and hlh-2/Da. A 
stochastic difference engages feedback loops, resulting in restriction of lin-12/Notch 
expression to the VU and the restriction of lag-2/DSL expression and HLH-2/Da protein 
to the AC.  (B) Deletion analysis of the hlh-2 promoter identified a small element, hlh-
2prox, that specifically drives expression in the α cells and their sisters.  (C, D) HLH-2 
protein is initially stable in the α cells. Three transgenic lines were generated with hlh-
2prox driving expression of GFP (C) or GFP-HLH-2(cDNA) (D). Late L1 / early L2 
larvae were scored for detectable GFP expression in each α cell. The percent of GFP+ 
cells is shown. The number of animals scored is in parentheses.  (E) In late L2 larvae, 
GFP expression is high in the AC and VU (E, upper). A representative photomicrograph 
with maximum intensity projection shows both α cells with GFP expression (E, lower). 
The two additional GFP(+) cells are β cells, the sisters of the α cells.  (F) GFP-HLH-2 is 
observed only in the AC and not the VU (F, top). A representative photomicrograph, with 
maximum intensity projection, shows GFP expression in the AC but not in the VU (F, 







































































Figure 2. HLH-2 protein down-regulation in the VU requires dimerization. (A) Different 
GFP-HLH-2 fusion proteins, represented to the left under the “cDNA Insert” heading, are 
expressed using the hlh-2prox. See Figure 1 for scoring details. (A, row 1) HLH-2 
contains two predicted protein degradation signal sequences (PESTs). GFP-HLH-
2(ΔPESTs) is down-regulated in the VU in both a wild-type and hlh-2(tm1768) mutants. 
The hlh-2(tm1768) deletion removes the PEST sequences, so neither GFP-HLH-2 nor 
endogenous hlh-2 has the PEST sequences (blue outlined bar). (A, row 2) A GFP fusion 
with the basic Helix-Loop-Helix domain and the C-terminus (bHLH+C) is observed in 
the AC and not the VU. (A, row 3) The GFP-tagged C-terminus of HLH-2 is stable in the 
AC and VU. (B) Residues required for HLH-2 dimerization are also required for HLH-2 
down-regulation in the VU. (B, row 1)  The hypomorphic bx108 mutation R316H has 
little effect on HLH-2 stability. (B, row 2,3)  Mutation of important dimerization residues 
completely stabilizes HLH-2 in the VU. (B, row 4) Mutation of a cysteine that is required 
for E protein homodimerization stabilizes HLH-2 in the VU. (C) Alignment of the bHLH 
domain of HLH-2 with the human ortholog E47 and the Drosophila ortholog 
Daughterless shows strong conservation (% sequence identity in parentheses). The sites 
of mutations in the bHLH domain are labeled in red. 









































































Cel-HLH-2    TDRRSQNNARERVRVRDINSAFKELGRMCTQHNQNTERNQTKLGILHNAVSVITQLEEQ!
Dme-Da       KERRQANNARERIRIRDINEALKELGRMCMTHLK-SDKPQTKLGILNMAVEVIMTLEQQ (59%)!
Hsa-E2A(E47) RERRMANNARERVRVRDINEAFRELGRMCQMHLK-SDKAQTKLLILQQAVQVILGLEQQ (63%)!















Figure 3. A rescue assay tests the activity of GFP-HLH-2 wild-type and mutant proteins. 
(A) In an hlh-2(+) background, a single AC is observed by morphology (left panel) and 
by the AC marker cdh-3p::gfp (inset), and young adults have a normal vulva (right panel). 
The arrowhead marks the AC. The arrow marks the vulva. (B) The hlh-2(bx108) 
mutation causes a low penetrance defect of two ACs, as observed by morphology (left 
panel) and by the AC marker (inset), and a highly penetrant abnormally everted vulva 
(Evl) defect (right panel). (C) GFP alone does not rescue the Evl defect (row 1), but two 
different lines expressing GFP-HLH-2 under the hlh-2prox rescue the Evl defect (rows 2 
and 3). GFP-HLH-2(ΔPESTs) can rescue as efficiently as wild-type GFP-HLH-2 (row 4), 
and the GFP-HLH-2(bx108) transgene can rescue the Evl defect as well (row 5). The 
dimerization mutations predicted to be the most disruptive also fail to rescue the Evl 
defect (rows 6-9). The array name and the number of animals examined for Evl are in 
parentheses, next to the respective protein expressed from the array. **p<0.001 in a two-








Protein expressed in hlh-2(bx108) %Evl 





















GFP (arEx1683,  n=81) 
GFP::HLH-2 (arEx1685,  n=84) 
GFP::HLH-2 (arEx1686, n=122) 
GFP::HLH-2(ΔPEST) (arEx1829, n=131) 
GFP::HLH-2[ΔC-term] (arEx1843, n=129) 
GFP::HLH-2[bx108] (arEx1837, n=302) 
GFP::HLH-2[I345D,L346E] (arEx1838, n=178) 
GFP::HLH-2[I353D] (arEx2039,   n=92) 
GFP::HLH-2[C329S] (arEx2133, n=129) 
GFP::HLH-2[C329S] (arEx2134, n=134) 
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Table 1. No Class II bHLH proteins show evidence of expression in the AC or VU. 
 
Reporters are translational fusions with a C-terminal GFP or YFP tag, and the sequence for each bHLH 
gene covers at least the entire gene-to-gene genomic region.  The arEx strains rescue pha-1(e2123).  
wgIs74 was provided by the CGC, and otEx4503 was provided by O. Hobert.  All strains were raised at 
25°C for scoring 
L2 and early L3 larvae were examined for expression of reporters in the α cells and in the AC and VU.  I 
scored the number of animals with any expression in the AC or VU.  I show the number of GFP+ or YFP+ 
















arEx2028 14/15 (93%) 
yes 
arEx2029 15/15 (100%) 
HLH-3-GFP 
arEx2041 0/15 (0%) 
yes 
arEx2042 0/15 (0%) 
HLH-4-YFP 
arEx1982 0/16 (0%) 
yes 
arEx1983 0/15 (0%) 
HLH-6-YFP 
arEx1986 0/16 (0%) 
yes 
arEx1991 0/15 (0%) 
HLH-8-GFP wgIs74 0/18 (0%) yes 
HLH-10-YFP 
arEx1988 0/15 (0%) 
yes 
arEx1989 0/14 (0%) 
HLH-12-GFP 
arEx2113 0/17 (0%) 
yes 
arEx2114 0/15 (0%) 
HLH-13-GFP 
arEx2031 0/15 (0%) 
yes 
arEx2032 0/16 (0%) 
HLH-14-GFP 
arEx2118 0/15 (0%) 
yes 
arEx2119 0/15 (0%) 
Reporter Array 
Expression  




arEx2055 0/16 (0%) 
yes 
arEx2059 0/15 (0%) 
HLH-16-GFP otEx4503 0/18 (0%) yes 
HLH-17-GFP 
arEx2120 0/17 (0%) 
yes 
arEx2121 0/16 (0%) 
HLH-19-GFP 
arEx2005 0/18 (0%) 
yes 
arEx2006 0/17 (0%) 
HLH-31-GFP 
arEx2117 0/16 (0%) 
yes 
arEx2150 0/16 (0%) 
CND-1-GFP 
arEx2115 0/16 (0%) 
yes 
arEx2116 0/16 (0%) 
HND-1-GFP 
arEx2026 0/16 (0%) 
yes 
arEx2027 0/15 (0%) 
LIN-32-GFP 
arEx1906 0/15 (0%) 
yes 
arEx1910 0/15 (0%) 
NGN-1-GFP 
arEx2120 0/16 (0%) 
yes 
arEx2121 0/16 (0%) 
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Table 2. An RNAi screen reveals no evidence for an HLH-2 heterodimer partner in 
promoting AC competence or in the AC/VU decision. 
 
All bHLH domain-containing genes were tested for a role in promoting AC competence or in promoting 
the AC/VU decision.  lin-12(RNAi) was used as  positive control and lacZ(RNAi) as a negative control.  lin-
12(RNAi) showed a significant difference from lacZ(RNAi) in every experiment.  The results are grouped 
(and significance was determined) by experiment. 
AC number was scored using the AC marker arIs51[cdh-3p::gfp].  No animals showed a 0AC defect (not 














RNAi 2AC (%) 
(+) lin-12** 31/40 (78%) 
(-) lacZ 8/41 (20%) 
hlh-15 6/41 (15%) 
hlh-33 12/41 (29%) 
ref-1 9/40 (23%) 
hlh-28 7/40 (18%) 
hlh-29 10/40 (25%) 
(+) lin-12** 25/40 (63%) 
(-) lacZ 8/41 (20%) 
aha-1 7/40 (18%) 
unc-3 8/41 (20%) 
sbp-1 9/40 (23%) 
ahr-1 6/40 (15%) 
2-tailed FET of RNAi vs. lacZi control, by experiment  * p=0.0016 
Strain:  hlh-2(bx108); cdh-3p::gfp; nre-1, lin-15b   ** p<0.0001 
RNAi 2AC (%) 
(+) lin-12** 26/41 (63%) 
(-) lacZ 6/40 (15%) 
hlh-11 6/42 (14%) 
hlh-12 6/41 (15%) 
hlh-30 5/40 (13%) 
hlh-31/32 8/42 (19%) 
hlh-34 9/42 (21%) 
(+) lin-12** 27/43 (63%) 
(-) lacZ 5/41 (12%) 
hlh-13 8/40 (20%) 
hlh-16 9/40 (23%) 
cnd-1 9/41 (22%) 
cky-1 6/42 (14%) 
lin-22 8/40 (20%) 
mdl-1 9/41 (22%) 
RNAi 2AC (%) 
(+) lin-12** 22/30 (73%) 
(-) lacZ 11/41 (27%) 
hlh-14 9/41 (22%) 
ngn-1 6/40 (15%) 
hlh-3 5/41 (12%) 
hlh-6 10/40 (25%) 
(+) lin-12* 25/41 (61%) 
(-) lacZ 10/40 (25%) 
mml-1 6/40 (15%) 
mxl-1 11/40 (28%) 
mxl-2 8/40 (20%) 
mxl-3 10/40 (25%) 
hlh-1 9/41 (22%) 
RNAi 2AC (%) 
(+) lin-12** 27/41 (66%) 
(-) lacZ 5/40 (13%) 
hlh-4 7/41 (17%) 
hlh-8 6/41 (15%) 
hlh-17 6/40 (15%) 
hlh-19 6/40 (15%) 
hlh-25 7/40 (18%) 
(+) lin-12** 36/41 (88%) 
(-) lacZ 7/40 (18%) 
hlh-26 5/41 (12%) 
hlh-27 9/40 (23%) 
hlh-10 8/41 (20%) 
hif-1 4/41 (10%) 
lin-32 9/40 (23%) 
hnd-1 12/40 (30%) 
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Table 3. An RNAi screen reveals no evidence for an HLH-2 heterodimer partner in 
inducing vulval development. 
 
All bHLH genes were tested for a role in promoting vulval induction.  Significance was determined using a 
two-tailed Fisher’s exact test comparing the vulval induction defect of a tested RNAi to the negative 
control lacZ(RNAi).  The positive control lin-3(RNAi) showed a significant difference from lacZ(RNAi) in 
every experiment.  The results are grouped (and significance was determined) by experiment. 
Vulval induction was scored in early L4 larvae by using the primary fate vulval marker arIs222[lag-
2p::tagrfp] and by looking for vulval invagination by the time the distal tip cells have reflexed.  The 
number of worms with failed induction is shown over the total worms scored, with the %failed vulval 











RNAi Failed vulval induction (%) 
(+) lin-3** 19/20 (95%) 
(-) lacZ 0/20 (0%) 
hlh-1 0/20 (0%) 
hlh-3 0/20 (0%) 
hlh-4 0/20 (0%) 
hlh-6 0/20 (0%) 
hlh-8 0/20 (0%) 
hlh-10 0/20 (0%) 
hlh-11 0/20 (0%) 
hlh-13 0/20 (0%) 
hlh-14 0/20 (0%) 
hlh-19 0/20 (0%) 
RNAi Failed vulval induction (%) 
(+) lin-3** 20/20 (100%) 
(-) lacZ 0/20 (0%) 
lin-22 0/20 (0%) 
ref-1 0/20 (0%) 
hlh-25 0/20 (0%) 
hlh-26 0/20 (0%) 
hlh-27 0/20 (0%) 
hlh-28 0/20 (0%) 
hlh-29 0/20 (0%) 
hlh-34 0/20 (0%) 
sbp-1 0/20 (0%) 
unc-3 0/20 (0%) 
2-tailed FET of RNAi vs. lacZ control 
Strain:  hlh-2(bx108); arIs222[lag-2p::2xnls-tagrfp]; nre-1 lin-15b  ** p<0.0001 
RNAi Failed vulval induction (%) 
(+) lin-3** 20/20 (100%) 
(-) lacZ 0/20 (0%) 
hlh-12 0/20 (0%) 
hlh-15 0/20 (0%) 
hlh-16 0/20 (0%) 
hlh-17 0/20 (0%) 
hlh-31/32 0/20 (0%) 
hnd-1 0/20 (0%) 
cnd-1 0/20 (0%) 
ngn-1 0/20 (0%) 
lin-32 0/20 (0%) 
hlh-30 0/20 (0%) 
RNAi Failed vulval induction (%) 
(+) lin-3** 19/20 (95%) 
(-) lacZ 0/20 (0%) 
aha-1 0/20 (0%) 
ahr-1 0/20 (0%) 
cky-1 0/20 (0%) 
mdl-1 0/20 (0%) 
mml-1 0/20 (0%) 
mxl-1 0/20 (0%) 
mxl-2 0/20 (0%) 
mxl-3 0/20 (0%) 
hif-1 1/20 (5%) 




Figure 4. Expression of the HLH-2 target lin-3 in the AC requires E box sequences that 
HLH-2 homodimers can bind. (A) The lin-3(ACEL) is sufficient for AC expression 
(Hwang and Sternberg 2004), but not if the E boxes are altered. The two CAGGTG E 
boxes of lin-3(ACEL[GG]) are bound by HLH-2 homodimers in vitro (Hwang and 
Sternberg 2004). I scored L2 larvae of three independent transgenic lines, and saw strong 
expression in the presumptive AC and the specified AC (top). The number of worms 
scored is in parentheses. lin-3(ACEL[TA]) is not expressed in the AC (bottom). (B,C) 
Representative photomicrographs of the lin-3 reporters have DIC and GFP images 
merged. (B) lin-3(ACEL[GG]) gfp is expressed in the AC. (C) lin-3(ACEL[TA])::gfp is 
not. The arrowhead marks the AC, and the scale bar is 10 µm.  (D) The ACEL sequences 
of four nematode species are aligned for two genes, lin-3 and egl-43. Both E-box 
sequences (black box) in the ACEL are CAGGTG (or CACCTG) for all four species for 
both genes.  HLH-2 homodimers have previously been shown to bind these sequences in 
vitro (Hwang and Sternberg 2004; Hwang et al. 2007). 
lin-3(ACEL) 



























Figure 5. Down-regulation of E2A(E47), the human homolog of HLH-2, requires 
conserved dimerization residues.  (A) hlh-2prox drives expression of the GFP-E47 
translational fusion.  GFP expression is observed in the AC but not in the VU (row 1). A 
mutation that disrupts dimerization causes GFP expression to be observed in the AC and 
variably in the VU (row 2). GFP-E47 with the ERK site mutated is observed in the AC 
but not in the VU, like wild-type E47 (row 3).  When both the ERK site and dimerization 
mutations are in cis, GFP is observed regularly in the AC and VU. See Figure 1 legend 
for scoring details.  (B) Two independent transgenic lines of GFP-E47 significantly 
rescue the Evl defect of hlh-2(bx108) (rows 3,4). The dimerization mutant form does not 























































GFP (arEx1683,   n=81) 
GFP-HLH-2 (arEx1686, n=122) 
GFP-E47 (arEx1903, n=131) 
GFP-E47 (arEx1904,   n=97) 
GFP-E47[I588D,L589E] (arEx2000, n=144) 
%Evl 







Figure 6. Model: HLH-2 homodimers function in the AC and are recognized and 
degraded in the VU.  In the presumptive AC, HLH-2 homodimers form and bind to 
CAGGTG E boxes in target genes.  These targets include lag-2, lin-3, and egl-43.  A 
hypothetical factor “X” is present in the VU but not in the AC, and it recognizes HLH-2 
















HLH-2 HLH-2 * *
X 
Presumptive AC Presumptive VU 
* * 
HLH-2 HLH-2 
lag-2, lin-3, egl-43 
E box: CAGGTG 
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Supplemental Table 1.  List of strains  
 
Strain Name Genotype Protein expressed by array
GS6727 pha-1(e2123ts); arEx1682 hlh-2(prox)::gfp
GS6728 pha-1(e2123ts); arEx1683 hlh-2(prox)::gfp
GS6729 pha-1(e2123ts); arEx1684 hlh-2(prox)::gfp
GS6730 pha-1(e2123ts); arEx1685 hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) = (FL)
GS6731 pha-1(e2123ts); arEx1686 hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) = (FL)
GS6732 pha-1(e2123ts); arEx1687 hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) = (FL)
GS7059 pha-1(e2123ts); arEx1828 hlh-2(prox)::gfp-hlh-2(aa1-72, 123-399) = (ΔPESTs)
GS7060 pha-1(e2123ts); arEx1829 hlh-2(prox)::gfp-hlh-2(aa1-72, 123-399) = (ΔPESTs)
GS7553 hlh-2(tm1768); pha-1(e2123); arEx1829 hlh-2(prox)::gfp-hlh-2(aa1-72, 123-399) = (ΔPESTs)
GS7099 pha-1(e2123ts); arEx1836 hlh-2(prox)::gfp-hlh-2(aa1-72, 123-399) = (ΔPESTs)
GS6745 pha-1(e2123ts); arEx1700 hlh-2(prox)::gfp-hlh-2(aa301-399) = (bHLH+C)
GS6746 pha-1(e2123ts); arEx1701 hlh-2(prox)::gfp-hlh-2(aa301-399) = (bHLH+C)
GS6747 pha-1(e2123ts); arEx1702 hlh-2(prox)::gfp-hlh-2(aa301-399) = (bHLH+C)
GS6742 pha-1(e2123ts); arEx1697 hlh-2(prox)::gfp-hlh-2(aa360-399) = (C)
GS6743 pha-1(e2123ts); arEx1698 hlh-2(prox)::gfp-hlh-2(aa360-399) = (C)
GS6744 pha-1(e2123ts); arEx1699 hlh-2(prox)::gfp-hlh-2(aa360-399) = (C)
GS7100 pha-1(e2123ts); arEx1837 hlh-2(prox)::gfp-hlh-2(R316H) = (bx108)
GS7110 pha-1(e2123ts); arEx1840 hlh-2(prox)::gfp-hlh-2(R316H) = (bx108)
GS7101 pha-1(e2123ts); arEx1838 hlh-2(prox)::gfp-hlh-2(I345D,L346E)
GS7134 pha-1(e2123ts); arEx1860 hlh-2(prox)::gfp-hlh-2(I345D,L346E)
GS7445 pha-1(e2123ts); arEx2039 hlh-2(prox)::gfp-hlh-2(I353D)
GS7446 pha-1(e2123ts); arEx2040 hlh-2(prox)::gfp-hlh-2(I353D)
GS7476 pha-1(e2123ts); arEx2058 hlh-2(prox)::gfp-hlh-2(I353D)
GS7565 pha-1(e2123ts); arEx2133 hlh-2(prox)::gfp-hlh-2(C329S)
GS7566 pha-1(e2123ts); arEx2134 hlh-2(prox)::gfp-hlh-2(C329S)
GS7567 pha-1(e2123ts); arEx2135 hlh-2(prox)::gfp-hlh-2(C329S)
GS3371 arIs51 cdh-3p::gfp
GS7075 hlh-2(bx108); arIs51 cdh-3p::gfp
GS7163 hlh-2(bx108); pha-1(e2123); arEx1683 hlh-2(prox)::gfp
GS6900 hlh-2(bx108); pha-1(e2123); arEx1685 hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) = (FL)
GS6901 hlh-2(bx108); pha-1(e2123); arEx1686 hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) = (FL)
GS7448 hlh-2(bx108); pha-1(e2123); arEx1829 hlh-2(prox)::gfp-hlh-2(aa1-72, 123-399) = (ΔPESTs)
GS7241 hlh-2(bx108); pha-1(e2123); arEx1837 hlh-2(prox)::gfp-hlh-2(R316H) = (bx108)
GS7194 hlh-2(bx108); pha-1(e2123); arEx1838 hlh-2(prox)::gfp-hlh-2(I345D,L346E)
GS7473 hlh-2(bx108); pha-1(e2123); arEx2039 hlh-2(prox)::gfp-hlh-2(I353D)
GS7609 hlh-2(bx108); pha-1(e2123); arEx2133 hlh-2(prox)::gfp-hlh-2(C329S)
GS7610 hlh-2(bx108); pha-1(e2123); arEx2134 hlh-2(prox)::gfp-hlh-2(C329S)
GS7428 pha-1(e2123ts); arEx2028 HLH-2-GFP translational fosmid (Sarov)
GS7429 pha-1(e2123ts); arEx2029 HLH-2-GFP translational fosmid (Sarov)
GS7451 pha-1(e2123ts); arEx2041 HLH-3-GFP translational fosmid (Sarov)
GS7452 pha-1(e2123ts); arEx2042 HLH-3-GFP translational fosmid (Sarov)
GS7358 pha-1(e2123ts); arEx1982 HLH-4-YFP translational fosmid (Hobert)
GS7359 pha-1(e2123ts); arEx1983 HLH-4-YFP translational fosmid (Hobert)
GS7362 pha-1(e2123ts); arEx1986 HLH-6-YFP translational fosmid (Hobert)
GS7367 pha-1(e2123ts); arEx1991 HLH-6-YFP translational fosmid (Hobert)
OP74 wgIs74 HLH-8-GFP translational fosmid (Sarov)
GS7364 pha-1(e2123ts); arEx1988 HLH-10-YFP translational fosmid (Hobert)
GS7365 pha-1(e2123ts); arEx1989 HLH-10-YFP translational fosmid (Hobert)
GS7537 pha-1(e2123ts); arEx2113 HLH-12-GFP translational fosmid (Sarov)
GS7538 pha-1(e2123ts); arEx2114 HLH-12-GFP translational fosmid (Sarov)
GS7431 pha-1(e2123ts); arEx2031 HLH-13-GFP translational fosmid (Sarov)
GS7432 pha-1(e2123ts); arEx2032 HLH-13-GFP translational fosmid (Sarov)
GS7542 pha-1(e2123ts); arEx2118 HLH-14-GFP translational fosmid (Sarov)
GS7543 pha-1(e2123ts); arEx2119 HLH-14-GFP translational fosmid (Sarov)
GS7472 pha-1(e2123ts); arEx2055 HLH-15-GFP translational fosmid (Sarov)
GS7477 pha-1(e2123ts); arEx2059 HLH-15-GFP translational fosmid (Sarov)
OH10162 otEx4503 HLH-16-GFP translational reporter (Hobert)
GS7544 pha-1(e2123ts); arEx2120 HLH-17-GFP translational fosmid (Sarov)
GS7545 pha-1(e2123ts); arEx2121 HLH-17-GFP translational fosmid (Sarov)
GS7399 pha-1(e2123ts); arEx2005 HLH-19-GFP translational fosmid (Sarov)
GS7400 pha-1(e2123ts); arEx2006 HLH-19-GFP translational fosmid (Sarov)
GS7541 pha-1(e2123ts); arEx2117 HLH-31-GFP translational fosmid (Sarov)
GS7596 pha-1(e2123ts); arEx2150 HLH-31-GFP translational fosmid (Sarov)
GS7539 pha-1(e2123ts); arEx2115 CND-1-GFP translational fosmid (Sarov)
GS7540 pha-1(e2123ts); arEx2116 CND-1-GFP translational fosmid (Sarov)
GS7426 pha-1(e2123ts); arEx2026 HND-1-GFP translational fosmid (Sarov)
GS7427 pha-1(e2123ts); arEx2027 HND-1-GFP translational fosmid (Sarov)
GS7209 pha-1(e2123ts); arEx1906 LIN-32-GFP translational fosmid (Sarov)
GS7214 pha-1(e2123ts); arEx1910 LIN-32-GFP translational fosmid (Sarov)
GS7544 pha-1(e2123ts); arEx2120 NGN-1-GFP translational reporter (Horvitz)


























Strain Name Genotype Protein expressed by array
Table 2 GS7447 hlh-2(bx108); arIs51; nre-1(hd20) lin-15b(hd126) cdh-3p::gfp
Table 3 GS7535 hlh-2(bx108); arIs222; nre-1(hd20) lin-15b(hd126) lag-2p::2xnls-tagrfp
GS7601 pha-1(e2123ts); arEx2151 lin-3(ACEL-[GG])p::4xnls-gfp
GS7602 pha-1(e2123ts); arEx2152 lin-3(ACEL-[GG])p::4xnls-gfp
GS7603 pha-1(e2123ts); arEx2153 lin-3(ACEL-[GG])p::4xnls-gfp
GS7604 pha-1(e2123ts); arEx2154 lin-3(ACEL-[TA])p::4xnls-gfp
GS7605 pha-1(e2123ts); arEx2155 lin-3(ACEL-[TA])p::4xnls-gfp
GS7606 pha-1(e2123ts); arEx2156 lin-3(ACEL-[TA])p::4xnls-gfp
GS7206 pha-1(e2123ts); arEx1903 hlh-2(prox)::gfp-e47 cDNA (aa1-651)
GS7207 pha-1(e2123ts); arEx1904 hlh-2(prox)::gfp-e47 cDNA (aa1-651)
GS7208 pha-1(e2123ts); arEx1905 hlh-2(prox)::gfp-e47 cDNA (aa1-651)
GS7391 pha-1(e2123ts); arEx2000 hlh-2(prox)::gfp-e47(I588D,589E)
GS7392 pha-1(e2123ts); arEx2001 hlh-2(prox)::gfp-e47(I588D,589E)
GS7393 pha-1(e2123ts); arEx2002 hlh-2(prox)::gfp-e47(I588D,589E)
GS7423 pha-1(e2123ts); arEx2023 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)
GS7424 pha-1(e2123ts); arEx2024 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)
GS7425 pha-1(e2123ts); arEx2025 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)
GS7441 pha-1(e2123ts); arEx2035 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)(I588D,589E)
GS7442 pha-1(e2123ts); arEx2036 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)(I588D,589E)
GS7443 pha-1(e2123ts); arEx2054 hlh-2(prox)::gfp-e47(S352A,T355A,S359A)(I588D,589E)
GS7249 hlh-2(bx108); pha-1(e2123); arEx1903 hlh-2(prox)::gfp-e47 cDNA (aa1-651)
GS7244 hlh-2(bx108); pha-1(e2123); arEx1904 hlh-2(prox)::gfp-e47 cDNA (aa1-651)
GS7450 hlh-2(bx108); pha-1(e2123); arEx2000 hlh-2(prox)::gfp-e47(I588D,589E)
Suppl. Fig. 1 GS7684 arTi3; nre-1(hd20) lin-15b(hd126) hlh-2(prox)::gfp-hlh-2 cDNA (aa1-399) miniMos insertion

















pMS80 hlh-2(prox)::gfp::unc-54 UTR 
pMS84 hlh-2(prox)::gfp-hlh-2::unc-54 UTR 
pMS108 hlh-2(prox)::gfp-hlh-2(ΔPESTs = aa1-72,aa123-399)::unc-54 UTR 
pMS91 hlh-2(prox)::gfp-hlh-2(aa301-399)::unc-54 UTR 
pMS90 hlh-2(prox)::gfp-hlh-2(aa360-399)::unc-54 UTR 
pMS115 hlh-2(prox)::gfp-hlh-2[R316H]::unc-54 UTR = bx108
pMS116 hlh-2(prox)::gfp-hlh-2[I345D,L346E]::unc-54 UTR 
pMS148 hlh-2(prox)::gfp-hlh-2[I353D]::unc-54 UTR 
pMS162 hlh-2(prox)::gfp-hlh-2[C329S]::unc-54 UTR 
pMS183 cky-1a in L4440   (partial gDNA, 88% of coding region) 
pMS163 hlh-4 in L4440      (partial gDNA, 90% of coding region) 
pMS164 hlh-8 in L4440      (partial gDNA, 81% of coding region) 
pMS171 hlh-17 in L4440    (full gDNA, 100% of coding region) 
pMS165 hlh-19 in L4440    (partial gDNA, 86% of coding region) 
pMS166 hlh-25 in L4440    (full gDNA, 100% of coding region) 
pMS167 hlh-26 in L4440    (full gDNA, 100% of coding region) 
pMS172 hlh-27 in L4440    (full gDNA, 100% of coding region) 
pMS173 hlh-34 in L4440    (full gDNA, 100% of coding region) 
pMS180 lin-22 in L4440     (partial gDNA, 69% of coding region) 
pMS184 mdl-1 in L4440     (partial gDNA, 100% of coding region)
pMS177 lin-3(ACEL[GG])::4xnls-gfp 
pMS179 lin-3(ACEL[TA])::4xnls-gfp 
pMS132 hlh-2(prox)::gfp::e12 cDNA::unc-54 UTR 
pMS130 hlh-2(prox)::gfp::e47 cDNA::unc-54 UTR 
pMS135 hlh-2(prox)::gfp::e47[I588D,L589E]::unc-54 UTR 
pMS143 hlh-2(prox)::gfp::e47[S352A,T355A,S359A]::unc-54 UTR 
pMS144 hlh-2(prox)::gfp::e47[S352A,T355A,S359A][I588D,L589E]::unc-54 UTR 
arIs222 pMS102 lag-2p::2xnls-tagrfp
arTi3 pMS175 hlh-2(prox)::gfp-hlh-2::unc-54 UTR in pCFJ910 miniMos backbone
pMS100 hlh-2(prox)::gfp-hlh-2[K342A]::unc-54 UTR 
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Supplemental Figure 1.  Deletion analysis of the hlh-2 intergenic region identifies the 
“prox” element.  The “prox” element of hlh-2 is required and sufficient for expression in 
the AC, in the context of the 5.2kb upstream of the translational start site of hlh-2.  




































Supplemental Figure 2.  Disrupting the proteasome causes GFP-HLH-2 to be stable in 
VUs.  Top: I performed RNAi by feeding to L1 larvae (arTi3[hlh-2prox::gfp-hlh-2]; nre-
1 lin-15b) and scored the number of GFP+ cells mid to late L2 stage larvae.  Percent of 
larvae with 1, 2, 3, or 4 GFP+ cells is shown, and the number scored is in parentheses.  
lacZ(RNAi) and mCherry(RNAi) are negative controls.  lin-12(RNAi) is a positive control, 
as loss of lin-12 causes the AC/VU decision to fail resulting in 2ACs.  rpt-3, rpt-4, and 
rpn-6 are essential components of the proteasome regulatory subunit.  Significant 
differences from the lacZ(RNAi) negative control were determined by two-tailed Fisher’s 
exact test.  Bottom: Shown are three planes of focus for GFP images of a representative 
worm treated with lacZ(RNAi) or rpt-3(RNAi).  The black and white images have been 
inverted, to make the GFP expression (black) easier to see.  An αVU and a βVU are in 
the first plane of focus, the AC is in the second, and the other βVU is in the third.  The 
arrowhead marks the AC, and arrows mark the VU. 
	  
p-value:    * <0.05 




































Supplemental Figure 3.  Expression of GFP-HLH-2 protein in the AC and three VUs.  
The fates of the two α cells Z1.ppp and Z4.aaa are specified by the AC/VU decision. 
Z1.ppp and Z4.aaa each have a sister cell, the β cell, that always becomes a VU.  
Expression of the GFP-HLH-2 constructs was also examined in these cells.  hlh-2prox 
transcription is frequently dimmer in the βVUs than in the αVUs, but it is always clearly 
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Supplemental Figure 4.  Expression of GFP-HLH-2 mutant proteins in the AC and three 
VUs.  All four mutations affect dimerization.  R316H is the point mutation created by the 
hlh-2(bx108) allele.  The middle two mutations are predicted to abolish activity of HLH-2 
dimers (both hetero- and homodimers).  The cysteine mutation is predicted to specifically 
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Supplemental Figure 5.  The predicted PEST sequences in HLH-2 are functional.  The 
N-terminus of HLH-2 is unstable in the AC and VUs in the absence of the bHLH domain 
and C-terminus.  HLH-2 contains two predicted PEST sequences from aa73-122.  These 
PESTs are functional, as deletion of these residues stabilizes the N-terminus.  
Additionally, nuclear localization stabilizes the N-terminus of HLH-2 even when the 
PEST sequences are present.  There is, however, no evidence of the PEST sequences 
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Supplemental Figure 6.  The C-terminus is required for HLH-2 turnover.  The C-
terminus of HLH-2 is aa361-399.  Deletion of the C-terminus causes HLH-2 to be 
stabilized in the VUs.  Finer-scale deletion analysis of the C-terminus resulted in some 
stabilization of HLH-2 in the VUs.  An alignment with E47 shows conservation in the C-
terminus, including several lysine residues.  Mutation of the five lysine residues (red in 
alignment) in the C-terminus affected nuclear localization of HLH-2 but did not have a 





HLH-2  301 KLGILHNAVSVITQLEEQVRQRNMNPKVMAGMKRKPDDDKMKMLDDNAPSAQFGHPRF*
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Supplemental Figure 7.  Optimizing RNAi conditions. I tested four different strains to 
identify a good genetic background for the RNAi screen in Table 2. Loss of lin-12 by null 
allele causes a 2AC defect, so I used it as a test for good RNAi conditions. All four 
strains carry the AC marker cdh-3p::gfp for scoring AC number. The marker alone does 
not show 2AC defects with lin-12 RNAi treatment.  The sensitizer nre-1, lin-15b shows a 
significant 2AC defect by a two-tailed Fisher’s exact test, but the effect was not strong. 
The 2AC defect of hlh-2(bx108) is not enhanced by lin-12 RNAi treatment, but adding 
the RNAi sensitizer to the hlh-2(bx108) background causes a dramatic enhancement of 
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Supplemental Figure 8.  Expression of GFP-E2A proteins in the AC and three VUs.  
The E2A gene has two isoforms, E12 and E47.  [I588D,L589E] has been shown to 
abolish dimerization in vitro.  The ERK site is required for Notch-dependent E47 
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Supplemental Figure 9.  Candidate trans factors do not show evidence of a role in GFP-
HLH-2 turnover in VUs.  Experimental conditions are the same as described in the Suppl. 
Fig. 2 legend.  All ACs are GFP+, and additional GFP+ cells are considered to be VUs.  
No significant differences were observed in the genes tested, except for the positive 
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Supplemental Table 3.  E12 and E47 rescue the 0AC defect of hlh-2(RNAi)-treated 
larvae. 
	  
L1 larvae were treated with hlh-2(RNAi) or lacZ(RNAi) by feeding at 25°C, and AC defects were scored in 
late L3 to early L4 animals.  The presence of an AC was scored by morphology and GFP expression or by 
vulval induction, a functional readout of AC activity.  GFP-HLH-2 is a control strain for RNAi efficiency 
(elimination of GFP expression and hlh-2 activity), and the dimerization mutant forms of E47 fail to rescue 








RNAi-treated animals with AC 
and/or induction (%) 
Genotype Transgene carries hlh-2(RNAi) lacZ(RNAi) 
pha-1; arEx1686 GFP::HLH-2 0/43 (0%) 33/33 (100%) 
pha-1; arEx1903 GFP::E47 33/51 (65%) 29/29 (100%) 
pha-1; arEx1904 GFP::E47 33/40 (82%) 38/38 (100%) 
Genotype Transgene carries hlh-2(RNAi) lacZ(RNAi) 
pha-1; arEx1686 GFP::HLH-2 7/70 (10%) 65/65 (100%) 
pha-1; arEx1903 GFP::E47 40/57 (70%) 27/27 (100%) 
pha-1; arEx2000 GFP::E47[dimer] 2/39 (5%) 31/31 (100%) 
pha-1; arEx2001 GFP::E47[dimer] 4/35 (11%) 23/23 (100%) 
pha-1; arEx1994 GFP::E12 36/53 (68%) 36/36 (100%) 








Chapter 3.  Two bHLH genes lin-32/atonal and hlh-12/TCF15 













 Distal tip cells (DTCs) are essential for gonad morphology and fertility in 
hermaphrodites of the nematode C. elegans.  Specification and function of the DTCs 
requires the basic Helix-Loop-Helix (bHLH) transcription factor hlh-2/E2A.  However, it 
is unknown what other factors are required for HLH-2 to specify cell fate and to promote 
migration and fertility.  I identify here lin-32/atonal and hlh-12/TCF15 as two 
functionally redundant heterodimer partners of HLH-2 for DTC leader function.  In 
addition, there is a novel role for lin-32 in promoting proper guidance of the migrating 
DTC.  This migration defect is distinct from the previously characterized role of hlh-12 in 
DTC migration.  I also present evidence that these genes may function redundantly to 
specify DTC fate.  Expression of lin-32 and hlh-12 is observed soon after DTCs are born, 
suggesting a cell-autonomous role in the DTC.  This work identifies important partners 
for HLH-2 as it promotes DTC function and possibly specification.  It also provides 
insight into how different combinations of bHLH transcription factors can have 
overlapping and non-overlapping roles in promoting the fate and function of a cell.   
 
INTRODUCTION 
During development, specification of different cell fates is a tightly regulated 
process. It requires precise spatial and temporal control of gene expression. Specified 
cells must then be able to migrate, to signal, to adopt specific shapes, to form junctions, 
and so on, in order to execute their differentiated functions.  Gonadogenesis in C. elegans 
provides several excellent contexts in which to study how cell fates are specified and how 
the functions of the cell are executed at the molecular level.  The two somatic gonad 
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precursor cells Z1 and Z4 give rise to the entire somatic gonad.  The hermaphrodite 
gonad is organized along a proximal-distal axis, with an anchor cell occupying a 
proximal position and two hermaphrodite distal tip cells (hDTCs) occupying each end of 
the gonad (Figure 1).  
In C. elegans, the Wnt signaling pathway and ceh-22/Nkx2.5 are important for the 
proximal-distal asymmetry of the first divisions of somatic gonad precursor cells 
(Siegfried and Kimble 2002; Siegfried et al. 2004; Lam et al. 2006).  Loss of pop-1/TCF 
or ceh-22, for example, causes a symmetric division that produces extra proximal cells at 
the expense of distal cells (Siegfried and Kimble 2002; Siegfried et al. 2004).  Thus these 
factors are required to specify the lineage that gives rise to the DTCs.  Unlike ceh-22 or 
pop-1 mutants, loss of hlh-2 causes DTC specification to fail without altering the DTC 
lineage (Karp and Greenwald 2004).  Thus hlh-2 is required for specification of DTC fate 
per se, but not for the distal lineage. 
hlh-2 encodes a basic Helix-Loop-Helix (bHLH) transcription factor that is the 
sole E protein in C. elegans (Krause et al. 1997).  E proteins, also called Class I bHLH 
proteins, are essential for development in C. elegans (Krause et al. 1997), Drosophila 
(Cronmiller and Cline 1987), and mammals (Zhuang et al. 1996).  Dimerization is 
essential for E protein activity.  Two bHLH proteins dimerize through hydrophobic 
interactions between their HLH regions; dimerization brings the DNA binding region of 
each protein together to create a functional transcription factor 	  
(Voronova and Baltimore 1990; Ellenberger et al. 1994).  E proteins can either 
homodimerize or they can heterodimerize with Class II bHLH partners, and choice of 
dimerization partner is thought to guide DNA binding specificity (Massari and Murre 
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2000).  Identifying the dimerization partners of HLH-2 is thus important for 
understanding how HLH-2 functions during development. 
Dimerization partners of HLH-2 are known to be important for specification and 
differentiation of many different cell types.  In male ray development, hlh-2 and the class 
II bHLH gene lin-32 are required to specify the ray neuroblast, and then they are required 
for differentiation of the ray lineage (Zhao and Emmons 1995; Portman and Emmons 
2000).  hlh-2 and the class II gene hlh-14 are required for fate specification in the 
PVQ/HSN/PSB, ASE, and C neuronal lineages, and also later during lineage 
differentiation (Frank et al. 2003; Poole et al. 2011).  In the hermaphrodite gonad, hlh-2 
homodimers are required for specification and differentiation of the anchor cell (Chapter 
2, Karp and Greenwald 2003; Karp and Greenwald 2004; Hwang and Sternberg 2004).   
In the hermaphrodite, hlh-2 is required for both DTC specification and terminal 
differentiation (Karp and Greenwald 2004; Tamai and Nishiwaki 2007; Chesney et al. 
2009).  Once its fate is specified, the DTC has two crucial functions:  (1) a leader 
function; and (2) a niche function (Kimble and Hirsh 1979; Kimble and White 1981; Lam 
et al. 2006).  The leader function involves DTC migration, which guides gonad 
elongation and thus the ultimate reflexed shape of the gonad.  The gonad is arranged with 
rotational symmetry along a proximal/distal axis.  The DTCs first migrate and extend the 
gonad in a distal direction, away from the worm midbody; then they turn and migrate to 
the dorsal side; and finally they turn and migrate in a proximal direction along the dorsal 
side toward the midbody region (Fig. 1).  The two turns create U-shaped gonad arms.  
DTC migration and turning is precisely controlled, and requires basement membrane 
remodeling and regulation of cell adhesion.  Remodeling depends on the activity of the 
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ADAMTS metalloprotease gon-1 and changes in cell adhesion require the α-integrins 
ina-1 and pat-2 (Blelloch and Kimble 1999; Meighan and Schwarzbauer 2007; Wong and 
Schwarzbauer 2012).  The class II bHLH protein HLH-12/TCF15 forms a heterodimer 
with HLH-2 to directly activate transcription of gon-1 (Tamai and Nishiwaki 2007).  Loss 
of hlh-12 causes failure of DTC migration and gonad elongation, resulting in a 
malformed gonad (Tamai and Nishiwaki 2007). 
The “niche function” of the DTC involves promoting germline proliferation 
through activation of the Notch signaling pathway (Lam et al. 2006).  DTCs express the 
DSL ligand lag-2, and neighboring germ cells express glp-1/Notch (Austin and Kimble 
1987; Henderson et al. 1994).  Long processes extend out from the DTCs and contact 
many germ cells (Fitzgerald and Greenwald 1995).  LAG-2 activates GLP-1/Notch in the 
germ cells that directly contact the DTC, which promotes mitosis and thus germ cell 
proliferation (Austin and Kimble 1987; Henderson et al. 1994).  Further down the gonad 
arm, germ cells lose contact with the LAG-2-expressing DTC, thereby losing GLP-
1/Notch activity and causing the germ cells to exit mitosis and enter meiosis (Austin and 
Kimble 1987; Henderson et al. 1994).  The niche function of the DTC is also dependent 
on HLH-2, as lag-2 is a direct transcriptional target of HLH-2 in the DTC (Chesney et al. 
2009). 
Until this work, the dimerization partners of HLH-2 for DTC specification were 
unknown.  Tamai and Nishiwaki (2007) showed that HLH-2 heterodimerizes with HLH-
12 to promote gonad elongation as part of the DTC leader function.  However, loss of 
hlh-2 enhances the DTC migration defect of hlh-12 null mutants, suggesting that an 
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additional dimerization partner may be involved in migration (Tamai and Nishiwaki 
2007).  
Here I identify a novel role for two class II bHLH transcription factors, lin-
32/atonal and hlh-12, in promoting DTC fate.  Neither gene is individually required, but 
simultaneous loss of both causes a complete failure of gonad elongation.  In addition, a 
DTC frequently cannot be identified by fluorescent marker.  This suggests that HLH-12--
HLH-2 and LIN-32--HLH-2 heterodimers are functionally redundant for DTC migration, 
and may also be required for DTC fate specification.  I find that loss of lin-32 causes a 
partially penetrant DTC guidance defect, unlike the elongation defect of hlh-12 mutant 
hermaphrodites.  This suggests that the roles of hlh-12 and lin-32 diverge somewhat after 
DTC specification, such that they have some non-overlapping roles in promoting the 
DTC leader function.  I observe lin-32 and hlh-12 expression soon after the DTCs are 
born, consistent with a cell-autonomous role in the DTC to specify its fate.  Additionally, 
a potential role is found for lin-32 in the male DTC, suggesting lin-32 may be an 
important regulator of both male and hermaphrodite gonad development. 
 
MATERIALS AND METHODS 
C. elegans Genetics 
Strains were grown and maintained under standard conditions at 15°C or 20°C 
(Brenner 1974).  The following alleles and transgenes were used in this study:  LGI: hlh-
2(bx108ts); LGIII: pha-1(e2123ts), LGIV: arIs51[cdh-3p::gfp], hlh-12(tk68), 
oxTi414[eft-3p::mCherry], ccIs4443[arg-1p::gfp]; LGV: arIs222[lag-2p::2xnls-tagrfp], 
him-5(e1490); LGX: nre-1(hd20) lin-15b(hd126), lin-32(tm1446).  hlh-12(tk68) and lin-
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32(tm1446) are both deletion alleles that remove a large portion of the bHLH domain, 
making them likely null alleles.  
The transgene arIs222 is described in Chapter 2.  See Supplemental Table 3 for a 
complete list of strains used in this study, including all new transgenic strains.  The 
transgene otIs[lin-32-gfp] is an integrated translational LIN-32-GFP fosmid reporter, 
generated from arEx1906 using standard procedures (Mello and Fire 1995).  The 
transgene otIs[hlh-12-gfp] is an integrated translational HLH-12-GFP fosmid reporter, 
generated from arEx2113.  Both integrants were generously provided by N. Masoudi 
(Hobert lab).  Details for the extrachromosomal arrays are described in the methods of 
Chapter 2. 
The following injection conditions were used to make the hlh-2p::gfp DTC 
marker arEx2194:  pMS2 (hlh-2(5.2kb)p::gfp::unc-54 UTR) and pBX (pha-1(+)) were 
injected at 1 ng/µL, pJL17 (ttx-3p::mCherry) at 2 ng/µL, and PvuII-digested N2 genomic 
DNA at 50 ng/µL into pha-1(e2123ts) P0 hermaphrodites.  Independent transgenic lines 
were isolated as described (see Chapter 2 methods).   
 
RNA interference 
RNA interference (RNAi) was administered through feeding worms bacteria 
expressing double-stranded RNA specific to a single gene.  RNAi clones for the 41 
bHLH genes (excluding hlh-2) either were made or were obtained from the Ahringer 
RNAi library (Kamath et al. 2003), and verified by sequencing.  See Chapter 2 for details 
of RNAi plasmid construction and RNAi experimental conditions.  Briefly, embryos 
were collected and allowed to hatch on RNAi plates at 25°C.  Approximately 40 hours 
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later, normal larvae at the early L4 larval stage have begun vulval invagination and the 
DTCs have completed both turns.  Animals were mounted on slides and examined using 
the 63x objective of a Zeiss Axio Imager D1 microscope to score DTC defects.  RNAi 
targeting lacZ was used as a negative control and RNAi targeting hlh-12 was used as a 
positive control for every experiment.  
For the bHLH gene RNAi screen, distal tip cells were identified by morphology 
and by expression of lag-2p::rfp, a marker of DTCs.  DTCs were scored as “defective” 
when vulval invagination was underway, but the distal tip cells had not completed both 
turns.  The hypomorphic hlh-2(bx108ts) allele was used to sensitize the strain to possible 
redundancy of HLH-2 dimerization partners in DTC specification and function.  nre-
1(hd20), lin-15b(hd126) was used to increase the sensitivity of somatic tissues to RNAi. 
For lin-32, the candidate identified by the RNAi screen, I repeated the experiment 
in triplicate, along with controls.  RNAi experiments were performed as described above.  
I scored expression of lag-2p::rfp, a direct transcriptional target of hlh-2 in the DTC 
(Chesney et al. 2009), as well as the same RNAi turning defects as described above.  I 
scored hlh-12(RNAi) and hlh-2(RNAi) as positive controls, and lacZ(RNAi) as a 
negative control. 
 
Scoring mutants for DTC defects 
 Mutant animals were grown as homozygotes except for double mutants with hlh-
12(tk68) due to complete or high sterility.  In those cases, hlh-12(tk68) mutants came 
from heterozygous mothers with hlh-12(tk68) balanced by either arIs51 or oxTi414.  
Mutants were grown at 25°C and examined for evidence of DTC defects, both defective 
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migration and specification.  To determine if DTC specification failed, I relied on three 
criteria: the lack of an obvious DTC by morphology, by DTC markers, and by a lack of 
gonad elongation, reflecting the lack of DTC leader function.  Migration defects included 
failure of gonad elongation and failure to properly guide gonad elongation.  See 
Supplemental Table 3 for the list of strains used.   
 The DTC markers lag-2p::rfp and hlh-2p::gfp were used to determine if DTC fate 
is specified.  The strain pha-1(e2123); hlh-12(tk68)/oxTi414[eft-3p::mCherry]; arIs222; 
lin-32(tm1446); arEx2194[hlh-2(5.2kb)p::gfp] was used, and oxTi414(+) and oxTi414(-) 
siblings were compared from hlh-12(tk68)/oxTi414 mothers.  Images were taken using 
the 40X objective of a Zeiss Axio Imager D1 microscope and a Zeiss AxioCam MRm 
camera.  Expression at a 10 ms GFP and 10 ms DsRed exposure time was scored as “ON.”  
tagRFP expression driven by lag-2 in the DTC is clearly visible, even when oxTi414 
(with brightly expressed mCherry in all cells) is present. 
 The male DTC marker arg-1p::gfp was used to determine if lin-32 has a role in 
mDTC development.  The him-5 mutation e1490 was used to generate males and 
ccIs4443[arg-1p::gfp] marks mDTCs.  Expression of the mDTC marker was examined in 
lin-32(tm1446) and hlh-2(bx108) single and double mutant backgrounds using the 
microscope described above.  Expression was readily visible with a 5 ms GFP exposure.  
Worms were synchronized via bleaching gravid hermaphrodites to harvest eggs.  The 
embryos were raised at 25°C for approximately two days, and L4 males were scored for 





bHLH reporter expression 
Gravid hermaphrodites were transferred to plates and kept at 25°C. Two days 
later, larvae were scored for GFP expression in the DTCs. Worms were mounted on 2% 
agarose pads on a slide and immobilized with 10 mM levamisole in M9. GFP expression 
was analyzed using the 63X objective of the microscope described above. Expression at a 
400 ms GFP exposure time was scored as “ON.”  The presence of him-5(e1490) made it 
possible to examine expression of lin-32 and hlh-12 in males and in hermaphrodites.  The 
hermaphrodite DTCs and the male linker cell were identified by morphology and position 
with DIC and then examined for GFP expression.  The male DTCs (mDTCs) can be 
harder to identify by morphology.  Also, later lin-32 expression in mDTCs becomes very 
dim, making it possible that the number of GFP(+) mDTCs are underreported, due to 
difficulties identifying them confidently. 
 
RESULTS 
An RNAi screen of bHLH genes reveals a role for lin-32 in the DTC. 
Previous work has shown that hlh-12 and hlh-2 are important in the DTC.  In hlh-
12(0) mutants, gonad elongation is frequently incomplete, but DTC specification and the 
niche function remain intact (Tamai and Nishiwaki 2007).  hlh-2, the heterodimer partner 
for HLH-12, is also required for DTC leader function (Karp and Greenwald 2004; Tamai 
and Nishiwaki 2007).  In addition, hlh-2 is required for DTC specification and niche 
function (Karp and Greenwald 2004; Chesney et al. 2009).  This suggests that HLH-2 
either homodimerizes or that it heterodimerizes with a second bHLH protein to carry out 
its other roles in DTC specification and the DTC niche function.   
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To identify potential partner(s) of HLH-2 in the DTC, I performed an RNAi-
based screen of the 41 other bHLH-containing worm genes, as identified by SMART 
(Schultz et al. 1998).  I used a genetic background that is sensitized in two ways:  (1) nre-
1 lin-15b to sensitize somatic tissue to RNAi (Schmitz et al. 2007), and (2) the 
hypomorphic allele hlh-2(bx108) or “hlh-2(h)” to sensitize worms to potential 
redundancy of HLH-2 partners.  By the early L4 stage, DTC turning has occurred and 
vulval invagination is underway (Kimble and Hirsh 1979).  I therefore used vulval 
invagination as an independent morphological marker of the stage to score DTC defects; 
a DTC was considered defective (or not specified) if the gonad arm had not reflexed 
(completed both turns) by the time vulval invagination had occurred, or if lag-2 
expression was absent.  
RNAi-mediated knockdown of hlh-12, in the genetic background described above, 
results in a highly penetrant DTC migration defect (Suppl. Fig. 1).  hlh-12(RNAi) animals 
retain the DTCs, but gonad elongation is abnormal.  This indicates that DTC specification 
is occurring and that DTC migration is defective, consistent with previous work (Tamai 
and Nishiwaki 2007).  The screen identified one other bHLH gene, lin-32, as a candidate 
partner for HLH-2 in the DTC (Suppl. Fig. 1).  LIN-32, the ortholog of Atonal, is a well-
characterized dimerization partner of HLH-2 in male ray development (Zhao and 
Emmons 1995; Portman and Emmons 2000), but it was previously unknown to play a 
role in the DTC.  
To determine if lin-32 is required for DTC specification or for DTC function, I 
retested lin-32 for DTC defects by RNAi, along with hlh-12(RNAi), hlh-2(RNAi), and the 
negative control lacZ(RNAi) (Fig. 2).  I scored the effect of RNAi on lag-2 expression in 
	  
 98 
the DTC and on DTC migration in the same genetically-sensitized background as used in 
the RNAi screen (hlh-2(h); lag-2p::rfp; nre-1, lin-15b).  lacZ(RNAi) control larvae show 
normal DTC turning and normal expression of lag-2 in the DTCs (Fig. 2B,C).  Loss of 
hlh-2 causes the complete failure of DTC migration and loss of lag-2 expression in the 
DTC, consistent with a failure of DTC specification (Fig. 2B,D).  Loss of hlh-12 causes a 
dramatic DTC migration defect but has no effect on expression of lag-2, which clearly 
still marks the DTC (Fig. 2B,E).  This indicates a failure in DTC migration but not in 
DTC specification or niche function.  
The lin-32(RNAi) defects are less penetrant but very similar to the DTC defects 
that are observed with loss of hlh-2 – simultaneous failure of DTC migration and lag-2 
expression (Fig. 2B,F).  lag-2 is a transcriptional target of hlh-2 in the hermaphrodite 
DTC (Chesney et al. 2009), and it is essential for the DTC niche function; without lag-2 
in the DTC to activate GLP-1/Notch in germ cells, germ cells do not undergo mitosis and 
instead undergo meiosis and differentiate into sperm (Kimble and White 1981; Austin 
and Kimble 1987; Lambie and Kimble 1991; Henderson et al. 1994).  Loss of lag-2 
expression could reflect a loss of the DTC niche function or a failure to specify DTC fate.  
However, the lin-32(RNAi) DTCs either appear normal by both lag-2 expression and 
migration (Fig. 2F, right), or show no detectable lag-2 expression or migration (Fig. 2F, 
left).  The small number of turned RFP(-) DTCs is similar between lin-32(RNAi) and the 
negative control lacZ(RNAi), indicating that the occasional DTC lacking lag-2 expression 
is due to the hlh-2(h) mutation and not to lin-32(RNAi).  These observations suggest that 
lin-32, like hlh-2, is required for DTC specification, independent of a possible role in 
promoting the DTC niche function or migration. 
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lin-32 and hlh-12 have distinct roles in leader function of the DTC 
 The RNAi results suggest that lin-32 may be involved in DTC specification, while 
hlh-12 is required for DTC migration. To better understand the role of each gene, I next 
examined the phenotype of null mutants.  Surprisingly, lin-32(0) hermaphrodites show no 
evidence of a DTC specification defect in an hlh-2(+) background, though a partially 
penetrant DTC migration defect is observed (Fig. 3A).  Only the posterior gonad arm 
shows migration defects, all of which involve defective DTC guidance rather than 
defective gonad elongation (Figure 3A, Suppl. Tables 2 and 3).  The most commonly 
observed defect is for the posterior arm to fail to turn and migrate toward the dorsal side 
(n = 12/50).  The DTC instead completes the proximal turn without the dorsal turn, and 
migrates back toward the worm midbody along the ventral side (Fig. 3E).  I observed a 
second related defect:  late migration of the DTC to the dorsal side.  In this case, as the 
DTC migrates back toward the worm midbody, it guides the reflexed gonad arm along 
the ventral side and then crosses to the dorsal side (n = 4/50). 
 By contrast, the DTCs of hlh-12(0) worms show clear evidence of gonad 
elongation defects (Suppl. Table 3).  The DTCs frequently fail to complete the two DTC 
turns (dorsal, then proximal) or they fail to turn at all by the time of vulval invagination 
(Fig. 3A,C; Suppl. Table 2).  hlh-2(h) single mutant hermaphrodites show no DTC 
defects (Fig. 3A,B), but hlh-2(h) enhances the migration defects of hlh-12(0) (Fig. 3A), 
suggesting that an additional bHLH gene is involved in the elongation function of DTC 
migration (Suppl. Table 2).  This is consistent with previous studies (Tamai and 
Nishiwaki 2007).  Thus, even though both hlh-12 and lin-32 are involved in DTC 
migration, they are required for separate functions.  hlh-12 appears to promote gonad 
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elongation, while lin-32 is important for guiding the dorsal turn of the DTC during gonad 
elongation.   
 
lin-32 and hlh-12 function redundantly to promote DTC fate. 
lin-32 and hlh-12 mutants individually show evidence of defective DTC migration, 
but DTC specification, niche function, and some leader function still occur.  However, in 
the hlh-2(h) background, loss of lin-32 by RNAi seems to cause failure of DTC 
specification.  This potentially implicates lin-32 in DTC specification, but it also suggests 
that other HLH-2 heterodimer partners may be sufficient to promote DTC specification.  
A simple hypothesis is that hlh-12 and lin-32 might act redundantly during DTC fate 
specification.  If so, then the hlh-12(0); lin-32(0) double mutant should have a highly 
penetrant failure of DTC specification and thus a complete lack of gonad elongation.  In 
50/50 hlh-12(0); lin-32(0) hermaphrodites, there is no evidence of gonad elongation (Fig. 
3A,E).   
To determine if hlh-12 and lin-32 are required for DTC fate specification or for 
DTC leader function, I looked for expression of two DTC markers, lag-2 and hlh-2, in 
hlh-12(0); lin-32(0) hermaphrodites.  hlh-12(0/+); lin-32(0) hermaphrodites rarely show 
evidence of DTC specification defects (Fig. 4A,B,D).  By contrast, I could not identify 
approximately 60% of DTCs in hlh-12(0); lin-32(0) double mutant hermaphrodites by 
either lag-2 or hlh-2 expression, suggesting that DTC fate was not specified (Fig. 
4A,C,E).  This interpretation will be further tested with additional DTC markers.  When 
lag-2 and hlh-2 expression is observed, it is often dim (Fig. 4E).  Interestingly, when lag-
2 and hlh-2 expression is observed, there is often evidence of germline proliferation (not 
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shown), suggesting that lin-32 and hlh-12 are not specifically required for the niche 
function of the DTC.  This observation is preliminary and will be investigated further. 
Since previous work showed that LIN-32 and HLH-12 are heterodimer partners of 
HLH-2 (Portman and Emmons 2000; Tamai and Nishiwaki 2007), I propose that HLH-2 
heterodimerizes with either LIN-32 or HLH-12 in Z1.aa and Z4.pp to promote DTC fate 
specification and migration.  These worms all have one AC (see vulval invagination in 
Fig. 4E), so the observed loss of DTCs is unlikely to be due to a Wnt pathway-related 
lineage defect (Siegfried and Kimble 2002). Thus in addition to their roles in DTC leader 
function, hlh-12 and lin-32 appear to function redundantly to specify DTC fate.   
 
hlh-12 and lin-32 are expressed in DTCs soon after the DTCs are born. 
I next used translational fosmid reporters to determine where and when lin-32 and 
hlh-12 are expressed.  In hermaphrodites, Z1.aa and Z4.pp are born in the first (L1) larval 
stage and become specified as hermaphrodite DTCs (hDTCs).  LIN-32-GFP and HLH-
12-GFP reporters both show expression in the hDTCs, starting in the L1 (Fig. 5A,E,G).  
HLH-2 expression has also been observed in the hDTCs in the late L1 but not in the 
parents of the hDTCs (Karp and Greenwald 2004).  The timing and location of lin-32 and 
hlh-12 expression is consistent with a cell-autonomous role for lin-32 and hlh-12 in 
promoting hDTC fate.  I also observe lin-32 and hlh-12 expression in hDTCs during later 
larval stages (Fig. 5A,C,E,I), which is consistent with their roles in the hDTC leader 
function. 
Until now, I have only discussed hermaphrodite gonad development.  However, 
the male gonad also has DTCs (mDTCs), so I examined males to look for expression of 
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lin-32 and hlh-12.  The male linker cell (LC) carries the leader function in male 
gonadogenesis, while the two mDTCs have the niche function.  Previous work showed 
that hlh-12 is expressed in the male LC (Tamai and Nishiwaki 2007), which migrates 
while the mDTCs remain stationary.  I also observed this pattern of expression (Fig. 
5B,C), though this reporter is not expressed frequently in older larvae.  I also observed 
lin-32 expression in both the mDTCs and later in the migrating LC (Fig. 5F,H,J).  Later 
lin-32 expression in the mDTCs becomes very dim, but the initial expression is bright.  It 
is thus possible that lin-32 is required for hermaphrodite and male DTC specification, and 
is then required for hermaphrodite DTC and male LC migration.   
 
lin-32 and hlh-2 are required in male DTCs for expression of arg-1. 
 To determine if lin-32 and hlh-2 are important for male DTC function and/or 
specification, I asked whether expression of the well-characterized mDTC marker arg-1 
is affected in lin-32 or hlh-2 mutant backgrounds (Fig. 6).  In a wild-type or hlh-2(bx108) 
background, robust arg-1 expression is observed in both mDTCs.  However, in a lin-
32(0) background, arg-1 expression is frequently observed in only one mDTC.  
Additionally, in the hlh-2(h); lin-32(0) double mutant background, males frequently show 
no expression of arg-1.  This suggests that lin-32 has a role in the mDTC, and the 
enhancement of the defect by hlh-2(h) suggests that other bHLH genes may play a role as 
well.  It is unclear whether the mDTC fails to be specified, or whether the expression of 
some mDTC genes is lost.  Further examination of these mutants will reveal if this is a 





 Here I investigate how the bHLH transcription factor HLH-2 is able to promote 
DTC specification and DTC function in the hermaphrodite gonad.  This work identifies 
two functionally redundant bHLH genes, lin-32 and hlh-12, as absolutely required for 
DTC migration and important for DTC specification.  In addition, lin-32 has a different 
specific role than hlh-12 has in promoting the leader function of the differentiated DTC.  
While hlh-12 is known to promote gonad elongation (Tamai and Nishiwaki 2007), lin-32 
is important for DTC guidance, particularly during the first turn toward the dorsal side.  
lin-32 and hlh-12 are expressed early in the DTC, consistent with a cell-autonomous role 
in specifying DTC fate and in promoting DTC guidance.  HLH-2 is an obligate dimer and 
LIN-32 and HLH-12 can heterodimerize with HLH-2 (Portman and Emmons 2000; 
Tamai and Nishiwaki 2007).  I propose that HLH-2 heterodimerizes with either LIN-32 
or HLH-12 to specify DTC fate in hermaphrodites, and that LIN-32--HLH-2 and HLH-
12--HLH-2 heterodimers play different roles in promoting DTC leader function (Fig. 7).  
Additionally, I find a novel role for lin-32 in the male DTC.  Here, I discuss how 
different dimerization partners for HLH-2 may direct cell fate specification in the gonad, 
the possibility of a proneural-like role for lin-32 in the DTC, and potential regulation of 
lin-32 downstream of the Wnt signaling pathway. 
 
Identification of dimerization partners of HLH-2 during gonadogenesis 
 During hermaphrodite gonadogenesis, hlh-2 is required to specify two different 
cell fates: the anchor cell (AC), and the hermaphrodite distal tip cell (hDTC).  The AC is 
specified as the result of a lin-12/Notch-mediated decision.  hlh-2 is required for AC 
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competence, for AC specification, and for AC function (Karp and Greenwald 2003; 2004; 
Hwang and Sternberg 2004).  In the DTC, the Wnt pathway and ceh-22/Nkx2.5 seem to 
be required for DTC competence (Siegfried and Kimble 2002; Siegfried et al. 2004; Lam 
et al. 2006), and hlh-2 is required for DTC specification and function (Karp and 
Greenwald 2004; Tamai and Nishiwaki 2007; Chesney et al. 2009).  The AC and the 
DTC have very different characteristics.  The AC remains in the middle of the gonad, 
expresses lin-3/EGF, invades the basement membrane, directs uterine development, and 
eventually fuses to the uterine seam cell.  The DTC, by contrast, has long cellular 
processes, drives gonad elongation as it migrates away from the center of the worm, 
promotes basement membrane remodeling, directs gonad reflexion as it turns twice, and 
migrates back toward the worm midbody.  How does HLH-2 promote fate and function 
of such different cells in the same tissue? 
 Chapters 2 and 3 show that HLH-2 has different dimerization partners in the AC 
and in the DTC.  HLH-2 functions as a homodimer to drive expression of specific targets, 
like lin-3 and lag-2 (see Chapter 2).  This chapter presents evidence that two HLH-2 
heterodimerization partners, LIN-32 and HLH-12, promote DTC function and fate 
specification.  The DTC specification defect of the hlh-12; lin-32 double mutant is highly 
penetrant, but a DTC is still able to be identified approximately 40% of the time.  By 
contrast, loss of hlh-2 by RNAi seems to cause a fully penetrant failure to specify DTC 
fate (Fig. 2).  No other candidate heterodimer partners for HLH-2 were identified in the 
initial DTC screen.  One explanation is that HLH-2 homodimers are capable of 
specifying DTC fate.  Alternatively, I may have missed a third heterodimer partner in the 
RNAi screen.  The first explanation is possible, because previous work has shown that 
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ectopically expressing HLH-2 alone can cause additional DTCs to be specified (Karp and 
Greenwald 2004).  This raises the possibility that HLH-2 alone may be sufficient to 
specify DTC fate.  However, it is not known which cell becomes ectopically specified as 
a DTC, so it is also possible that lin-32 or hlh-12 is expressed in that cell.  
I am also interested in knowing if lin-32 acts cell-autonomously to promote DTC 
fate, and if so, what its transcriptional targets are.  Unfortunately, attempts to rescue lin-
32(0) in the DTCs were unsuccessful, due to dominant defects cause by overexpressing 
lin-32 in the DTCs (not shown).  Indeed, even the LIN-32-GFP fosmid reporter causes 
the animals to be unhealthy with occasional DTC defects.  However, hlh-12 and lin-32 
are expressed in the DTC in the L1 stage, consistent with a cell-autonomous role in 
promoting DTC specification.   
Targets of HLH-2 in the DTC include gon-1 and lag-2.  Interestingly, although 
lag-2 expression depends on hlh-2 in both the AC and the DTCs, different cis elements in 
the lag-2 promoter drive expression in the different cells (Karp and Greenwald 2003; 
Chesney et al. 2009).  Due to the many differences between the AC and DTCs, hlh-2 
likely is required to drive different target genes in these cells.  The dimerization partner 
of E proteins like HLH-2 are generally thought to guide target specificity (Massari and 
Murre 2000).  I therefore propose that expression of lin-32 and hlh-12 guides the choice 
of HLH-2 transcriptional targets in the DTC, and that the lack of partners of HLH-2 in 
the AC allows HLH-2 homodimers to form and to drive expression of other target genes.   
In the DTC, hlh-12 and lin-32 could in principle drive expression of the same 
transcriptional targets or of different targets.  Each mutant has different DTC migration 
defects individually, suggesting that hlh-12 and lin-32 may have some non-overlapping 
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targets.  However, the double mutant migration defect is much more severe even when a 
DTC is specified, and this could be explained in two ways:  (1) hlh-12 and lin-32 could 
redundantly drive expression of some of the same targets, or (2) hlh-12 and lin-32 drive 
expression of different target genes, and those two sets of target genes are individually 
sufficient to promote DTC migration.  These possibilities will be distinguished in future 
studies by examining the expression of different DTC markers in the different single and 
double mutant backgrounds. 
 
Possible functional redundancy of HLH-2 partners in other contexts 
 hlh-2 is required for embryonic development and viability (Krause et al. 1997; 
Nakano et al. 2010).  By contrast, null mutations in most HLH-2 dimerization partners do 
not affect viability.  In the case of the DTC, hlh-12(0) and lin-32(0) mutants show no 
specification defect on their own.  However, the double mutant is sterile due to the 
malformed gonad and what is likely a highly penetrant failure in DTC specification.  
It is possible that functionally redundant dimerization partners mask the role of 
bHLH genes in other tissues as well.  For example, hlh-3 is an Achaete-Scute family 
member, and it is expressed in many cells including many neuronal precursors during 
embryogenesis (Krause et al. 1997).  However, hlh-3(0) mutants are viable and have 
relatively mild defects, primarily affecting differentiation of the hermaphrodite-specific 
neuron (Doonan et al. 2008).  By contrast, mice lacking the Achaete-Scute family 
member Mash-1 die at birth and show severe neurogenesis defects that affect the 
telencephalon and the olfactory sensory epithelium (Guillemot et al. 1993; Bertrand et al. 
2002).  It is perhaps surprising that loss of hlh-3 has such a comparatively mild 
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phenotype.  One possible explanation is that functionally redundant partners of HLH-2 
are expressed in those tissues, which might mask the full developmental role for hlh-3.  
There are three other Achaete-Scute family members in C. elegans.  However, bHLH 
genes of different families can be functionally redundant, as this work shows in the DTC 
with lin-32 and hlh-12.  The findings in this chapter suggest that in future studies of 
bHLH genes, functional redundancy should be an important consideration.   
 
LIN-32/Atonal/Atoh1 in development and disease 
 lin-32 and its orthologs, atonal in Drosophila and Atoh1/Math1 in humans, are 
considered to be proneural because of their many roles during neuron development.  In C. 
elegans, lin-32 is required to specify the male ray neuroblast and then later to promote the 
differentiation of neuroblast descendants (Portman and Emmons 2000).  lin-32 is also 
required for specification of the neuroblasts that give rise to the touch receptor neurons 
AVM, PVM, PLM, and PVD (Way and Chalfie 1989), as well as for ALM migration (Du 
and Chalfie 2001).  In Drosophila, atonal is required to specify sensory organ precursor 
cells that give rise to the chrodotonal, or stretch-sensing, organs of the peripheral nervous 
system (Jarman et al. 1993).  It is also required during eye development to specify the R8 
photoreceptor, which then induces further photoreceptor cell specification (Jarman et al. 
1994).  In humans, Atoh1 is required for granule neuronal precursor proliferation in the 
developing cerebellum, and overexpression of Atoh1 is implicated in medulloblastoma 
(Roussel and Hatten 2011). 
I find here a role for lin-32 in the (non-neuronal) distal tip cells of the 
hermaphrodite somatic gonad.  Interestingly, the dorsal turn of migrating DTCs relies on 
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the netrin guidance system, which is also used by many neurons for migration and axon 
guidance.  The DTC expresses unc-5 and unc-40, two netrin receptors (Su et al. 2000; 
Chan et al. 1996).  Loss of either receptor or loss of unc-6/netrin results in a DTC 
migration defect, where DTCs frequently fail to make the dorsal turn (Hedgecock et al. 
1990).  Instead, the gonad reflexes and grows toward the worm midbody along the 
ventral surface.  The posterior DTC fails much more frequently than the anterior DTC.   
lin-32(0) DTCs also show similar defects: failure of the posterior DTC to turn toward the 
dorsal side.  hlh-3 is important for unc-40 expression in HSNs (Doonan et al. 2008), so I 
speculate that in the DTC, lin-32 might be required for unc-5 or unc-40 expression.  If 
this were the case, then lin-32 might be important for some of the neuronal-like 
characteristics (netrin guidance for migration) in the DTC.   
I also find that lin-32 is expressed in the male linker cell (LC).  Hermaphrodites 
and males have some very interesting differences with regard to their distal tip cells.  In 
the hermaphrodite, the leader function and the niche function are both carried out by the 
hDTC.  By contrast, in the male, the mDTC has the niche function, but the LC has the 
leader function and it guides gonad elongation and migration (Kimble and Hirsh 1979).  
It is possible that lin-32 has the same role in males as it does in hermaphrodites: 
specifying DTC fate and guiding migration of the leader cell.  Consistent with this 
possibility, lin-32 is expressed early in the mDTCs and also in the LC around the time it 
begins to migrate.  Preliminary results suggest that lin-32 plays a role in the mDTC, and I 





The Wnt pathway and bHLH expression 
 In the proximal hermaphrodite gonad, hlh-2 promotes AC competence.  By 
contrast, the Wnt signaling pathway and ceh-22/Nkx2.5 promote the distal lineage in the 
gonad (Siegfried and Kimble 2002; Siegfried et al. 2004; Lam et al. 2006).  The Wnt 
pathway transcription factor POP-1/TCF directly promotes ceh-22 transcription in the 
distal lineages (Lam et al. 2006).  This indicates that the Wnt pathway promotes ceh-22 
expression, which may confer the competence to adopt DTC fate.  hlh-2 is then required 
to specify DTC fate and to promote its function (Karp and Greenwald 2004; Tamai and 
Nishiwaki 2007; Chesney et al. 2009).   
How do Wnt pathway activity and ceh-22 promote DTC competence?  One 
possibility is that they might regulate expression of factors involved in DTC specification.  
The lin-32 promoter contains three potential Nkx2.5 consensus DNA binding sites 
(TNAAGTG, (Riazi et al. 2009), and the lin-32 promoter of C. briggsae and C. brenneri 
have four and two consensus sites, respectively.  Perhaps ceh-22 directly promotes lin-32 
expression in the DTC.  However, the hlh-12 promoter does not contain Nkx2.5 
consensus sites, so it would likely be regulated either indirectly by ceh-22 or by another 
trans factor.   
 During development, timing and location of specifying cell fate is crucial.  I am 
interested in understanding how the DTC adopts its fate and carries out specific functions.  
While hlh-2 was known to be required for DTC specification and function, it was unclear 
which partners dimerize with HLH-2 to provide the DNA-binding capability and 
specificity needed to activate specific targets.  It remains unknown how HLH-2 promotes 
DTC niche function.  However, this work has revealed how HLH-2 functions to promote 
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DTC specification and migration: as a heterodimer with the class II bHLH partners LIN-
32 and HLH-12.  It will be exciting to determine how Wnt pathway activity and ceh-22 






























Figure 1.  Early hermaphrodite gonad development produces two DTCs that are required 
for gonad shape and fertility.  Top: Two somatic gonad precursor cells begin dividing in 
the first larval stage and produce Z1.aa and Z4.pp, the two distal tip cells (DTCs).  
Somatic cells (black) and germ cells (white) occupy the middle of the gonad.  The DTCs 
(red) each occupy a distal position, one anterior and one posterior.  Vertical lines 
represent the symmetric pattern of divisions Z1 and Z4 undergo to produce the L2 
somatic gonad.  Once born, the DTCs are specified.  Bottom: Each DTC has two 
functions.  Left: They both have a “leader function,” which promotes gonad elongation 
and guidance.  This involves two turns – one toward the dorsal side and one toward the 
worm midbody – to complete DTC reflexion.  Right: They also both have a “niche 
function,” which promotes mitosis and proliferation in nearby germ cells.  This requires 
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Figure 2.  Loss of lin-32 causes DTC specification defects.  (A) Cartoon of an early L4 
gonad, where vulval invagination is underway and both the dorsal and proximal DTC 
turns have occurred.  This stage (early- to mid-L4) was scored for DTC defects that result 
in failing to complete the two turns.  (B) RNAi experiments were performed in triplicate, 
with 20 larvae scored per experiment.  I used a bHLH RNAi-sensitized strain, hlh-
2(bx108); lag-2p::rfp; nre-1(hd20), lin-15b(hd126).  lacZ(RNAi) serves as a negative 
control.  hlh-2(RNAi), hlh-12(RNAi), and lin-32(RNAi)-treated animals show different 
DTC defects.  DTCs that completed the two turns (dorsal and proximal) were scored as 
“turned.”  DTCs that had not completed both turns by invagination were scored as “not 
turned.”  “RFP+” DTCs expressed the lag-2 transcriptional reporter, and “RFP-” did not.  
Representative photomicrographs are shown for each gene knocked down by RNAi, with 
DIC and fluorescent images merged.  (C) lacZ(RNAi) reveals two lag-2p::rfp-expressing 
migrated DTCs (white arrowheads) in both the anterior (left) and posterior (right) gonad 
arms at the time of vulval invagination (white asterisk).  The shape of the gonad is outline 
(dashed white line).  (D) hlh-2(RNAi) appears to cause failure of DTC specification, as 
assessed by DTC morphology, gonad morphology, and lag-2p::rfp expression.  hlh-
2(RNAi) additionally causes failure of anchor cell specification, which causes no vulva to 
be induced (black asterisk).  (E) hlh-12(RNAi) shows evidence of gonad elongation, but 
DTC migration is defective and the gonad frequently fails to turn.  DTC specification 
may also fail, as indicated by lack of lag-2p::rfp expression.  (F) lin-32(RNAi) frequently 
causes a DTC defect, where no DTC is identifiable and no gonad elongation is observed 
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Figure 3.  lin-32 and hlh-12 are redundantly required for DTC function, and have 
different individual requirements for DTC migration.  (A) DTC defects of different 
mutants at 25°C were scored.  hlh-2(bx108), or hlh-2(h), shows no DTC defects alone.  
However, it enhances DTC defects of the bHLH gene null (0) alleles, hlh-12(tk68) and 
lin-32(tm1446).  A DTC was scored as “normal” if it completed both turns by the time of 
vulval invagination.  A “defective” DTC failed to complete both turns, due to DTC 
guidance defects or to gonad elongation defects.  “No” DTC indicates that no gonad 
elongation was observed.  (B-E) Representative photomicrographs show DTC defects 
observed (posterior arms shown).  (B) Reflexion occurs normally in hlh-2(h) mutants, 
where the DTC completed both dorsal and proximal turns, and the reflexed gonad arm 
migrates along the dorsal side to the worm midbody.  (C) Gonad elongation and failed 
DTC turning is frequently observed in hlh-12(0) mutants.  (D) Gonad elongation occurs 
in lin-32(0) mutants, but the dorsal turn of the posterior DTC can fail, so the reflexed 
gonad arm remains ventral.  (E) The hlh-12(0); lin-32(0) double mutants show no 
evidence of DTC function by morphology or gonad elongation.  Lines with arrows 
indicate the DTC migration path.  Thin dashed lines outline the gonad shape. 
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hlh-12(0); lin-32(0) lin-32(0) 
B C 
D E 
Normal turned DTC 
Defective DTC 







0% 50% 100% 100% 50% 















Figure 4. lin-32 and hlh-12 promote DTC fate specification and migration.  (A) In a lin-
32(0) background, heterozygous hlh-12(0/+) hermaphrodites do not enhance the DTC 
specification and migration defects of lin-32(0).  Both DTCs express lag-2p::rfp and hlh-
2p::gfp.  By contrast, hlh-12(0); lin-32(0) double mutant hermaphrodites frequently lack 
one or both DTCs, as assessed by loss of lag-2 and hlh-2 expression.  (B,C) Schematic 
representations show the DTC defect observed.  hlh-12(0/+); lin-32(0) hermaphrodites 
have two DTCs that are specified and that migrate (B).   hlh-12(0); lin-32(0) double 
mutant hermaphrodites frequently have only one DTC specified, though that DTC shows 
no evidence of migration (C).  (D) A representative photomicrograph of a hlh-12(0/+); 
lin-32(0) hermaphrodite shows the DTC with normal processes extended and expressing 
both DTC markers lag-2p::rfp and hlh-2p::gfp (below).  The high red background is due 
to the presence of oxTi414[eft-3p::mCherry], which is used to balance hlh-12(0).  (E) A 
representative photomicrograph of a hlh-12(0); lin-32(0) double mutant hermaphrodite 
shows only one DTC expressing the DTC markers lag-2p::rfp and hlh-2p::gfp (below).  
Expression of the DTC markers is dimmer than in hlh-12(0/+); lin-32(0), and is easier to 
see with a higher exposure time (shown).  Arrowheads mark the DTC, and the asterisk 
marks the site of vulval invagination.  See Fig. 3 legend for allele names. 
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Figure 5.  hlh-12 and lin-32 are expressed during hermaphrodite and male gonadogenesis.  
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gonad shows the two hermaphrodite DTCs (hDTCs) occupying opposite ends of the 
gonad.  The translational HLH-12-GFP reporter is expressed in both hDTCs once they 
are born in the L1, and expression remains in later larval stages.  The percent of worms 
with GFP expression in either the anterior (a) or posterior (p) hDTC is shown.  (B) A 
schematic of an L2 male gonad shows the two male DTCs (mDTCs) occupying the 
posterior end of the gonad, and the linker cell (LC) occupying the migrating anterior end. 
HLH-12-GFP is not expressed in the mDTCs at any stage, though expression is observed 
in the LC.  The percent of worms with GFP expression in either the LC or in one or both 
mDTCs is shown.  (C,D) Representative photomicrographs show HLH-12-GFP 
expressed in both hDTCs and in the male LC.  DIC and GFP images are merged, and 
GFP alone is shown in the inset panels.  (E) The translational LIN-32-GFP fosmid 
reporter is expressed in both hDTCs once they are born in the L1, and expression remains 
in later larval stages.  (F) LIN-32-GFP is expressed in the mDTCs, and expression is 
observed in the LC beginning in the L2 larval stage.  (G,H) Representative 
photomicrographs show LIN-32-GFP expressed in both hDTCs and mDTCs in the L1 
larval stage.  DIC and GFP images are merged, and GFP alone is shown in the inset 
panels.  (I,J) Representative photomicrographs show LIN-32-GFP expressed in both 
hDTCs, in the male LC, and dimly in one mDTC in the L2.  DTCs are marked with 
arrowheads, and the LC is marked with an arrow.  The gray lines mark where two images 
of the same worm in different focal planes are joined, allowing observation of both 





Figure 6.  lin-32 is required for expression of the DSL ligand arg-1 in the male DTC.  
arg-1 is well-expressed in the two male DTCs (mDTCs), and its expression was 
examined in a wild-type background and in mutant backgrounds. Expression could be 
lost in one mDTC (1 GFP+) or in both mDTCs (0 GFP+).  lin-32(tm1446) is the null 
allele used, and hlh-2(bx108ts) is the hypomorphic hlh-2 allele used.  All strains also 
carry ccIs4443 [arg-1p::gfp] and him-5(e1490), and experiments were performed at 25°C.   
 




























Figure 7.  Model: Three bHLH genes regulate DTC specification and migration.  Top: 
Two heterodimers, HLH-12--HLH-2 and LIN-32--HLH-2, are functionally redundant and 
promote DTC specification.  Bottom: The same two heterodimers have separate functions 
in promoting the DTC leader function.  The HLH-12--HLH-2 heterodimer is required for 
gonad elongation, while the LIN-32--HLH-12 heterodimer is required for the dorsal turn 
during DTC migration. 
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Supplemental Figure 1.  An RNAi screen of bHLH genes identifies a role for lin-32 in 
the DTC.  All bHLH domain-containing genes were tested for a role in promoting DTC 
specification and leader function.  Worms were considered to have DTCs defects if both 
turns were not completed by the time vulval invagination was underway.  lag-2p::rfp 
marks DTCs.  Only lin-32(RNAi) enhanced the rare DTC defect of hlh-2(bx108) mutants.  
The percent of worms with DTC defects in one DTC (gray bar) or in both DTCs (black 
bar) is shown, with 20 larvae scored for each RNAi clone.  hlh-12(RNAi) was used as  
positive control and lacZ(RNAi) as a negative control.  hlh-12(RNAi)showed a significant 
difference from lacZ(RNAi) in every experiment.  The results are grouped (and 
significance was determined) by experiment. 
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Genetic background: hlh-2(bx108); lag-2p::rfp; nre-1 lin-15b 

























































Supplemental Table 2.  lin-32 and hlh-12 mutant DTCs have different DTC migration 
defects.   
 
DTC defects were scored at 25°C in larvae showing vulval invagination.  The anterior and posterior DTCs 
were scored separately.  Turning is “complete” if both the dorsal and proximal turns are complete when 
vulval invagination is underway.  A “guidance defect” indicates that gonad elongation is occurring but that 
the DTC turning is defective (early, late, or skipped turns).  “Stalled turning” indicates that DTC turning 
started but was not completed, possibly due to stalled gonad elongation.  “No turning” indicates that 
turning did not begin.  Both double mutants containing hlh-12(0) came from heterozygous mothers, with 
arIs51 balancing hlh-12(0).  Three hlh-2(h); hlh-12(0) mutants showed completed turning in both DTCs.  
These three animals looked wild-type and may have been recombinants.  The number of worms with the 
defect out of the total number scored is shown below, with the percent in parentheses.   













 Anterior Turning Posterior Turning 
  Complete Guidance defect 
Stalled 
turning 









50/50   
(100%) 0 0 0 
50/50   
(100%) 0 0 0 
hlh-12(0) 
41/63   
(65%) 
1/63             
(2%) 
16/63             
(25%) 
5/63             
(8%) 
35/63   
(56%) 
2/63             
(3%) 
19/63             
(30%) 
7/63             
(11%) 
lin-32(0) 
50/50   
(100%) 0 0 0 
32/50   
(64%) 
18/50         
(36%) 0 0 
hlh-2(h); hlh-12(0) 
3/54      
(6%) 0 
23/54    
(43%) 
28/54    
(52%) 
5/54      
(9%) 0 
26/54    
(48%) 
23/54    
(43%) 
hlh-2(h); lin-32(0) 
18/51         
(35%) 
2/51              
(4%) 0 
31/51        
(61%) 
14/51                  
(27%) 
3/51                  
(6%) 0 
34/51    
(67%) 
hlh-12(0); lin-32(0) 0 0 0 
50/50   
(100%) 0 0 0 




Supplemental Table 3.  The gonads of hlh-12; lin-32 double mutants fail to elongate.  
 
Evidence of any gonad elongation is scored as “+,” and no gonad elongation was scored as “-.”  See Suppl. 











Anterior Elongation Posterior Elongation 
 + - + - 
hlh-2(h) 
50/50   
(100%) 0 
50/50   
(100%) 0 
hlh-12(0) 
62/63     
(98%) 
1/63      
(2%) 
63/63     
(100%) 0 
lin-32(0) 
50/50   
(100%) 0 
50/50   
(100%) 0 
hlh-2(h); hlh-12(0) 
54/54   
(100%) 0 
54/54   
(100%) 0 
hlh-2(h); lin-32(0) 
20/51          
(39%)    
31/51        
(61%) 
17/51         
(33%) 
34/51    
(67%) 
hlh-12(0); lin-32(0) 0 
50/50   
(100%) 0 
























1. Summary of results. 
1.1  Differential regulation of HLH-2 in the AC/VU 
During C. elegans gonadogenesis, the bHLH transcription factor hlh-2 is required 
to promote AC competence, the AC/VU decision, and function of the specified AC.  
Previous work showed that HLH-2 promotes AC fate during the AC/VU decision, and 
that post-transcriptional regulation removes HLH-2 from the ventral uterine precursor 
cell (VU), where LIN-12/Notch promotes VU fate (Karp and Greenwald 2003).  In 
chapter 2, I have investigated how HLH-2 is post-transcriptionally regulated during the 
AC/VU decision.  I find that HLH-2 is regulated at the protein level, causing its 
differential expression in the AC and VU.  This differential expression depends on a 
novel dimerization-dependent mechanism that promotes HLH-2 down-regulation in the 
VU.  Expression analysis of Class II bHLH genes and two different phenotypic assays 
suggest that HLH-2 functions as a homodimer for AC function and for turnover in the 
VU.  Mutational analysis of the HLH-2 transcriptional target lin-3 supports the 
hypothesis that HLH-2 homodimers bind to specific E boxes in the AC.  I also find that 
the human ortholog E2A rescues loss of hlh-2, and that E47 protein is down-regulated in 
the VU through dimerization.  This raises the exciting possibility that this novel mode of 
bHLH protein regulation could be conserved. 
Taken together, these results support a model for differential targeting of HLH-2 
dimers for degradation during the AC/VU decision.  In the presumptive AC, HLH-2 
homodimers bind to specific E boxes (CAGGTG) of target genes like lin-3, lag-2, and 
egl-43.  In the VU where hlh-2 is also transcribed, HLH-2 homodimers form, but they are 
recognized and targeted for degradation.  I speculate that LIN-12 activity in the 
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presumptive VU leads to HLH-2 homodimer recognition and turnover.  In sections 2 
through 4, I discuss the novel dimerization-dependent mechanism that promotes E protein 
turnover in VUs.  I also explore possibly trans factors and modifications that could 
promote HLH-2 turnover.  And last, I discuss the implications of this work in identifying 
HLH-2 targets.  
 
1.2  lin-32 and hlh-12 in DTC specification and migration 
While investigating potential dimerization partners for HLH-2 in the AC/VU 
decision, I serendipitously discovered a novel role for the bHLH genes lin-32 and hlh-12 
in specifying the distal tip cell (DTC), another gonadal cell whose specification requires 
hlh-2.  hlh-2 is required for DTC specification and function, and LIN-32 is a Class II 
heterodimer partner of HLH-2.  I find that loss of lin-32 in an hlh-2 hypomorph 
background causes failure of DTC specification.  Surprisingly, lin-32 null mutants show 
only a partially penetrant DTC migration defect, but DTC specification occurs normally.  
I show that lin-32 and hlh-12 play functionally redundant roles in specifying the DTC, as 
the double mutant frequently fails to specify DTCs.  lin-32 and hlh-12 are expressed in 
the DTC, consistent with cell-autonomous roles in promoting DTC specification and 
function.  I propose that the HLH-12--HLH-2 heterodimer and the LIN-32--HLH-2 
heterodimer are each sufficient to specify the DTC.  After specification, they have some 
non-overlapping functions, as the migration defects of hlh-12 and lin-32 are different.  In 
sections 5 through 7, I discuss the importance of bHLH proteins during DTC 
specification and differentiation.  I also consider how DTC specification is regulated in 
the distal gonad lineage, and how bHLH genes might promote DTC differentiation.  
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2. Dimerization-dependent turnover of E proteins during the AC/VU decision 
In chapter 2, I provide evidence that HLH-2 turnover in the VU requires 
dimerization.  Since DNA binding requires dimerization, I discuss some findings that 
indicate that dimerization per se, and not DNA binding, is required for HLH-2 turnover. 
 
2.1  HLH-2 protein turnover in the VU requires dimerization. 
The basic Helix-Loop-Helix domain (bHLH) has two important and connected 
activities:  dimerization through the HLH region and DNA-binding through the basic 
region.  bHLH proteins must dimerize before they can bind to DNA (Voronova and 
Baltimore 1990), because both basic regions from the two proteins make important 
contacts with the DNA (Ellenberger et al. 1994).  Thus, mutating the DNA binding 
domain or important dimerization residues should both prevent DNA binding.  Is HLH-2 
turnover in the VU dependent on DNA binding then, or on dimerization?  I made an 
additional mutation that suggests that DNA binding is not required for HLH-2 turnover.  
The first residue of Helix 2 is K342.  In vitro studies indicated that mutating this 
lysine to alanine in the human ortholog E47 was sufficient to disrupt dimerization and 
DNA binding (Voronova and Baltimore 1990).  I made this same mutation in HLH-2 and 
saw a very weak effect on HLH-2 stability in VU (Fig. 1).  However, this mutant form of 
HLH-2 is unable to rescue the hypomorphic hlh-2 allele bx108, indicating that its activity 
is abolished.  This result was surprising, given the clear importance of dimerization for 
the other three mutant forms of HLH-2 to be turned over in the VU.  A closer look at the 
E47 homodimer crystal structure reveals that the human equivalent of K342 makes 
important contacts with DNA (Ellenberger et al. 1994).  Thus, it is likely that the main 
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effect of K342 is to bind DNA rather than to promote dimerization.  This suggests that 
HLH-2 dimerization, but not DNA binding, is important for HLH-2 turnover in the VU.  
 I also made another DNA-binding mutation in HLH-2, based on analogous 
mutations made in E47: R303G,R304G.  This mutation disrupts E47 DNA binding but 
does not affect dimerization (Voronova and Baltimore 1990).  This mutation also does 
not stabilize HLH-2 in the VU, but it is able to partially rescue hlh-2(bx108), indicating 
that the mutation is not sufficient to abolish DNA binding.  Clearly, my results are not 
consistent with the reported effect of the mutations on E47 dimerization and DNA 
binding activity.  The in vitro studies may not have been sensitive enough to detect 
reduced levels of DNA binding or dimerization, which could explain the difference 
between our findings.  Alternatively, it could be that HLH-2 is not affected in the same 
way by these mutations, or that the in vivo activity of these proteins is different than their 
in vitro activity.  More mutations of the basic region would be required to definitively 
establish that DNA binding is not required.  These results are consistent with 
dimerization specifically and not DNA binding being required for HLH-2 turnover in the 
VU. 
 
2.2  E47 is a functional ortholog of HLH-2 and is down-regulated in the VU. 
HLH-2 is the sole C. elegans E protein, as determined by sequence homology and 
by dimerization with Class II bHLH proteins (Krause et al. 1997).  Here, I show that 
GFP-E47 is able to rescue hlh-2(bx108), suggesting that E47 is a functional ortholog of 
HLH-2.  E47 is clearly able to homodimerize to bind DNA, which is how I propose 
HLH-2 functions in the AC.   
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I also find that E12 is able to rescue hlh-2(bx108), and can be turned over in the 
VU (not shown).  This is also expected, as E12 can heterodimerize with E47, and 
possibly HLH-2 as well.  I was surprised to find that GFP-E12 can also rescue loss of 
hlh-2 by RNAi (Chapter 2 Suppl. Table 3), given that E12 is generally viewed as being 
an obligate heterodimer.  Two simple explanations can account for this result.  RNAi can 
only reduce hlh-2 expression, so remaining hlh-2 might heterodimerize with E12 to 
function.  An alternative explanation is that E12 dimerizes with something else to 
promote AC fate.  It could heterodimerize with a bHLH protein that I did not detect, or it 
could homodimerize.  Though considered an obligate heterodimer, there is evidence that 
E12 can homodimerize in vitro, albeit much more weakly than E47 (Benezra et al. 1990; 
Pesce and Benezra 1993; Benezra 1994). 
The conservation of HLH-2 in sequence and function raises the possibility that 
my findings in the AC/VU decision may be relevant for regulating E proteins in other 
systems.  Here I am studying negative regulation of HLH-2 stability.  A recent study 
shows that elevated activity of E47, through either dominant mutation or through loss of 
Id, is frequently associated with Burkitt’s lymphoma (BL) (Schmitz et al. 2012).  
Mutations that affect E47 all were found in the HLH domain, and all but one mutation 
were in residues that are conserved in HLH-2.  The effect of some of these mutations is to 
decrease affinity of E47 for Id (Schmitz et al. 2012), a dominant negative regulator of E 
protein activity (Benezra et al. 1990).  However, other mechanisms for regulating E47 
activity in BL likely exist (Schmitz et al. 2012).  Once the trans-acting factor that 
regulates HLH-2 is identified, it will be interesting to see if that factor (or factors) shows 
evidence of being mutated in BL cases.  If it is, then it would be very important to see if 
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simply supplying that trans factor to BL cell lines would be sufficient to suppress E 
protein activity and cell proliferation. 
 
3. Investigating trans-acting factor(s) regulating HLH-2 protein stability 
Our work shows that HLH-2 protein is down-regulated in the VU through a novel 
dimerization-dependent mechanism.  GFP-HLH-2 is stabilized in VUs when proteasome 
components are knocked down via RNAi.  This evidence is indirect, but it is consistent 
with HLH-2 ubiquitination and turnover in the VU.  I suggest that a trans-acting factor 
recognizes the HLH-2 dimer specifically and promotes its down-regulation.  
 
3.1  Notch represses bHLH protein activity in several developmental contexts.  
Ultimately, I am interested in understanding the following questions:  (1) what 
recognizes HLH-2 dimers and promotes HLH-2 down-regulation, and (2) what is the 
consequence of failing to down-regulate HLH-2?  In the presumptive AC, HLH-2 
promotes expression of lag-2/DSL, which can then activate LIN-12/Notch in the 
presumptive VU.  HLH-2 protein is turned over, and I speculate that LIN-12/Notch 
activity promotes HLH-2 turnover in the VU.  I have found that in a lin-12(0) background, 
GFP-HLH-2 is stable in both α cells, and in a lin-12(d) background, GFP-HH-2 is 
unstable in both α cells.  However, in both backgrounds, there is a cell fate 
transformation: 2AC and 0AC, respectively.  Thus I have been unable to identify a direct 
connection between LIN-12 activity and GFP-HLH-2 stability. 
bHLH protein stability is known to be regulated downstream of Notch activity in 
other systems.  Below I describe two different examples of Notch regulating bHLH 
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proteins, which use different mechanisms and different trans factors to regulate bHLH 
protein stability (summarized in Fig. 2).  This indicates that several regulatory 
mechanisms exist to promote bHLH protein turnover and that there may be more 
mechanisms to discover, possibly including HLH-2 regulation during the AC/VU 
decision. 
In the developing mouse pancreas, Notch activity promotes proliferation of 
pancreatic progenitor cells and ductal call fate, and Ngn3 promotes endocrine fate in 
progenitor cells (Afelik and Jensen 2013).  Ngn3 is thought to promote Dll1 expression, 
and Dll1 can then activate Notch in neighboring cells to promote progenitor proliferation 
(Afelik and Jensen 2013).  Ngn3 protein is turned over downstream of Notch activity (Qu 
et al. 2013).  Recent work showed that Fbw7, part of a multisubunit E3 ligase complex, 
recognizes Ngn3 and promotes its turnover in the pancreas(Sancho et al. 2014).  Similar 
substrate recognition sites are present in the worm ortholog NGN-1, but not in HLH-2.  
Additionally, GFP-HLH-2 is not stabilized in the VU by loss of sel-10/Fbw7 (data not 
shown), though sel-10 is expressed and functioning in the AC/VU (Sundaram and 
Greenwald 1993).  This indicates that HLH-2 protein turnover is regulated by a different 
trans factor than in the mouse pancreas.   
In humans, E2A is essential for hematopoiesis (Massari and Murre 2000).  In the 
absence of Notch activity, E2A promotes the B cell lineage (Massari and Murre 2000); 
E47 protein is turned over downstream of activated Notch in B cells (Nie et al. 2003; 
King et al. 2007; Nie et al. 2010).  Cell context is important for Notch-dependent E2A 
turnover.  In T cell lines, for example, activated Notch does not promote E2A protein 
turnover (Nie et al. 2003).  In B cells, E47 turnover involves an E3 ligase complex (Cul1-
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Skp1-Skp2), which binds E47 and promotes its ubiquitination and turnover.  While this 
complex alone can promote E47 turnover, Notch activity can accelerate E47 turnover 
through promoting Asb2 expression (Nie et al. 2010).  A dimeric E3 complex consisting 
of the Cul1-Skp1-Skp2 complex plus the Cul5-Asb2 complex has higher E3 activity and 
promotes higher E47 ubiquitination and turnover (Nie et al. 2010).  Preliminary RNAi 
experiments show that individually knocking down these components (cul-1/Cul1, skr-
1/Skp1, skpt-1/Skp2, M60.7/Asb2) does not stabilize GFP-HLH-2 in the VU (Suppl. Figs. 
1 and 3 in Chapter 2).  This suggests that HLH-2 turnover in the VU is dependent on a 
different trans factor(s) than E2A turnover in B cells.  Intriguingly, this work shows that 
E47 can be regulated in the same way as HLH-2, so in investigating how HLH-2 is 
regulated, we may learn of a novel way through which E47 and other bHLH proteins are 
regulated.  Additionally, once we identify a trans factor, then it will potentially allow us 
to investigate a possible interplay between HLH-2 turnover and LIN-12 activity.  For 
example, if LIN-12 directly drives expression of the trans factor, we will be able to 
identify LAG-1 binding sites (LBSs) through which LIN-12 promotes transcription of the 
trans factor. 
 
3.2  trans-acting factors and post-translational modifications potentially cause HLH-
2 turnover. 
The trans factor regulating HLH-2 in the VU remains unknown.  To understand 
how HLH-2 regulation is coordinated with the AC/VU decision, we need to determine 
the trans-acting factor(s) involved in HLH-2 turnover.  I have recently developed the 
tools to investigate this question, and am currently working to identify the trans-acting 
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factor by RNAi.  As indicated above, once the factor is identified, I will look for 
conserved LAG-1 Binding Sites (LBSs), target DNA sequences through which LIN-
12/Notch activates transcription.  HLH-2 down-regulation could also potentially be 
through non-transcriptional Notch activity, as was found to regulate the kinase ASK1 
(Mo et al. 2013).  Alternatively, I may find that LIN-12 does not promote HLH-2 protein 
turnover in the VU.  
 Different types of trans factors could potentially contribute to the regulation of 
HLH-2 protein stability.  For example, phosphorylation of HLH-2 could lead to its 
degradation, as can be the case with other destabilized proteins.  HLH-2 has 35 predicted 
phosphorylation sites (NetPhos 2.0), and 50 predicted kinase binding sites (NetPhosK 
1.0) (Fig. 3).  I did not mutate these sites due to the number of sites and due to concerns 
that the endogenous wild-type hlh-2 might be sufficient to promote protein turnover in 
trans.  This could mask the importance of the sites being tested.  However, now that 
GFP-HLH-2 can be stabilized in the VU by knocking down proteasome components, we 
have the potential to immunoprecipitate GFP-HLH-2 from the AC and VU.  Presumably, 
by inhibiting the proteasome, modified forms of HLH-2 would accumulate in the VU.  
We could use a Western blot to test HLH-2 for ubiquitination, which would be more 
direct evidence that HLH-2 itself is ubiquitinated.  Or, perhaps mass spectrometry could 
be used to identify post-translational modifications of HLH-2 that may be important in 
regulating its stability.  Then candidate sites could be mutated and tested for a role in 
regulation of HLH-2 stability and/or activity in the VU. 
 Several different mechanisms can promote protein degradation: lysosome-
mediated proteolysis, calpain-mediated protein cleavage, and ubiquitin-mediated 
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degradation via the proteasome.  Knocking down proteasome components stabilizes 
GFP-HLH-2 in the VU, so we focus here on proteasome-mediated degradation.  (It is 
important to note, however, that this experiment does not directly implicate the 
proteasome.)  For this type of protein degradation, the protein substrate must be 
polyubiquitinated in order to be recognized and degraded by the proteasome (Kipreos 
2005).  The ubiquitin-activating (E1) enzyme UBA-1 transfers ubiquitin to ubiquitin-
conjugating (E2) enzymes.  The ubiquitin-protein ligases (E3) recognize and bind the 
protein substrates, and transfer ubiquitin from the E2s to the substrates.  There are many 
different types of E3 ligases: HECT-domain, RING finger, U-box, cullin-based 
complexes, and APC (Kipreos 2005).  An RNAi screen against these components could 
reveal how HLH-2 protein is turned over in the VU, though this would be a large screen 
to undertake.  Also, we do not know with certainty that ubiquitin and the proteasome are 
directly promoting HLH-2 turnover, so it is possible that this approach might miss the 
trans factor.  Given this caveat and the size of the RNAi experiment, it might be better to 
perform an unbiased forward genetic screen for mutations that stabilize HLH-2 in the VU.  
 
3.3  What is the consequence of stabilizing HLH-2 in the VU? 
 Why does this mechanism for HLH-2 turnover exist?  Finding a specific way to 
stabilize HLH-2 in the VU, either through mutation of sequences in cis or through loss of 
a negative regulator in trans, will reveal the consequence of stabilizing HLH-2 in the VU.  
Due to the pro-AC activity of HLH-2, one might expect stabilizing it to promote AC fate, 
thereby specifying more than one AC.  Alternatively, since HLH-2 directly promotes 
transcription of the DSL ligand lag-2, perhaps ectopic HLH-2 will cause LAG-2 to be 
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expressed in both α cells, activating LIN-12 activity and causing a 0AC defect.  This is 
effectively what happens when Ngn3 is ectopically expressed during pancreas 
development: constitutive Ngn3 activity drives DSL expression, DSL activates Notch, 
and activated Notch promotes ductal fate (Qu et al. 2013). 
There may be additional ways to regulate HLH-2 activity, such that even 
stabilized HLH-2 is not active in the VU; in this case, stabilizing HLH-2 on its own 
would not be sufficient to cause an AC number defect.  This type of phenomenon has 
been observed with LIN-45/Raf in specifying 1° vulval fate in C. elegans:  activation or 
stabilization of LIN-45 alone does not cause dominant cell fate transformations, but both 
stabilizing and activating LIN-45 does (la Cova and Greenwald 2012).  Ultimately, 
learning the consequence of stabilizing HLH-2 in the VU will be essential to our 
understanding of the AC/VU decision.  More generally, this will contribute to our 
understanding of how opposing inputs (the pro-AC activity of HLH-2 vs. the pro-VU 
activity of LIN-12) can be resolved during cell fate specification. 
 
3.4  Implications for investigating bHLH proteins in other contexts 
I also show that other bHLH proteins can be down-regulated in the VU (Appendix 
section 1).  In the case of LIN-32, I find that its turnover is dimerization-dependent.  
While this down-regulation of other bHLH proteins is unlikely to be relevant during the 
AC/VU decision, it does demonstrate that the mechanism promoting HLH-2/E47 
turnover in the VU can likely act on other bHLH targets.  Are there other contexts where 
HLH-2 and/or other bHLH proteins are turned over?  I attempted to address this question 
for HLH-2, but was unable to generate stable transgenic lines, possibly due to 
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overexpression of hlh-2.  Our understanding of bHLH protein regulation is somewhat 
piecemeal.  The worm could be a powerful system for investigating differential bHLH 
protein stability in a more systematic way.  Fosmid reporters could be generated where 
transcription is reported in RFP and a GFP translational fusion reports protein 
expression/stability.  During development, cells that are RFP+ but not GFP+ would 
reflect post-transcriptional bHLH gene regulation.  Given the high degree of conservation 
of these proteins, it is likely that this type of expression analysis would reveal additional 
in vivo contexts for studying bHLH gene regulation.  Of course, it will be interesting to 
determine if bHLH protein turnover in those contexts is dimerization-dependent. 
 
4. Identification of targets of HLH-2 in the AC 
To better understand how HLH-2 functions in the AC, we are interested in 
identifying more transcriptional targets of HLH-2.  I discuss how these findings could 
help identify novel targets of HLH-2, and I describe some strategies to identify targets on 
a large scale. 
 
4.1  HLH-2 homodimers bind CAGGTG, and several AC-expressed targets have 
CAGGTG E box sequences. 
I investigated what bHLH protein dimerizes with HLH-2 to promote its turnover, 
and I provide several different lines of evidence that an HLH-2 homodimer is the relevant 
dimer substrate.  This is the first evidence of an in vivo context where HLH-2 functions 
as a homodimer.  In investigating this hypothesis, I realized that in vitro DNA binding 
assays for HLH-2 all use the CAGGTG-type of E box (Krause et al. 1997; Harfe et al. 
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1998b; Zhang et al. 1999; Portman and Emmons 2000; Hwang and Sternberg 2004; 
Hwang et al. 2007).  The one exception is in Harfe et. al. (1998b).  They show that HLH-
2 homodimers bind to CAGGTG E boxes, but not to CATATG E boxes.  However, many 
different HLH-2 heterodimers are able to bind a CATATG E box (Harfe et al. 1998b; 
Grove et al. 2009).  This suggests that HLH-2 homodimers may be more limited in which 
E boxes they can bind.   
I reasoned that if HLH-2 homodimers bind specifically to CAGGTG E boxes, 
then targets of HLH-2 in the AC should have CAGGTG E boxes, and they should be well 
conserved.  I find that the previously-defined AC enhancer element of the HLH-2 target 
lin-3 contains two CAGGTG E boxes (Hwang and Sternberg 2004), and sequence 
comparisons with three other nematode species show that al four species have two 
CAGGTG E boxes.  Additionally, egl-43, another target of HLH-2 in the AC, has two 
CAGGTG E boxes in its previously-characterized AC enhancer (Hwang et al. 2007), and 
three other nematode species have two conserved CAGGTG E boxes as well (Fig. 4 in 
Chapter 2).  Indeed, lag-2, nhr-67, and exc-6 are all expressed in the AC and have 
CAGGTG E boxes in their promoters (Fig. 4 in this chapter).  Promoter mutations or 
deletions that remove all CAGGTG E boxes result in loss of AC expression (Karp and 
Greenwald 2003; Verghese et al. 2011; unpublished observations).  Notably, these 
mutated promoters all retain E box sequences, but not CAGGTG.  These observations 






4.2  Strategies to identify novel targets of HLH-2 in the AC/VU 
It is important to test more targets of HLH-2 in the AC for dependence on 
CAGGTG E boxes.  This could have important implications for computational searches 
for targets of HLH-2 in the AC.  Requiring E box sequences to be CAGGTG and to be 
conserved in other nematode species would drastically reduce the number of predicted 
targets genes, and it would make mutational analysis of promoter regions simpler – 
mutating the CAGGTG E boxes, rather than all CANNTG E boxes.   
It is still a mystery how HLH-2 can promote AC competence, the AC/VU 
decision, and AC function as a homodimer.  Does it drive expression of different targets 
at different times, or does it continuously drive expression of the same targets?  All of the 
best-characterized targets of hlh-2 in the AC are also expressed early in the α and β cells.  
These include lag-2, lin-3, egl-43, and nhr-67 (Wilkinson et al. 1994; Karp and 
Greenwald 2003; Hwang and Sternberg 2004; Hwang et al. 2007; Verghese et al. 2011).  
However, these are only four of presumably many transcriptional targets of HLH-2 in the 
AC.  Does HLH-2 promote transcription of different target genes for its different roles?  
A great way to begin addressing this question is by finding and analyzing more 
targets of HLH-2 in the AC.  A straightforward approach is to computationally identify 
more targets of HLH-2 by searching for conserved CAGGTG sequences.  Another 
approach is using INTACT (Isolation of Nuclei TAgged in specific Cell Types) to obtain 
transcriptional profiles of α and β cells at different time points, through specific labeling 
and sorting of α and β nuclei and sequencing mRNA transcripts (Deal and Henikoff 
2010).  The identification of hlh-2prox allows this kind of experiment, due to its tissue-
specificity.  The most powerful approach might be a combination of the two – to obtain a 
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transcriptional profile and to look for conserved CAGGTG E boxes in the genes 
expressed in the α and β cells.  The anchor cell will provide an excellent opportunity to 
study how a single transcription factor can somehow promote competence, specification, 
and terminal differentiation of the AC. 
 
5. LIN-32 and HLH-12 are implicated in DTC fate specification and function. 
In investigating the role of bHLH proteins in the AC, I uncovered a novel role in 
the DTC for HLH-12 and LIN-32, two Class II bHLH proteins.  The DTC is frequently 
studied as a model for cell migration, but it must first be born and specified.  Components 
of the Wnt pathway are important for asymmetric divisions that lead to the birth of the 
DTCs (Siegfried and Kimble 2002; Siegfried et al. 2004).  Then, hlh-2 is required to 
specify the hermaphrodite distal tip cell (DTC) (Karp and Greenwald 2004; Chesney et al. 
2009).  Once specified, the terminally differentiated DTC has two key functions:  the 
niche function to promote germline mitosis and thus fertility, and the leader function to 
promote and guide gonad elongation and turning.  Both of these functions are also 
dependent on hlh-2 (Tamai and Nishiwaki 2007; Chesney et al. 2009).   
hlh-12 is the only partner of HLH-2 that has been implicated in promoting DTC 
function (Tamai and Nishiwaki 2007), and no Class II partners have been implicated in 
DTC specification prior to this work.  The dimerization partners of HLH-2 that promote 
DTC specification were unknown.  The RNAi screen identified the Class II bHLH gene 
lin-32 as being required for DTC specification, but only in combination with a 
hypomorphic mutation that compromises hlh-2.  HLH-2 is an obligate dimer, which leads 
to two simple hypotheses: to specify DTC fate, HLH-2 either homodimerizes or it 
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heterodimerizes with at least one other partner.  Since hlh-12 is expressed early in the 
DTC, I asked whether it could be functionally redundant with lin-32 in DTC specification.  
This work shows that DTC specification frequently fails and that DTC leader function 
completely fails in an hlh-12(0); lin-32(0) double mutant.  So in addition to finding a role 
for lin-32 in DTC specification and leader function, I found that hlh-12 likely promotes 
DTC specification as well.  I was unable to rescue the lin-32(0) because expressing LIN-
32 (GFP-tagged or untagged) under the control of the hlh-12 promoter caused dominant 
negative DTC migration defects and occasionally sterility.  But lin-32-gfp and hlh-12-gfp 
reporters are both expressed in the DTCs during the late L1 stage, consistent with a cell-
autonomous role in promoting DTC specification. 
Class II bHLH proteins heterodimerize with HLH-2.  Here, th redundant function 
of two Class II proteins HLH-12 and LIN-32 masked their roles in function and 
specification of the DTC, though each shows a DTC migration defect.  I was able to 
implicate lin-32 in DTC specification when hlh-2 activity was also reduced by a 
hypomorphic mutation.  This may prove to be a useful approach in other cell types for 
revealing functional redundancy of bHLH proteins during cell fate specification or 
differentiation.  As discussed earlier, C. elegans is an excellent system for studying 
bHLH proteins, and the short generation time, the transparency, and the ease of RNAi 
would allow for systematic approaches to understanding how bHLH proteins regulate 






6. lin-32 promotes proper DTC guidance, and particularly dorsal migration. 
I asked if lin-32(0) mutants fail to specify DTCs in an hlh-2(+) background. lin-
32(0) hermaphrodites are healthy and fertile, and do not show any evidence of failed 
DTC specification.  However, I occasionally observe DTC migration defects.  Most 
defective DTCs failed in their first turn toward the dorsal side.  Instead, the DTC reflexed 
and migrated back toward the worm midbody, remaining on the ventral side.  I also 
noticed that only the posterior DTC showed the turning defect.  
The lin-32(0) phenotype strongly resembles the defects observed in unc-5 and 
unc-40/netrin receptor mutant DTCs, and in unc-6/netrin mutant DTCs (Hedgecock et al. 
1990).  unc-40 is expressed in DTCs beginning in the L2 stage, and unc-5 expression 
begins when they begin their dorsal migration (Chan et al. 1996; Su et al. 2000).  Netrin 
acts as a dorsal guidance cue, and netrin receptor-expressing cells can respond to netrin 
and migrate dorsally.  In the absence of netrin or its receptors, DTCs frequently fail to 
migrate dorsally and instead reflex and migrate ventrally (Hedgecock et al. 1987).  
Several different unc-5, unc-40, and unc-6 mutants were tested, and the penetrance of the 
DTC dorsal turning defect was found to be much higher in the posterior than anterior 
DTC (Hedgecock et al. 1990), which is surprisingly what I observe in lin-32(0) mutants.  
In addition, robust unc-40 expression in the hermaphrodite-specific neuron has 
previously been found to require hlh-3, a different dimerization partner of HLH-2 
(Doonan et al. 2008), indicating that bHLH genes can regulate unc-40 expression. 
The similarity between lin-32(0) mutants and unc-5, unc-6, and unc-40 mutants, 
as well as the bHLH-dependent expression of unc-40 raise the possibility that unc-5 or 
unc-40 expression (either directly or indirectly) depends on lin-32 (Fig. 5).  This would 
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be a particularly interesting connection because the netrin guidance system is important 
for neuronal migration as well (Hedgecock et al. 1990), and lin-32, the Atonal ortholog, 
is best characterized as a proneural gene (Way and Chalfie 1989; Jarman et al. 1993; 
1994; Zhao and Emmons 1995; Portman and Emmons 2000).  And perhaps this 
connection could be more widespread; lin-32 is important in the Q and PVM lineages 
(Way and Chalfie 1989; Way et al. 1992), which produce neurons that require unc-40 for 
proper migration (Hedgecock et al. 1990; Way et al. 1992).  Future investigation of 
targets of LIN-32 in the DTC will undoubtedly shed light on nature of the lin-32(0) DTC 
turning defect. 
 
7. A model for regulation of DTC specification  
We now have a better understanding of how HLH-2 promotes DTC specification 
and differentiation.  This leaves two big questions: What regulates HLH-2 and its 
partners, and what do they regulate?  Here, I discuss a hypothesis for how the early role 
for the Wnt pathway may be linked to HLH-2 and its partners.  
 
7.1  Hypothesis: lin-32 is regulated by the Wnt pathway and ceh-22/Nkx2.5 for DTC 
specification. 
The Wnt pathway components lin-17/Frizzled, wrm-1/sys-1/β-catenin, lit-
1/Nemo-like kinase, and pop-1/TCF are all required for the asymmetric division of Z1 
and Z4, the somatic gonad precursors (Sternberg and Horvitz 1988; Siegfried and Kimble 
2002; Siegfried et al. 2004).  Loss of any of these components causes the first Z1 and Z4 
division to be symmetric, also called the Sys defect (Symmetrical sisters), and extra 
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proximal cells are specified at the expense of distal cells (Sternberg and Horvitz 1988; 
Siegfried and Kimble 2002).  A key role for the Wnt pathway is to activate expression of 
the transcription factor ceh-22/Nkx2.5 (Lam et al. 2006).  ceh-22 is required for the distal 
lineage, so ceh-22 mutants have no DTCs (Siegfried et al. 2004; Lam et al. 2006).  
Ectopic ceh-22 expression is sufficient to cause ectopic DTC specification (Lam et al. 
2006).  This indicates that ceh-22 is a critical regulator of DTC fate downstream of Wnt 
pathway activity.   
Could the expression of hlh-12 or lin-32 be regulated downstream of ceh-22, 
possibly as direct transcriptional targets?  The consensus Nkx2.5 binding site is 
TNAAGTG (Riazi et al. 2009), and this hypothesis is particular intriguing due to the 
presence of three CEH-22/Nkx2.5 consensus sites in the 2kb lin-32 promoter.  C. 
briggsae and C. brenneri have four and two Nkx2.5 consensus sites, respectively, 
upstream of lin-32.  Perhaps CEH-22 activates expression of lin-32 through one or more 
of these sites to allow DTC specification by LIN-32--HLH-2 heterodimers (Fig. 5).  hlh-
12 does not have Nkx2.5 sites, however, and hlh-12 is sufficient to promote DTC fate in 
the absence of lin-32, so it is likely that ceh-22 is important for more aspects of DTC 
specification than simply promoting expression of an HLH-2 heterodimerization partner.  
However, this could be one way that Wnt pathway activity and ceh-22 are connected to 
HLH-2 and its partners in DTC specification.  This would be an interesting case, because 
it would be the opposite of LIN-32 and Wnt activity in the male ray lineage in C. elegans.  
There, Wnt pathway activity negatively regulates lin-32 expression during differentiation, 
thus restricting LIN-32 expression to the appropriate lineages (Miller and Portman 2011).  
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Mutating the Nkx2.2 binding sites in the lin-32 promoter would indicate whether lin-32 
expression in DTCs requires CEH-22. 
 
7.2  Hypothesis: hlh-12 expression can be regulated by HLH-2 homodimers. 
What might regulate hlh-12 expression?  While hlh-12 does not contain Nkx2.5 
sites, it does contain many E boxes, including one CAGGTG E box.  This is the kind of E 
box that HLH-2 homodimers can bind.  Could expression of hlh-12 be activated by HLH-
2 homodimers?  A simple test would be to mutate the CAGGTG E box and check for an 
effect on hlh-12 expression.   
This hypothesis would address a second question about DTC specification:  how 
can ectopic hlh-2 expression specify a functional DTC, if it requires either LIN-32 or 
HLH-12 as a heterodimer partner?  (Karp and Greenwald 2004, this work)  Though hlh-
12(0); lin-32(0) double mutant hermaphrodites can still have DTC fate specified, those 
DTCs are highly defective, and never show evidence of having any leader function 
(n>50).  If HLH-2 homodimers could drive expression of hlh-12, then an ectopic DTC 
form and differentiate using the resulting HLH-12--HLH-2 heterodimers.  It remains 
unclear if ceh-22 regulates bHLH gene expression and activity during DTC specification, 
and these types of experiments might provide clues about how (or if) they are connected. 
 
7.3  hlh-12 and lin-32 have non-overlapping roles in DTC leader function. 
How do hlh-12 and lin-32 function to promote DTC specification and function?  
Do they act on the same targets, different targets, or both?  Neither lin-32 nor hlh-12 
single mutants have DTC specification defects, so a reasonable hypothesis is that LIN-
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32--HLH-2 and HLH-12--HLH-2 heterodimers can drive expression of the same (or 
functionally redundant) targets for DTC specification.  The INTACT approach is 
discussed above for identifying targets of HLH-2 in the AC.  A similar approach could be 
used to isolate DTC nuclei from lin-32(0) mutants and hlh-12(0) mutants.  
Transcriptional profiles could be obtained and compared to see if there are any clear 
differences in mRNA transcripts between the two genotypes. 
As for DTC leader function, hlh-12 and lin-32 clearly have at least some non-
overlapping roles, as shown by their difference in migration defects.  lin-32(0) mutants 
occasionally show failure of the posterior DTC to turn dorsally.  This has the appearance 
of a guidance defect.  By contrast, hlh-12(0) mutants show highly penetrant defects in 
elongation and migration (Tamai and Nishiwaki 2007).  At least one important direct 
transcriptional target of hlh-12 is gon-1, a member of the ADAMTS family.  GON-1 is an 
extracellular protease that is proposed to be secreted by the DTC to remodel the basement 
membrane locally, thereby allowing DTC migration (Blelloch and Kimble 1999).  
Supplying gon-1 to the DTCs in a hlh-12(0) background partially suppresses the 
migration defect, indicating that the hlh-12(0) migration defect is due in part to failure to 
remodel the basement membrane.  A better understanding of the targets of hlh-12 and lin-
32 would lead to a better understanding of how they promote proper DTC migration and 
turning. 
 
8. Closing thoughts 
This thesis investigates the function and regulation of the bHLH transcription 
factor HLH-2 in specifying different cell fates during C. elegans gonad development.  
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This work gives insight into how HLH-2 functions in the AC and how it is eliminated 
from the VU during the AC/VU decision, and my studies of the human ortholog E47 
raise the exciting possibility that I am studying a new mechanism of bHLH protein 
turnover that may be conserved.  I also discovered functionally redundant transcription 
factors that possibly specify DTC fate and that promote its differentiated function.   
hlh-2 is required for the specification and function of both the anchor cell in the 
proximal gonad and the distal tip cells.  In each context, I was able to determine an 
important functional component of HLH-2 activity: its dimerization partner.  It is 
interesting that we are left with similar questions in each cell context.  What regulates 
HLH-2 and its partners?  What do HLH-2 and its partners regulate?  How do the same 
transcription factors promote specification of a cell fate in addition to terminal 
differentiation of that cell fate?  Are different targets expressed during specification than 
during differentiation?  The work performed in this thesis advances our understanding of 
cell fate specification in the somatic gonad and it allows us to begin to answer these 


































Figure 1.  Separation-of-function mutations in hlh-2 can help distinguish between 
dimerization and DNA binding.  (Row 1) Wild-type HLH-2 can dimerize and bind DNA, 
and is down-regulated in the VU.  (Row 2) Mutating K342 is predicted to disrupt DNA 
binding with a small effect on dimerization.  The mutation has a small effect on HLH-2 
stability in the VU.  (Rows 3-5) Three different mutations that are predicted to disrupt 
dimerization completely stabilize HLH-2 in the VU.  All four mutant forms of HLH-2 
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Figure 2.  Notch regulates bHLH gene activity in other developmental contexts.  Left: In 
mouse pancreatic progenitor cells, Neurogenin3 (Ngn3) promotes specification of 
endocrine cells.  Notch promotes progenitor proliferation and prevents specification by 
repressing Ngn3.  Notch promotes HES expression, which represses Ngn3 transcription.  
An additional mechanism eliminates Ngn3 protein: an SCF E3 ligase complex containing 
Fbw7 promotes Ngn3 ubiquitination and degradation.  Right: In human B cells, E47 
protein is sensitive to levels of Notch activity.  High Notch activity promotes expression 
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Figure 3.  HLH-2 contains several predicted phosphorylation sites.  Above: The protein 
sequence of HLH-2 is shown, with relevant features highlighted.  A simple hypothesis is 
that HLH-2 is post-translationally modified in the VU, promoting its turnover.  Below: I 
looked for phosphorylation sites in HLH-2, and there are several predicted by NetPhosK 
1.0.  Column 1: The listed residue in HLH-2 is predicted to be phosphorylated. Column 2: 
The predicted kinase that can phosphorylate that HLH-2 residue is shown. Column 3: 
NetPhosK 1.0 assigns a score to the prediction, with a higher number (on a scale of 0 to 
1) reflecting a higher confidence prediction.  Bold residues are also predicted to be 
phosphorylated by NetPhos 2.0. 
1 !MADPNSQLTS ATTVATAAIA QPQVMLPNAY DYPYNIDPTT IQMPDYWSGY!50!
!
51 !HLNPYPPMQT TDIDYSSAFL PTHPPTETPA SVAAPTSATS DIKPIHATSS!100!
!
101 !TSTTAPSTAP APTSTTDVLE LKPTTAPATN SAETSAIVAP QPLTNLTAPI!150!
!
151 !DAMSSMYTWP QTYPGYLPPS EDNKASEAVN PYISIPPTYT FGADPSVADF!200!
!
201 !SSYQQQLAGQ PNGLGGDTNL VDYNHQFPPA GMSPHFDPNG YPGMTGMPPG!250!
!
251 !SSASSVRNDK SASRATSRRR VQGPPSSGIP TRHSSSSRLS DNESMSDDKD!300!
!
301 !TDRRSQNNAR ERVRVRDINS AFKELGRMCT QHNQNTERNQ TKLGILHNAV!350!
!




Site   Kinase   Score! Site   Kinase   Score!
---------------------! ---------------------!
S-6       CKI    0.52! S-255     PKC    0.89!
S-6     DNAPK    0.59! T-266     PKC    0.85!
T-39      PKC    0.63! S-267     RSK    0.53!
T-61      PKG    0.53! S-267     PKC    0.84!
Y-65     INSR    0.55! S-276    cdc2    0.53!
T-78     cdk5    0.67! S-277    cdc2    0.57!
S-81      PKC    0.67! T-281     PKC    0.61!
T-89      PKC    0.66! S-284     PKA    0.63!
S-100    cdc2    0.51! S-285     RSK    0.56!
S-102     PKC    0.56! S-285     PKA    0.53!
T-103     PKC    0.84! S-286     PKC    0.56!
S-107    cdc2    0.56! S-287     CKI    0.56!
T-108     PKC    0.67! S-287     PKC    0.66!
S-114     CKI    0.51! S-287    cdc2    0.52!
T-129     PKC    0.50! S-290    CKII    0.53!
Y-157    EGFR    0.57! S-290     RSK    0.52!
T-158     PKC    0.62! S-294    CKII    0.56!
Y-182    EGFR    0.55! S-294     CKI    0.51!
Y-182    INSR    0.52! S-294   DNAPK    0.55!
S-196     PKC    0.53! S-296    CKII    0.71!
Y-223    EGFR    0.55! S-296    cdc2    0.52!
S-233  p38MAPK   0.57! T-301     PKC    0.74!
S-233    cdk5    0.55! S-305   DNAPK    0.63!
S-251    GSK3    0.51! S-351  CaM-II    0.50!




Figure 4.  Expression of several genes in the AC may rely on CAGGTG E boxes.  lag-2, 
exc-6, lin-3, and egl-43 are all expressed in the AC.  Mutational analysis of lin-3 and egl-
43 shows that AC expression depends absolutely on two CAGGTG E boxes.  lin-3 
expression is also lost if those E boxes are changed to CATATG.  lag-2 expression in the 
AC is lost when a subset of E boxes are mutated, including the CAGGTG E boxes.  exc-6 
expression in the AC requires the 5’ promoter sequence, which contains the only 
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Figure 5.  Model: LIN-32 and HLH-12 promote DTC specification and the DTC leader 
function.  Top:  LIN-32--HLH-2 heterodimers and HLH-12--HLH-2 heterodimers are 
functionally redundant for DTC specification.  The lin-32 promoter contains predicted 
Nxk2.5 binding sites, and the hlh-12 promoter contains CAGGTG E boxes.  I 
hypothesize that lin-32 expression is promoted by CEH-22/Nkx2.5 and that hlh-12 
expression is promoted by HLH-2 homodimers.  Bottom: lin-32 mutants occasionally 
show DTC guidance defects that are similar to those seen in netrin mutants.  This is 
different from the DTC migration defect of hlh-12, which involves failed gonad 
elongation and failed basement membrane remodeling.  I hypothesize that lin-32 
promotes expression of netrin receptors unc-5 and/or unc-40.  Novel findings are in blue, 
and previously known genes and connections are in black.  Hypothesized transcriptional 
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1.  Investigating the differential stability of ectopic bHLH transcription factors in 
the AC and VU  
 The goal in Chapter 2 was to understand how the bHLH protein HLH-2 is 
regulated during the AC/VU decision.  I provide evidence that HLH-2 homodimerizes in 
the AC to promote AC fate, and that HLH-2 homodimers are targeted for degradation in 
the VU.  Initially, however, I considered that HLH-2 could have a heterodimer partner in 
the AC/VU, and that the partner might provide the necessary signal sequence for HLH-2 
turnover in trans.  Therefore, I sought to investigate the stability of different potential 
heterodimer partners for HLH-2 and different tethered dimer forms of HLH-2.  
Interestingly, I found that other bHLH proteins can be down-regulated in the VUs, raising 
the possibility that their stability is regulated in their endogenous contexts as well.  
 
Materials and Methods 
Plasmids 
 A plasmid carrying the cDNA for LIN-32 was obtained from Doug Portman 
(Portman and Emmons 2000), and plasmids carrying the cDNAs for HLH-2, HLH-4, 
HLH-6, HLH-8, and NGN-1 were obtained from Marian Walhout (Grove et al. 2009).  I 
used PCR fusion to generate translational GFP-bHLH fusion DNAs.  I then sub-cloned 
these fusion products into pMS111 using KpnI and BsiWI to create hlh-2prox::gfp-bHLH 
cDNA::unc-54 3’UTR.   
pMS131 (hlh-2prox::gfp-hlh-1 cDNA::unc-54 3’UTR)  
pMS159 (hlh-2prox::gfp-hlh-4 cDNA::unc-54 3’UTR) 
pMS156 (hlh-2prox::gfp-hlh-6 cDNA::unc-54 3’UTR) 
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pMS157 (hlh-2prox::gfp-hlh-8 cDNA::unc-54 3’UTR) 
pMS158 (hlh-2prox::gfp-ngn-1 cDNA::unc-54 3’UTR) 
pMS107 (hlh-2prox::gfp-lin-32 cDNA::unc-54 3’UTR) 
pMS137 (hlh-2prox::gfp-lin-32 cDNA(aa68-142)::unc-54 3’UTR) 
Site-directed mutagenesis (see Chapter 2 methods) was used to make 
dimerization-defective forms of LIN-32 and HLH-2. 
pMS139 (hlh-2prox::gfp-lin-32[L95F]::unc-54 3’UTR) 
pMS146 (hlh-2prox::gfp-lin-32[I121D]::unc-54 3’UTR) 
PCR fusion and sub-cloning was used to make the tethered dimer constructs as 
described (Neuhold and Wold 1993).  Site directed mutagenesis was used to introduce 
mutations into the LIN-32-HLH-2 tethered dimer constructs.  For the HLH-2-HLH-2 
tethered homodimer constructs, mutations were introduced by generating PCR fusion 
products (3’ half of hlh-2 cDNA –linker – 5’ half of hlh-2 cDNA) with BstEII overhangs.  
The 3’ half of the hlh-2 cDNA contains the bHLH domain of the first hlh-2 cDNA, so 
PCRs used pMS111 for hlh-2(+) or pMS116 for hlh-2[I345D,L346E]. The fusion 
products were then sub-cloned into either pMS111 or pMS116, to have either hlh-2(+) or 
hlh-2[I345D,L346E] respectively as the second hlh-2 cDNA in the tethered dimer. 
pMS112 (hlh-2prox::gfp-lin-32 cDNA-linker-hlh-2 cDNA::unc-54 3’UTR) 
pMS133 (hlh-2prox::gfp-lin-32-linker-hlh-2[I345D,L346E]::unc-54 3’UTR) 
pMS153 (hlh-2prox::gfp-lin-32[I121D]-linker-hlh-2 cDNA::unc-54 3’UTR) 
pMS154 (hlh-2prox::gfp-lin-32[I121D]-linker-hlh-2[I345D,L346E]::unc-54 3’UTR) 
pMS101 (hlh-2prox::gfp-hlh-2 cDNA-linker-hlh-2 cDNA::unc-54 3’UTR) 
pMS168 (hlh-2prox::gfp-hlh-2-linker-hlh-2[I345D,L346E]::unc-54 3’UTR) 
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pMS169 (hlh-2prox::gfp- hlh-2[I345D,L346E]-linker-hlh-2[I345D,L346E]::unc-54 
3’UTR) 
 
Transgene generation and scoring 
 I used the same injection methods and conditions, and the same scoring criteria, 
as discussed in Chapter 2.  Briefly, linearized pMS## plasmid, pCW2.1 (ceh-22p::gfp) 
and pBX (pha-1(+)) were injected at 1 ng/µL along with PvuII-digested N2 gDNA at 50 
ng/µL into 20 pha-1(e2123ts) (GS6014) P0 hermaphrodites.  Injected P0s were kept at 
15°C for 3 days, then shifted to 22°C for four days.  Independent transgenic lines were 
isolated from F2s, generating a maximum of one line per injected P0.  All animals were 
maintained at 20°C or 22°C and scored at 25°C. 
 Gravid adults were transferred to plates and kept at 25°C.  Two days later, mid-L2 
to early L3 worms were scored for GFP expression in the AC and VU.  Worms were 
mounted on 2% agarose pads on a slide and immobilized with 10 mM levamisole in M9.  
GFP expression was analyzed using the 63X objective of a Zeiss Axio Imager D1 
microscope and a Zeiss AxioCam MRm camera.  Expression at a 400 ms GFP exposure 
time was scored as “ON.” 
 
Results and Discussion 
 I made translational GFP-bHLH fusion proteins and used the hlh-2prox enhancer 
element to drive expression in the AC and in the three VUs.  I chose Class II bHLH 
proteins based on potentially interesting sequence differences (eg., prolines in the loop, 
presence of serines, etc) and cDNA availability (Grove et al. 2009).  Figure 1 shows the 
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alignment the bHLH domains of the Class II proteins, including the ones tested (Figure 2).  
HLH-1/MyoD homodimerizes and does not dimerize with HLH-2, and it was stable in 
VUs (Fig. 2B).  Two Achaete-Scute homologs HLH-4 and HLH-6 are not down-
regulated (Fig. 2C,G), nor is the Twist homolog HLH-8 (Fig. 2D).  By contrast, NGN-
1/Neurogenin and LIN-32/Atonal are down-regulated in VUs (Fig. 2E,F).  These 
transgenes appeared to have a dominant negative effect:  ectopic expression of LIN-32 
occasionally caused a 2AC defect, and ectopic NGN-1 caused a 0AC defect.  I thus 
interpret LIN-32-expressing animals with 2 GFP+ cells as having 2 ACs, and NGN-1-
expressing animals with 0 GFP+ cells as having 0ACs.  This shows that the mechanism 
that down-regulates HLH-2 in VUs does not down-regulate all bHLH proteins, but can 
act to down-regulate some bHLH proteins.  It would be interesting to investigate if these 
proteins are differentially regulated during development in their endogenous contexts.  
One way to do that would be to generate bicistronic fosmid reporters or CRISPR alleles, 
where one fluorophore would reflect transcription and another fluorophore would reflect 
post-transcriptional changes in expression.  Since so much work on bHLH protein 
stability is done in vitro or in ex vivo contexts, studying this in C. elegans would 
potentially be extremely valuable. 
For LIN-32, I next asked whether LIN-32 turnover is dependent on dimerization 
(Fig. 3A).  I made two mutant forms of GFP-LIN-32 and assessed their stability in VUs.  
L95F is a hypomorphic mutation of a conserved residue (Fig. 3B), and it is identical to 
the lin-32 allele e1926, which affects but does not abolish dimerization.  I121D is a 
mutation predicted to abolish dimerization, as the corresponding I353D mutation does in 
GFP-HLH-2 (see Chapter 2).  The hypomorphic mutation has a small effect on GFP-LIN-
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32 stability in VUs (Fig. 3A row 2), and the predicted stronger mutation completely 
stabilizes GFP-LIN-32 in VUs (Fig. 3A row 3).  Interestingly, neither of these mutant 
proteins showed a dominant negative phenotype like GFP-LIN-32(+) does, suggesting 
that these mutations likely disrupt LIN-32 activity (Fig. 3A).  Also like GFP-HLH-2, 
GFP-LIN-32 turnover seems to not require any N-terminal sequences, including the only 
S-P and T-P phosphorylation sites (Fig. 3A row 4). 
Additionally, I attempted to analyze how forced dimerization would affect HLH-2 
stability in the VUs.  I made forced dimers using the previously established method of 
linking two bHLH proteins together with a flexible protein tether (Neuhold and Wold 
1993).  At the time, I did not know if HLH-2 homodimerizes or heterodimerizes in the 
AC/VU, so I made both a GFP-LIN-32-HLH-2 tethered heterodimer and a GFP-HLH-2-
HLH-2 tethered homodimer.  The GFP-LIN-32-HLH-2 tethered dimer caused dominant 
defects, including the 2AC defect and failed vulval induction (not shown).  The GFP-
LIN-32-HLH-2 tethered dimer also shows stabilization in VUs that is dimerization-
dependent (Fig. 4A row 1).  Introducing a dimerization mutation to either LIN-32 or 
HLH-2 permits down-regulation in VUs (Fig. 4A rows 2,3).  However, dimerization 
mutations affecting both LIN-32 and HLH-2 simultaneously cause stabilization in VUs, 
indicating that dimerization is required for down-regulation (Fig. 4A row 4). 
Forced GFP-HLH-2-HLH-2 homodimers also showed some stabilization in VUs, 
though not to the same extent as GFP-LIN-32-HLH-2 forced heterodimers (compare Fig. 
4A row 1 to Fig. 4B row 1).  They also showed dependence on dimerization, as mutating 
both copies of HLH-2 causes stabilization in VUs (Fig. 4B row 3).  Unfortunately, 
introducing a dimerization mutation in one of the two HLH-2 copies was not sufficient to 
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promote HLH-2 turnover (Fig. 4B row 2), making the tethered homodimer difficult to 
interpret.  One possible explanation is that the stability I observe in the homodimer is not 
due to forced dimerization but rather due to the artificial nature of the construct.  Another 
possible explanation is that in the context of the tethered dimer, the mutation is not 
sufficient to disrupt dimerization.  It would be interesting to see by EMSA if GFP-HLH-
2-HLH-2[+ or I345D,L346E] can bind DNA, which can only occur when HLH-2 is part 
of a dimer. 
 Finally, I investigated whether high LIN-12 activity promotes HLH-2 protein 
turnover in VUs (Fig. 5).  I examined the stability of several different GFP-tagged 
proteins in VUs in lin-12(n302d).  In this background, LIN-12 activity is elevated, 
causing all four cells to adopt the VU fate.  hlh-2prox transcription is not noticeably 
affected; it is still strongly expressed in all four cells.  I still observe brighter hlh-2prox 
expression in the α cells than in the β cells, suggesting that the difference between those 
two types of cells is maintained in this background.  GFP-HLH-2(+) is down-regulated in 
all VUs while the dimerization mutant form is stable in all four VUs, as one would 
predict.  The tethered dimers do appear to show sensitivity to levels of LIN-12 activity, as 









2.  Deletion analysis of the promoter region of hlh-2 
 HLH-2 is required for AC competence.  Somehow, hlh-2 expression is initiated in 
the parents of the AC and VUs, and early expression allows for AC fate to be specified 
during the L2.  As part of my interest in understanding the function of HLH-2 in 
promoting AC competence, I am interested in finding out how hlh-2 itself is controlled.  
hlh-2 is expressed in Z1.pp and Z4.aa (the parents), in the four daughters (the α cells and 
β cells), in the AC and VUs, and in many (but not all) of the ventral uterine descendants 
of the VUs.  In principle, the different spatial and temporal expression of hlh-2 could be 
regulated by many different enhancers.  I performed a deletion analysis of the hlh-2 
promoter region to better understand its cis regulation.  This analysis found a single 
327bp element that is required and sufficient to drive expression of hlh-2 in the gonad 
continuously from the late L1 (in the parents) through the fusion of the AC to the uterine 
seam cell in the L4.  I call this element hlh-2prox, in reference to its exclusive expression 
in the proximal cells of the developing somatic gonad.  This enhancer element was 
essential for the analysis of HLH-2 in Chapter 2. 
 
Materials and Methods 
Plasmids 
 I made a transcriptional reporter for hlh-2 with the 5.2kb promoter (-5253-1) from 
GS#p683 and with 2xnls-yfp-unc-54 UTR GS#p625.  I set “0” as the translational start 
site for hlh-2, so “-1” refers to the position immediately 5’ to the start site, and “-5253” is 
the position 5253bp 5’ to the start site.  I added hlh-2 introns 1 and 2 upstream of the 
promoter by PCR and sub-cloning.  I deleted 4.4kb of the 5.2kb promoter by excising the 
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HindIII fragment, leaving hlh-2(-562-1) and the hlh-2(-5253-4927) HindIII fragment.  I 
used these pieces and GS#p625 (2xnls-yfp::unc-54 UTR) to make different combinations 
of promoter elements driving YFP expression.   
pMS8   (hlh-2(intron1)::(intron2)::(-5253-1)::2xnls-yfp::unc-54 3’UTR) 
pMS49  (hlh-2(- 5253-1)::2xnls-yfp::unc-54 3’UTR) 
pMS51  (hlh-2(-5253-4927, -562-1)::2xnls-yfp::unc-54 3’UTR) 
pMS50   (hlh-2(-562-1)::2xnls-yfp::unc-54 3’UTR) 
pMS63  (hlh-2(-5253-4927)::2xnls-yfp::unc-54 3’UTR) 
pMS62  (hlh-2(-4926-1)::2xnls-yfp::unc-54 3’UTR) 
I used PCR fusion for further deletion analysis of the hlh-2(-5253-4927) sequence, 
now called hlh-2prox.  I looked for sufficiency of a region of hlh-2(-5253-4927) to drive 
expression in the AC early and / or late.  I used pXZ20 (from Xinyong Zhang) as a source 
of gcy-5(min 200bp)::2xnls-yfp::unc-54 UTR to provide a basal promoter region, and I 
amplified and fused regions of hlh-2(-5253-4927) to the gcy-5(min) sequence.   
prox hlh-2(-5253-4927)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
seq#1: hlh-2(-5146-4927)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
seq#2: hlh-2(-5116-4927)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
seq#3: hlh-2(-5086-4927)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
seq#4: hlh-2(-5026-4927)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
seq#5: hlh-2(-5146-5076)::gcy-5(min)::2xnls-yfp::unc-54 UTR 
Transgene generation and scoring 
 I used the same injection methods and conditions, and the same scoring criteria, 
as discussed in Chapter 2.  Briefly, linearized pMS## plasmid or gcy-5(min)–based PCR 
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products, pCW2.1 (ceh-22p::gfp) and pBX (pha-1(+)) were injected at 1 ng/µL along 
with PvuII-digested N2 gDNA at 50 ng/µL into 20 pha-1(e2123ts) P0 hermaphrodites.  
Injected P0s were kept at 15°C for 3 days, then shifted to 22°C for four days.  
Independent transgenic lines were isolated from F2s, generating a maximum of one line 
per injected P0.  All animals were maintained and scored at 25°C.  Worms were mounted 
on 2% agarose pads on a slide and immobilized with 10 mM levamisole in M9.  GFP 
expression was analyzed using the 63X objective of a Zeiss Axio Imager D1 microscope 
and a Zeiss AxioCam MRm camera.  Any visible YFP expression in the AC/VU 
precursor cells (the α and β cells) and later in the AC was scored as “ON.”  Shown is the 
data for expression in the AC, but earlier expression was examined as well.  All lines that 
show YFP expression in the AC also show it early in the α and β cells (not shown).   
 
Results and Discussion 
 The first two hlh-2 introns were thought to be important for expression in the AC, 
so I started with a large hlh-2(-5253-1) promoter and the first two hlh-2 introns (Fig. 6A 
row 1).  I find that the introns are not necessary - the long hlh-2(-5253-1) promoter is 
sufficient for AC expression  (Fig. 6A row 2, Fig. 6C).  The 5’ region hlh-2(-5253-4927) 
plus the 3’ region hlh-2(-562-1) are sufficient for expression in the AC (Fig. 6A row 3).  
The 5’ region hlh-2(-5253-4927) alone is sufficient for expression in the AC (Fig. 6B 
rows 1,3), but the 3’ region hlh-2(-562-1) is not (Fig. 6B row 2).  Additionally, the 5’ 
region hlh-2(-5253-4927) is required for expression in the AC:  hlh-2(-4926-1), which 
lacks the 5’ region, is not expressed in the AC (Fig. 6B row 4, Fig. 6D).  I also note that 
hlh-2(-5253-1) is expressed in the vulval cells and the DTCs, but that expression is lost in 
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hlh-2(-5253-4927,-562-1) (Fig. 7).  This indicates that the elements required for vulval 
and DTC expression are in the (-4927-563) promoter region that was deleted.  
 I next focused on the 5’ region hlh-2(-5253-4927), since it is required and 
sufficient for both the early AC precursor expression and for the later AC expression.  I 
now call this 5’ region hlh-2prox in reference to its expression in proximal gonad cells.  I 
fused hlh-2prox to a minimal gcy-5 promoter to provide a basal promoter (Fig. 8A), and 
deleted different regions of hlh-2prox to further understand the transcriptional regulation 
of hlh-2 expression in the gonad.  I asked if there are conserved sequences that could 
guide the deletion analysis.  Interestingly, there is some conservation of hlh-2prox in 
other worm species.  The conserved sequence is removed in hlh-2(seq#1).  I find that hlh-
2(seq#1), like hlh-2prox, is sufficient for gonad expression (Fig. 8B rows 1,2, Fig. 8C and 
D).  Thus I was unable to use conservation and sequence alignments to direct the deletion 
analysis. 
 As I further truncated hlh-2prox, I found that expression remained in the AC but 
that it became much dimmer.  hlh-2(seq#2), (seq#3), (seq#4), and (seq#5) are all 
expressed in the AC (Fig. 8B rows 3-6), but they are dimmer than hlh-2prox or hlh-
2(seq#1).  This observation is necessarily qualitative, due to the nature of multicopy 
transgenic arrays and the on/off scoring method.   
One deletion did result in a difference in pattern.  When I look in L2 and early L3 
worms, when the AC is relatively young and the Pn.p cells have not begun dividing, hlh-
2(seq#4) and hlh-2(seq#5) are expressed well in the AC (Fig. 9A, left graphs).  However, 
in older L3 animals when the Pn.p cells have divided once (Pn.px) or twice (Pn.pxx), I 
see strong expression of hlh-2(seq#4) (Fig. 9A right graphs, Fig. 9B), but no expression 
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of hlh-2(seq#5) (Fig. 9A right graphs, Fig. 9C).  This indicates that hlh-2(seq#5) lacks a 
sequence necessary for maintaining hlh-2 expression in the AC.   
Our results raise the possibility that multiple sequences in hlh-2prox act to 
promote robust expression in the AC (summarized in Fig. 10).  I propose that there are at 
least two different sequence elements that promote the pattern of hlh-2 expression in the 
α and β cells and in the AC.  Both are contained in hlh-2prox and hlh-2(seq#1).  However, 
further deletion of hlh-2prox results in dimmer expression, possibly due to loss of one of 
the pattern elements.  While hlh-2(seq#2), (seq#3), and (seq#4) all maintain expression in 
the later AC, hlh-2(seq#5) does not.  This indicates that seq#5 lacks a sequence element 
promoting maintenance of hlh-2 expression in the AC.  This element would be in the hlh-
2(-5026-4927) region of the hlh-2 promoter.  I used MEME finder and MatInspector to 
try to identify transcription factor binding sites, and I tested a few candidates (TCF and 
Ikaros binding sites, but did not find the binding sites or the transcription factor(s) that 
promote hlh-2 expression in the proximal gonad. 
Ultimately, the goal is to identify the trans-acting factor that promotes early 
expression of hlh-2 in the gonad, thus permitting the AC/VU decision.  In the future, as 
binding site predictions improve, perhaps these bashing data can be revisited and 
candidate transcription factor binding sites will be identified.  Alternatively, an RNAi 
screen of transcription factors could be done to identify the important transcription factor.  
To determine if multiple sequences do promote overall strength of hlh-2 expression, 
MosSCI could be used to generate single-copy insertions of different hlh-2 promoter 
fragments into one locus.  In this case, the expression of different promoter fragments 
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could be compared directly, which might allow the identification of potentially 
meaningful differences in expression level.   
Though I did not find the trans factor, the isolation of the hlh-2prox element 
allowed the analysis of HLH-2 in the AC/VU decision.  I was able to use this enhancer 
element for tissue-specific RNAi, where rde-1(0) makes RNAi defective everywhere in 
the worm except the proximal gonad, where hlh-2prox drives expression of rde-1(+).  In 
addition, we are developing hlh-2prox::Cre recombinase, so we can generate tissue-


















3.  Investigating differences between AC-competent cells 
 The AC/VU decision specifies the fates of the α cells.  However, initially their 
sisters the β cells are competent to adopt the AC fate as well (Seydoux et al. 1990).  
While the α cells retain their AC competence, the β cells become committed to the VU 
fate very quickly (Seydoux et al. 1990).  Specification of the α and β cells provides a 
simple yet elegant system to investigate how the state of a cell – competent versus 
specified – is determined and regulated.  In addition, it provides a way to understand how 
different signals can potentially work together to promote the same fate (the VU fate).   
I investigated the possibility that glp-1, the lin-12 paralog, could act redundantly 
with lin-12 to specify VU fate in β cells.  These results suggest that βVU fate 
specification does not require Notch signaling.  Additionally, I observed that the Wnt 
signaling pathway component pop1/TCF is expressed more strongly in the α cells than in 
the β cells, even in very young L2 worms.  This raises the possibility that Wnt activity is 
involved in the difference between α and β cells. 
 
Materials and Methods 
Fosmid recombineering and plasmid construction 
 Fosmid recombineering was done essentially as described (Tursun et al. 2009).  
The main difference is that I transformed approximately five times more PCR product to 
increase the chances of a recombination event.  The GFP tag in the lag-2 fosmid is C-
terminal, immediately before the stop codon of lag-2.  LAG-2-GFP was membrane-
localized, as expected, and was clearly visible in the α and β cells, the DTCs, the AC, and 
P6.p.  The GFP tag in the glp-1 fosmid was placed inside the glp-1 coding region, with 
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the goal to make it as similar as possible to the rescuing lin-12p::lin-12-gfp(Levitan and 
Greenwald 1998).  Later, an integrated GLP-1-GFP fosmid with the GFP tag inserted 
immediately before the glp-1 stop codon became available (tnIs39).  Its expression 
looked identical to the glp-1-gfp fosmid I made, except that tnIs39 shows germline 
expression.  tnIs39 can also rescue a glp-1(0) mutation, including sterility. 
fosMS3 lag-2p::lag-2-gfp fosmid, from WRM0620cE03 
fosMS4 glp-1p::glp-1-gfp fosmid, from WRM066aC10 
 I made hlh-2(prox)(-562-1)::yfp-lin-45[aa281-480] by removing yfp-lin-
45[aa281-480] from pCC164 from Claire de la Cova with NotI, and that fragment was 
inserted into pMS71 (hlh-2(prox)(-562-1)—NotI—unc-54 3’UTR). 
pMS82 hlh-2(prox)(-562-1)::yfp-lin-45[aa281-480]::unc-54 3’UTR 
Transgene generation 
 Fosmids were linearized and injected at 15 ng/µL, along with pBX (pha-1(+)) and 
pCW2.1 (ceh-22p::gfp) at 1 ng/µL and PvuII-digested N2 gDNA at 50 ng/µL, into 20 
pha-1(e2123ts) P0 hermaphrodites.  The lin-45 sensor plasmid pMS82 was linearized and 
injected at 1 ng/µL, along with pBX (pha-1(+)) and pCW2.1 (ceh-22p::gfp) at 1 ng/µL 
and PvuII-digested N2 gDNA at 50 ng/µL, into 20 pha-1(e2123ts) P0 hermaphrodites.  
Injected P0s were kept at 15°C for 3 days, then shifted to 22°C for four days.  
Independent transgenic lines were isolated from F2s, generating a maximum of one line 
per injected P0.  All animals were scored at 25°C.  Worms were mounted on 2% agarose 
pads on a slide and immobilized with 10 mM levamisole in M9.  GFP or YFP expression 
was analyzed using the 63X objective of a Zeiss Axio Imager D1 microscope and a Zeiss 




lin-12, glp-1 phenotypic analysis 
GS6259 lin-12(n941)/hT2[qIs48(myo-2p::gfp)]; arIs51 (cdh-3p::gfp) 
GS6332 lin-12(n941); arIs51; lon-3(e2175) sel-10(ar41) 
GS6355 lin-12(n941) glp-1(q46)/hT2[qIs48]; arIs51; arEx576 (lin-12p::lin-12(+),  
                              unc-122p::gfp, mir-84p::2xnls-yfp) 
Fosmid Reporters: 
GS6433 pha-1(e2123); arEx1552 (glp-1p::glp-1-gfp fosmid) 
GS6434 pha-1(e2123); arEx1553 (glp-1p::glp-1-gfp fosmid) 
GS6435 pha-1(e2123); arEx1554 (lag-2p::lag-2-gfp fosmid)   
Activity sensors: 
GS6911 qIs74 (pop-1p::gfp-pop-1); arIs208 (hlh-2(-5253-1)p::2xnls-tagRFP) 
GS6910    zIs356 (daf-16p::daf-16-gfp); arIs208 
GS6908   mIs27 (daf-8p::daf-8::gfp); arIs208 
GS6907    qcIs6 (sma-3p::gfp-sma-3); arIs208 
   -----  Ex[hlh-2(prox)(-562-1)::yfp-lin-45(aa281-480)] – not frozen 
GS7003    pha-1(e2123); arIs208; arEx1482 (lin-45p::yfp-lin-45 fosmid) 
Obtaining and scoring lin-12(0) and lin-12(0) glp-1(0) 
 Strains were grown at 20°C for scoring AC number defects of the different 
mutants.  lin-12(0) mutants were chosen by loss of the pharyngeal GFP marking the 
balancer hT2[qIs48].  AC number was scored by counting the number of bright GFP+ 
cells, as marked by cdh-3p::gfp.  Some other non-AC uterine cells can express cdh-
3p::gfp very dimly, especially later in the L3, and those very dim cells were not counted 
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as ACs.  lin-12(0) homozygotes were grown very slowly at 20°C, by placing a large 
number of lin-12(0) hermaphrodites (lacking the balancer) on a plate and waiting for 
growth.  lin-12(0); sel-10(0) animals are healthy enough to be grown without a balancer.   
lin-12(0) glp-1(0) mosaic animals were chosen by loss of pharyngeal GFP 
marking the balancer hT2[qIs48] in addition to mosaic loss of the extrachromosomal 
array.  The MS lineage gives rise to all somatic gonad cells and to the six coelomocytes.  
I scanned plates for mutants lacking the balancer and lacking GFP expression in all six 
coelomocytes (unc-122p::gfp).  Once the mosaics-of-interest were identified, I waited 
until cdh-3p::gfp was visible under the dissecting scope and then mounted the worms on 
a slide to score the number of ACs.  At this step, I also verified that the lin-12(+) array 
was lost in the gonad by checking for loss of mir-84p::yfp expression.  All three animals 
very clearly had only 2ACs. 
Scoring activity reporters 
I used a red hlh-2 transcriptional reporter to mark α and β cells.  All worms were 
grown at 25°C and examined in the early L2 to mid L2.  I mounted worms as described 
above, and looked for visible differences in expression level and localization between α 
and β cells. 
 
Results and Discussion 
 In late L1, two parent cells Z1.pp and Z4.aa divide.  Each parent contributes an α 
cell and a β cell, and the four cells (two α cells and two β cells) initially have the potential 
to adopt either the AC or VU fate (Fig. 11A).  There are several interesting differences 
between the α and β cells (summarized in Fig. 11).  (1) The β cells become committed to 
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the VU fate while the α cells retain their AC competence for much longer (Seydoux et al. 
1990) (Fig. 11B).  (2) The α cells absolutely require lin-12 activity to specify the VU fate 
(Greenwald et al. 1983) (Fig. 11C).  The β cells, by contrast, usually become VUs even in 
the absence of lin-12, even though they are initially AC-competent (Seydoux et al. 1990) 
(Fig. 11C).  This indicates that unlike their sisters, the β cells do not require lin-12 for 
VU fate.  However, there is a second Notch gene glp-1 that could potentially act 
redundantly with lin-12.  (3) Rapid specification of the β cells is dependent on lin-12, as 
β cells retain their AC competence much longer in a lin-12(0) background (Seydoux et al. 
1990) (Fig. 11B).  (4) In the absence of lin-12, ablation of the α cells frequently causes 
the β cells to become ACs (Seydoux et al. 1990) (Fig. 11D).  This indicates that the α 
cells are important for the β cells to become VUs.  Since the presence or absence of the α 
cells affects the fate of the β cells, this indicates that additional signaling is occurring to 
either promote βVU fate or to promote α cell competence. 
 Two additional observations may be relevant to understanding the α/β difference:  
sel-10(0) can suppress the 2AC defect of lin-12(0) (Sundaram and Greenwald 1993), and 
that lin-15AB(0) can enhance the AC defect in the β cells (i.e., more 3AC and 4 AC 
worms) (Sternberg and Horvitz 1989; Fig. 11E).  The lin-15AB observation is interesting 
and was repeated with AC markers by another student in the lab, Yuting Deng, but I did 
not investigate this further.  sel-10 was identified in a screen for mutations that suppress 
the egg-laying defect of a hypomorphic lin-12 allele (Sundaram and Greenwald 1993).  
The screen identified many sel genes, which are suppressors and/or enhancers of lin-12 
(Sundaram and Greenwald 1993).  A surprising finding is that loss of the E3 ligase sel-10 
can suppress both the lin-12 hypomorph and the null (Sundaram and Greenwald 1993).  
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This observation was repeated with the AC marker cdh-3p::gfp (Table 1).  sel-10(0) 
suppresses both lin-12 and glp-1 mutants (Sundaram and Greenwald 1993), and a SEL-10 
substrate recognition site (CPD) is present in both lin-12 and glp-1, so perhaps this 
reveals a role for glp-1:  loss of sel-10 would stabilize GLP-1, resulting in higher Notch 
activity in the α and β cells.  Another possible explanation is that the lin-12(0) animals 
scored come from heterozygous mothers, leaving open the question of maternal rescue.  
This explanation could also account for the βVU fate in lin-12(0) worms. 
  First, I tested whether a maternal contribution of lin-12 can account for the VU 
fate of β cells.  I grew lin-12(0) homozygotes until I obtained enough animals to score for 
AC number.  This has not been done before, likely due to the highly penetrant sterility 
defect of lin-12(0) worms.  However, whether lin-12(0) progeny came from heterozygous 
or homozygous lin-12(0) mothers, approximately 90% of worms still had only 2ACs, 
indicating that maternal lin-12 is not sufficient for VU fate in β cells (Table 1).   
 To determine if glp-1 is promoting VU fate in the somatic gonad, I looked for glp-
1 expression and glp-1 function.  To look at expression, I made a GLP-1-GFP 
translational fosmid reporter and a LAG-2-GFP translational fosmid reporter, to see if 
GLP-1 and LAG-2 protein are expressed in the α and β cells.  While LAG-2-GFP is 
clearly expressed in the α and β cells (Fig. 12A-C), GLP-1-GFP is not (Fig. 12D).  
Surprisingly, I did see GLP-1-GFP expression later in VU descendants (Fig. 12E,F), but I 
never saw it early enough to be consistent with a role for glp-1 in the AC/VU decision. 
 I next asked whether glp-1 might be functioning redundantly with lin-12 to 
promote VU fate in the β cells.  If so, I would expect lin-12(0) glp-1(0) worms to all have 
4ACs.  Since glp-1(0) hermaphrodites are sterile, I maintained the lin-12(0) glp-1(0) 
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mutants as heterozygotes with a balancer.  Additionally, lin-12(0) glp-1(0) larvae all die 
in the L1 stage (Lambie and Kimble 1991).  To bypass the early lethality, I used mosaic 
analysis and examined animals with a lin-12(+) rescuing array that permitted viability but 
was lost in the somatic gonad.  The array arEx576 carries the coelomocytes marker unc-
122p::gfp and the somatic gonad marker mir-84p::2xnls-yfp.  When the array is retained, 
the array marker mir-84p::2xnls-yfp is clearly visible in the AC and other cells, and 1AC 
is specified (Fig. 12G).  Loss of both markers is indicative of loss of the lin-12(+) array 
in the MS lineage, which gives rise all cells of the somatic gonad.  Thus, I were able to 
examine viable mutants with a lin-12(0) glp-1(0) somatic gonad.  I obtained three mosaic 
animals with no YFP+ somatic gonad cells and with no GFP+ coelomocytes.  All three 
had two ACs, as assessed by the AC marker cdh-3p::gfp (Table 1, Fig. 12H).  Since these 
lin-12(0) glp-1(0) double mutants were from heterozygous mothers, we cannot exclude 
the possibility that maternal glp-1 is sufficient to promote βVU fate.  However, together 
with the expression data, the simplest explanation is that something other than Notch is 
sufficient to promote VU fate in β cells.   
 We are left wondering what promotes VU fate in β cells.  I propose a simple 
hypothesis:  lin-12 promotes VU fate in α cells, and lin-12 plus another signaling 
pathway promotes VU fate in β cells.  This hypothesis accounts for the low penetrance 
AC fate for lin-12(0) β cells, and for my evidence that glp-1 is not involved in βVU fate.  
As mentioned previously, in lin-12(0) mutants, the fate of the β cell is influenced by the 
presence or absence of the α cell (Fig. 11D).  This suggests that an additional signaling 
pathway is involved.  The signal could come from the α cell or from some other source, 
as the β cells could move to a more proximal position in the absence of α cells, changing 
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their position relative to a signal source.  The signal could be pro-AC competence or pro-
VU specification. 
 I decided to examine activity reporters for several different signaling pathways:  
Wnt, insulin, TGFβ, and Ras-MAPK.  An ideal activity reporter would have either 
protein stability or subcellular localization change upon activation of a particular 
signaling pathway.  Activity reporters for each of these pathways have been characterized.  
POP-1/TCF nuclear expression is lower in cells with higher Wnt activity (Maduro et al. 
2002).  Insulin signaling keeps DAF-16/FoxO in the cytoplasm, and loss of daf-2/InsR 
causes DAF-16 to translocate to the nucleus (Henderson and Johnson 2001).  There are 
two different TGFβ pathways in C. elegans, Dauer and Sma/Mab (Savage-Dunn 2005).  
Nuclear localization of different receptor Smads, DAF-8/R-Smad and SMA-3/R-Smad, 
indicates activation of the respective TGFβ pathways (Savage-Dunn 2005).  And recently, 
degradation of LIN-45/Raf has been shown to result from activation of the 
EGFR/Ras/MAPK pathway (la Cova and Greenwald 2012).  Additionally, the reporters 
for Wnt, Insulin, and TGFβ are each driven by their own promoters, allowing us to assess 
expression and pathway activity at the same time.  A LIN-45-YFP fosmid reporter was 
also examined and showed no evidence of expression in α and β cells. 
 I looked at the activity reporters with the help of summer student Taner Aydin, 
paying special attention to differences in expression or subcellular localization between α 
and β cells (Table 2).  GFP-POP-1 showed asymmetric expression levels between α and β 
cells.  Expression was consistently higher in α cells than in β cells, which could indicate 
higher Wnt activity in β cells than in α cells.  DAF-16-GFP showed dim expression in the 
α and β cells, but DAF-16 localization was uniform and nuclear in both α and β cells.  
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DAF-8-GFP expression in α and β cells was not determined, due to the strength of the 
other background expression of the reporter.  We did observe nuclear DAF-8-GFP 
expression in the AC, but this is too late for our purpose.  GFP-SMA-3 expression was 
not observed in the α and β cells, so we could not look for an α/β difference.  We used 
hlh-2prox to drive expression of a YFP-LIN-45 activity sensor (la Cova and Greenwald 
2012), but we did not observe any α/β differences. 
 The Wnt asymmetry result is intriguing, raising the possibility that Wnt promotes 
VU fate in the β cells.  Wnt does act earlier in the somatic gonad lineage (in Z1 and Z4) 
to promote distal fate (Siegfried and Kimble 2002).  Perhaps Wnt similarly acts in the 
more distal β cells to promote VU fate.  This earlier role for Wnt activity has prevented 
the analysis of its potential role in the α and β cells, as pop-1 mutants have extra α and β 
cells at the expense of distal gonadal cells (Siegfried and Kimble 2002).  We are currently 
working to optimize a tissue-specific RNAi strain using hlh-2prox to rescue an RNAi 
defective mutant rde-1 only in the proximal gonad after the early role for Wnt.  We will 
make a single-copy insertion of hlh-2prox::rde-1(+) in a lin-12(0); rde-1(0); nre-1 lin-
15b background.  We will then test the effect of pop-1 RNAi in the α and β cells (and/or 
their parents) on AC number.  If this hypothesis is correct, that lin-12 plus Wnt promotes 
VU fate in β cells, then we should see a high frequency of 4AC animals.  If the 
simultaneous loss of Wnt and Notch does not cause a 4AC defect, then that same genetic 
background could be used for a small-scale RNAi screen.  We could knock down 
components of other signaling pathways to identify what else is promoting VU fate. 




4.  A role for the microRNAs mir-61 and mir-250 in the AC/VU decision 
 The first project that I worked on was an investigation into the role of two 
microRNAs mir-61 and mir-250 in the AC/VU decision.  microRNAs are small RNAs 
that bind to target sites, frequently in the 3’ untranslated region (UTR), in mRNA 
molecules.  Previous work in our lab demonstrated a role for mir-61 downstream of LIN-
12/Notch activity in the vulval precursor cells (VPCs) (Yoo and Greenwald 2005).  These 
microRNAs are also expressed in the somatic gonad in the VUs.  Since the VUs also 
have high LIN-12 activity, I am interested in understanding if the microRNAs are 
important for execution of VU fate downstream of LIN-12 activity.  I find that 
maintenance of mir-61/250 expression depends on LIN-12 activity, but initiation of 
expression does not.  Due to complicated genetic backgrounds and difficulties with 
transgenes, I was unable to firmly establish a mir-61/250 phenotype in the somatic gonad.  
However, microRNAs generally seem important, as loss of the Argonaut alg-1 enhances 
the 2AC defect of hypomorphic lin-12 mutants. 
 
Materials and Methods 
Strains: mir-61 expression 
GS4100  pha-1(e2123); arIs107(mir-61p::2xnls-yfp)  
GS4123  pha-1(e2123); arEx711(mir-61(LBS-mut)p::2xnls-yfp) {Yoo:2005hs}  
Strains: 2AC defect 
GS5161  unc-32(e189); arIs51(cdh-3p::gfp); nDf59 
GS5803  unc-32(e189) lin-12(n676n930ts); arIs51(cdh-3p::gfp) 
GS5015  unc-32(e189) lin-12(n676n930ts); arIs51(cdh-3p::gfp); nDf59 
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GS5947  unc-32(e189) lin-12(n676n930ts); arIs51(cdh-3p::gfp); sel-11(tm1743) 
GS6000  unc-32(e189); arIs51(cdh-3p::gfp); alg-1(gk214) 
GS6021  unc-32(e189) lin-12(n676n930ts); arIs51(cdh-3p::gfp); alg-1(gk214) 
Plasmids and injections 
pMS23  hlh-2(intron2)::(intron1)::(-5253-1)p::mir-61/250  This plasmid contains the 
entire mir-61/250 locus from inside part of the mir-61/250 promoter through to the stop 
codon of sel-11. 
pMS24  hlh-2(intron2)::(intron1)::(-5253-1)p::lsy-6  This plasmid contains the pri-mRNA 
sequence of lsy-6, following the construction of egl-17p::lsy-6 (Yoo and Greenwald 
2005).   
fosMS2  mir-61/250p::gfp fosmid.  I recombineered GFP into WRM0611bB04, replacing 
the mir-61 and mir-250 microRNAs with GFP.  No expression was observed (data not 
shown; linearized fosmid was injected at 15 ng/µL with pBX (pha-1(+)) and pCW2.1 
(ceh-22p::gfp) at 1 ng/µL and PvuII-digested N2 gDNA at 50 ng/µL into 20 pha-
1(e2123ts) P0 hermaphrodites).   
 Plasmids were linearized and injected at 1 ng/µL along with pCW2.1 (ceh-
22p::gfp) at 1 ng/µL and PvuII-digested N2 genomic DNA at 50 ng/µL into GS6014 
(pha-1(e2123)), as described above.  Independent transgenic lines were also isolated as 
described above. 
GS6022   arIs51; arEx1407 (hlh-2(intron2)::(intron1)::(-5253-1)p::mir-61/250) 
Scoring of transgenic lines and mutants 
Worms were maintained at 20°C and scored at 25°C. Worms were mounted on 
2% agarose pads on a slide and immobilized with 10 mM levamisole in M9.  GFP or YFP 
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expression was analyzed using the 63X objective of a Zeiss Axio Imager D1 microscope 
either by eye or with a Zeiss AxioCam MRm camera.   
I scored AC number by bright expression of the AC marker cdh-3p::gfp.  I used a 
one-tailed Fisher’s exact test to test for significant enhancement of lin-12(n676n930).  I 
use a one-tailed instead of a two-tailed test because I was looking for enhancement, and 
not more broadly for a difference between the different worm strains.   
I scored Egl by looking for adult hermaphrodites displaying any evidence of 
abnormal egg-retention, including the bag-of-worms phenotype. 
 
Results and Discussion 
 In the developing vulva, LIN-12 activity promotes adoption of the secondary (2°) 
vulval fate.  As part of the 2° fate, LIN-12 directly promotes transcription of mir-61 (Yoo 
and Greenwald 2005).  Ectopic expression of mir-61 in a different vulval precursor cell is 
sufficient to cause a 2° marker to be expressed, indicating that the microRNAs are 
important for 2° fate (Yoo and Greenwald 2005).  They tested and validated vav-1 as a 
target of mir-61, and show that vav-1 negatively regulates lin-12 in the vulva (Yoo and 
Greenwald 2005). 
 For my investigation of the somatic gonad, I asked the following three questions: 
(1) Which somatic gonadal cells express mir-61/250, and is expression lin-12-dependent?  
(2) Is there genetic evidence supporting a role for the microRNAs in the gonad?  (3) Are 
any of the predicted targets expressed in the somatic gonad and regulated through their 
3’UTR?  Since the locus is bicistronic, the microRNAs will be referred to as mir-61/250.  
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However, they are two independent microRNAs with different predicted targets 
(Hammell et al. 2008). 
 The mir-61/250p::2xnls-yfp reporter is expressed initially in the α and β cells, in 
addition to several other somatic cells early in the L2.  Later, the expression appears to 
become restricted to the three VUs and their descendants (Fig. 13A,C,D).  The mir-
61/250(LBSmut)p::2xnls-yfp reporter still shows the early expression in the α and β cells, 
but later, the VU expression is gone (Fig. 13B,E).  This result indicates that initiation of 
mir-61/250 expression in the gonad is independent of lin-12, but later expression in the 
VUs is lin-12-dependent.  Interestingly, this is similar to lin-12 transcription: initiation of 
lin-12 expression is lin-12 independent, but maintenance in VUs requires lin-12 
(Wilkinson et al. 1994).  In fact, several important genes are expressed in α and β cells in 
the early L2.  In most cases, we do not understand how expression is initiated, but 
expression is maintained and restricted to the AC and/or VUs by hlh-2 and lin-12, 
respectively.  Examples include lag-2, lin-12, lin-3, egl-43, nhr-67, and so on.  These 
results add mir-61/250 to this list, and they suggest that it is a direct transcriptional target 
of lin-12 in the VUs.  It will be interesting to see if initiation of expression of these genes 
is connected to establishing AC competence in the α and β cells.  Perhaps deletion 
analysis of several promoters and/or a genetic screen will shed light on how expression is 
initiated.  
 I next asked if mir-61/250 is functionally important in the AC/VU decision 
downstream of lin-12.  The mir-61/250(0) phenotype in the somatic gonad is unclear.  
The only available mir-61/250(0) allele is nDf59, a deficiency that removes not only mir-
61 and mir-250, but also part of the suppressor and/or enhancer of lin-12 gene sel-11 
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(Choi et al. 2010).  I looked for an effect of mir-61/250 loss on the hypomorphic lin-12 
allele n676n930ts.  I hoped to compare the following genotypes: lin-12(ts); sel-11(0) and 
lin-12(ts); sel-11(0) mir-61/250(0).  I would expect the additional loss of mir-61/250 to 
enhance the 2AC defect of lin-12(ts); sel-11(0).  However, the two sel-11 alleles are 
different.  tm1743 is an N-terminal deletion allele with an insertion that keeps the rest of 
the SEL-11 protein in-frame.  nDf59 is a deletion allele that removes part of the C-
terminus of SEL-11.  It is also unclear if these are null alleles, as sel-11 is a RING-
domain E3 ligase and both deletions leave the RING domain intact (Fig. 14A).  The 
results match the prediction: the additional loss of mir-61/250 enhances the 2AC defect 
(Fig. 14B).  However, I would need to determine that the sel-11 alleles are null alleles 
before drawing conclusions from this experiment about the role of mir-61/250 in the 
AC/VU decision.   
 I next ask a broader question: are microRNAs important for LIN-12 activity in the 
AC/VU decision?  I introduced null allele of the Argonaut alg-1 into the lin-12(h) 
background and asked if loss of alg-1 enhances the 2AC defect of lin-12(h).  lin-12(h) 
causes a 2AC defect in approximately 30% (17/58) of animals (Fig. 14B).  This defect is 
significantly enhanced by loss of alg-1 to approximately 50% (27/56) of animals.  This 
likely underreports the importance of microRNAs in the AC/VU, as the worm has two 
Argonauts, alg-1 and alg-2.  These double mutant worms were generally very sick and 
slow-growing, unlike either single mutant on its own.  This may indicate that microRNAs 
and lin-12 work together in many other developmental contexts, and that alg-1 enhances 
the lin-12(h) defects in other tissues as well. 
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 I also asked the reciprocal question: does ectopic mir-61/250 expression in the AC 
promote VU fate?  I looked for a mostly tissue-specific promoter to drive expression of 
the microRNAs in the alpha cells during the AC/VU decision.  I tried using the published 
promoter sdz-12p::2xnls-yfp (Large and Mathies 2010), but were unable to find optimal 
injection conditions for consistent expression.  I also tried using the more widely-
expressed hlh-2(intron1)::(intron2)::(-5253-1) promoter to drive expression of mir-61/250 
and I used expression of the unrelated microRNA lsy-6 as a negative control.  I looked 
for egg-laying defects (Egl), which would occur if the AC fate was disrupted or if only 
VUs were specified.  Unfortunately, I did not see any defects due to ectopic mir-61/250 
expression (Fig. 14C).  However, due to the broad expression pattern of the hlh-2 
promoter, there may have been selection against arrays with high levels of expression.  
Thus I am unable to conclude whether or not mir-61/250 expression might be sufficient 
to promote VU fate. 
 I also asked if I could identify mRNA targets of mir-61 and mir-250.  For this, I 
used the microRNA target prediction program mirWIP (Hammell et al. 2008).  To test 
predicted mRNA targets of the microRNAs, I required a promoter that drives expression 
evenly in the AC and VUs.  My goal was to use the hlh-2 promoter to drive expression of 
YFP and CFP, each with a different 3’UTR – a candidate microRNA target 3’UTR and 
the canonical neutral unc-54 3’UTR, respectively.  These would function as target 
sensors for microRNA activity.  I would expect a true target of the microRNAs to be 
down-regulated in the VUs but stable in the AC.  I thought to use the 3’UTR of vav-1 as a 
positive control.  However, I was unable to find conditions under which the vav-1 UTR 
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caused reduced reporter expression in the VUs.  Thus I was unable to confidently assess 
any of the predicted targets of mir-61 and mir-250. 
 Future work will require a simpler mir-61/250(0) allele, which could be generated 
by CRISPR.  This will allow us to determine if loss of mir-61/250 causes an AC/VU 
defect.  Following the hlh-2 promoter deletion analysis, we now also have hlh-2prox, 
which drives expression specifically in the α and β cells and in the AC and VUs.  This 
more specific enhancer element could be used to ask the question:  Is ectopic mir-61/250 
expression sufficient to promote VU fate?  We could also use MosSCI or miniMos for a 
single-copy insertion of the target sensors, so that comparisons of the stability of different 
UTRs could be made.  If mir-61/250 does not enhance the lin-12(h), then we would look 
for other microRNAs that are potentially direct transcriptional targets of lin-12, because 







































Figure 1.  Alignment of the bHLH domains of HLH-2 and the Class II bHLH proteins. 
I have aligned the bHLH domains of HLH-2 and its human ortholog E47, which are both 
Class I bHLH proteins.  Additionally, the 18 Class II bHLH proteins in C. elegans are 
shown, arranged alphabetically.  HLH-1(isoform a)/MyoD homodimerizes and is not 
thought to dimerize with HLH-2.  Many residues show a high degree of conservation.  
Blue highlights similar residues and yellow highlights identical residues.  Bold sequences 
mark the bHLH genes that were tested for stability in VUs in Figure 2. 
































Figure 2.  A subset of Class II bHLH proteins is down-regulated in VUs.   
(A-G) I generated translation fusions, adding a GFP tag to the N-terminus of several 
different full-length bHLH gene cDNAs.  Expression of all GFP-fusion proteins is driven 
specifically in the α and β cells by hlh-2prox, with a neutral unc-54 3’UTR.  The left 
column shows a stick-figure schematic of the fusion proteins, including the placement of 
the bHLH domain (to scale).  The basic region is in black and the HLH region is in tan.  
The middle column is the scoring data for the GFP-bHLH proteins.  Each of the four cells 
(βVU, AC, αVU, and βVU) was scored during the mid-L2 to early-L3 as GFP(+) or 
GFP(-), and the y-axis shows the percent of animals with GFP(+) expression for each 
respective cell.  The observed pattern is summarized as a cartoon of the four cells above 
each graph, with green cells indicating GFP(+) expression and white cells denoting lack 
of GFP expression.  The full genotype is pha-1(e2123ts); arEx### and the number of 
worms score for each transgenic line is in parentheses.  Some of the GFP-bHLH proteins 
cause dominant AC defects, which are shown in the right column. 
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Figure 3.  LIN-32/Atonal down-regulation in VUs is dimerization-dependent.   
(A) I introduced mutations predicted to disrupt LIN-32 dimerization with HLH-2.  The 
lin-32 allele e1926 is a loss-of-function allele, but not a null.  This indicates that it can 
still dimerize, and it is also quite unstable in VUs.  I121D is predicted to abolish 
dimerization, and it stabilizes LIN-32 in VUs.  The equivalent mutation abolishes HLH-2 
activity.  Expression of the GFP-LIN-32 proteins is driven specifically in the α and β 
cells by hlh-2prox, with a neutral unc-54 3’UTR.  The left column shows a stick-figure 
schematic of GFP-LIN-32 and the mutations made.  The basic region is in black and the 
HLH region is in tan.  The middle column is the scoring data for the GFP-bHLH proteins.  
(See Figure 2 legend for scoring details)  GFP-LIN-32 causes dominant AC defects, but 
dimerization mutant forms of GFP-LIN-32 do not, which is shown in the right column.  
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Figure 4.  Attempts to use forced dimers to investigate HLH-2 dimerization.  (A) Dimer 
formation was forced by tethering LIN-32 and HLH-2 cDNAs together with a flexible 
linker, as described (Neuhold and Wold 1993).  This caused stabilization in VUs, as well 
as AC defects (not shown).  Intramolecular dimerization was disrupted by introducing 
dimerization mutations into one of the two cDNAs (characterized in Chapter 2 and Figure 
3), and this resulted in down-regulation in the VUs.  Disrupting dimerization in both 
causes stabilization in VUs.  (B) Homodimer formation was also forced.  This resulted in 
stability in VUs, but the single dimerization mutation did not result in down-regulation in 
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Figure 5.  Assessing stability of HLH-2 constructs in a lin-12(d) background.  Top: I 
assessed the stability of different proteins driven by hlh-2prox n a lin-12(+) background.  
This data is shown elsewhere, and summarized in table form for the comparison below.  
Bottom: I assessed the stability of the same proteins in a weak lin-12 gain-of-function 
background, in which there are no ACs and four VUs.  The dimerization mutant form of 
HLH-2 (I345D,L346E) is stable in lin-12(+) and lin-12(d) VUs.  The wildtype form of 
HLH-2 is unstable in lin-12(+) and lin-12(d) VUs.  The stability of the tethered dimers 
decreases in the lin-12(d) VUs as compared with the lin-12(+) VUs.   The most 
commonly observed category is highlighted in yellow. 
GFP Pattern 
Genotype Transgene in 0 VUs in 1-3 VUs in all 4 VUs 
lin-12(weak d); arEx1683 GFP 0/28 (0%) 0/28 (0%) 28/28 (100%) 
lin-12(weak d); arEx1838 GFP::HLH-2[I345D,L346E] 0/31 (0%) 2/31 (6%) 29/31 (94%) 
lin-12(weak d); arEx1686 GFP::HLH-2 24/33 (73%) 9/33 (27%) 0/33 (0%) 
lin-12(weak d); arEx1783 GFP::HLH-2::HLH-2 30/39 (77%) 9/39 (23%) 0/39 (0%) 
lin-12(weak d); arEx1812 GFP::LIN-32::HLH-2 6/32 (19%) 23/32 (72%) 3/32 (9%) 
Full$genotype:"lin&12(n302)"pha&1(e2123ts);"arEx##"
Full$genotype:"pha&1(e2123ts);"arEx##"
VU# VU# VU#AC#VU# VU# VU#AC#
VU# VU# VU#VU# VU# VU# VU#VU#
GFP Pattern 
Genotype Transgene in 0 VUs in 1-2 VUs in all 3 VUs 
lin-12(+); arEx1683 GFP 0/19 (0%) 0/19 (0%) 19/19 (100%) 
lin-12(+); arEx1838 GFP::HLH-2[I345D,L346E] 0/21 (0%) 4/21 (19%) 17/21 (81%) 
lin-12(+); arEx1686 GFP::HLH-2 18/22 (82%) 4/22 (18%) 0/22 (0%) 
lin-12(+); arEx1783 GFP::HLH-2::HLH-2 4/26 (15%) 20/26 (77%) 2/26 (8%) 





Figure 6.  hlh-2prox drives tissue-specific expression in the proximal somatic gonad.  
(A) Deletion analysis of the hlh-2 promoter shows that the first two hlh-2 introns and 
4.4kb of the hlh-2(-5253-1) promoter are not required for expression in the AC.  (B) Left 
column: Schematic of the promoter deletion analysis.  Numbers refer to the DNA base-
pair position, relative to the translational start site, which is set at “0”.  Middle column: 
Four independent transgenic lines were scored for YFP expression in the α and β cells 
(not shown) and in the AC.  The percent of animals with YFP expression in the AC is 
shown, and the number of animals scored is in parentheses to the right of each transgenic 
line (named arEx###).  (C) An L3 worm with hlh-2(-5253-1)p::yfp at the Pn.pxx vulval 
stage shows YFP expression in the AC, as well as vulval cells P5/7.pxx.  (D) An L3 
worm with hlh-2(-4926-1)p::yfp at the Pn.pxx vulval stage shows no YFP expression in 


















































































Figure 7.  The hlh-2 promoter sequences required for vulval and distal tip cell expression 
are in the (-4926-563) region.  YFP expression driven by different hlh-2 promoter regions 
was examined in several tissues during the L3 stage: the anchor cell (AC), the ventral 
uterine precursor cells (VUs) and descendants, vulval cells, and distal tip cells (DTCs).  
In addition, the α and β cells were examined for YFP expression in the L2.  “+” indicates 
that expression was regularly observed in multiple transgenic lines in that tissue.  The 
number of lines with that expression is in parentheses.  “-”indicates that expression was 
not observed.  The weak expression in the AC and VUs was part of broad dim expression, 

































































Figure 8.  Deletion analysis of hlh-2prox indicates that multiple sequences promote 
proximal gonad expression.  (A) Deletion analysis of hlh-2prox was done by injecting 
PCRs of truncated forms of hlh-2prox fused to the short gcy-5 promoter fragment called 
gcy-5(minimal) driving 2xnls-yfp.  (B) Left: Schematic of the promoter deletion analysis.  
hlh-2(-5253-4927 or “prox”)::gcy-5 minimal::2xnls-yfp 
arEx1555 100% 26 
arEx1543 96% 27 
arEx1556 100% 26 
arEx1557 100% 25 
arEx1558 100% 22 
arEx1559 100% 25 
arEx1560 81% 27 
arEx1613 86% 21 
arEx1614 100% 31 
arEx1615 100% 20 
arEx1561 92% 23 
arEx1562 96% 24 
arEx1563 86% 21 
arEx1616 62% 26 
arEx1617 100% 20 
arEx1618 74% 27 
arEx1619 25% 20 
arEx1620 38% 21 
arEx1621 43% 20 
hlh-2(-5253-4927) 
%worms with  
















See Methods for details of the seq# fragments positions within the hlh-2 promoter.  
Right: At least three independent transgenic lines were scored for YFP expression in the 
α and β cells (not shown) and in the AC, and the number of animals scored is to the right 
of each transgenic line (arEx###).  See Figure 5 legend for scoring and genetic details.  
(C) A photomicrograph (YFP and DIC merged) of an early L3 worm shows YFP 
expression of hlh-2prox::gcy-5(min) in the AC.  The arrowhead marks the AC.  (D) A 
photomicrograph (YFP and DIC merged) of an L3 Pn.pxx stage worm shows YFP 



















Figure 9.  hlh-2(seq#4) carries sequences that maintain AC expression.  (A) Young L3 
(Pn.p stage) and older L3 (Pn.px or xx stage) worms were scored for hlh-2(seq#4) and 
hlh-2(seq#5).  The number of worms scored is in parentheses to the right of each 
transgenic line.  See Figure 5 legend for scoring and genetic details.  (B) A 
photomicrograph (YFP and DIC merged) of an L3 Pn.pxx stage worm shows YFP 
expression of hlh-2(seq#4)::gcy-5(min) in the AC.  (C) A photomicrograph (YFP and 
DIC merged) of an L3 Pn.pxx stage worm shows no YFP expression of hlh-
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Figure 10.  hlh-2 promoter deletion analysis summary.  (A) hlh-2prox is required and 
sufficient for proximal gonad expression, and (B) hlh-2prox contains multiple sequences 
to promote and maintain expression.  The deletion analysis supports a model where 
multiple sequence elements promote the proximal gonad expression pattern (“pattern 
elements”), and at least one other sequence element is required to maintain expression in 
the AC (“maintenance element”).  A large “+” indicates strong bright expression, a small 
“+” indicates dim expression, and “-“ indicates lack of expression in the α and β cells 
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Figure 11.  Summary of known differences between α cells and β cells.  (A) Z1.pp and 
Z4.aa divide, and each contributes one α cell and one β cell.  Both α and β cells are born 
with the competence to adopt either AC or VU fate.  (B) In a lin-12(+) background, β 
cells commit to the VU fate quickly, and α cells retain their AC competence.  In a lin-
12(0) background, both α and β cells retain their competence for longer, as shown by 
ablation experiments (Seydoux et al. 1990).  (C) Normally, the AC/VU decision occurs 
between α cells and is mediated by lin-12.  A stochastic difference (birth order (Karp and 
Greenwald 2003)) between the α cells causes one to adopt AC fate and the other to adopt 
VU fate.  In the absence of lin-12, both α cells adopt the AC fate.  Occasionally, one or 
two β VUs adopt the AC fate as well, but usually they become VUs.  This shows that 
βVU fate does not require lin-12, unlike the α cells.  (D) In approximately 90% of lin-
12(0) animals, the two α cells become ACs and the two β cells become VUs.  When α 
cells are ablated in the lin-12(0) background, the β cell fate seems to change: 8/12 
animals develop one or two ACs from  the β cells (Seydoux et al. 1990).  (E) Some 
AC competent AC competent 
β cells α cells 
α α β β 
lin-12(+) 
α α β β 
lin-12(0) 
VU VU α α α α β β AC competent 
Committed to VU fate, 
early commitment 
requires lin-12 
*Ablating α cells in 
lin-12(0) causes β cells 
to become ACs 
AC/VU decision, 
requires lin-12 to 
specify VU 
Committed to VU fate, 
lin-12-independent 
(Kimble and Hirsh, Dev Biol 1979) 
(Kimble, Dev Biol 1981) 
(Greenwald et al., Cell 1983) 
(Seydoux et al., Cell 1990) 
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known mutations can enhance or suppress the AC number defects of lin-12(0).  
Simultaneous loss of lin-15ab enhances the AC number defect (Sternberg and Horvitz 
1989), causing more β cells to adopt AC fate.  Conversely, loss of sel-10 suppresses the 












































Table 1.  The β cells adopt the VU fate in the absence of lin-12 (zygotic and 






















Relevant Maternal Genotype  Genotype scored 1AC 2AC >2AC 
lin-12(0) 





lin-12(0) lin-12(0) 0 10/11 (91%) 
1/11 
(9%) 
lin-12(0); sel-10(0) lin-12(0); sel-10(0) 22/38 (58%) 
16/38 
(42%) 0 
lin-12(0) glp-1(0); Ex[lin-12(+)] 
           Bal lin-12(0) glp-1(0); Ex[gonad(-)] 0 
3/3 
(100%) 0 
All strains carry the AC marker arIs51[cdh-3p::gfp]  
lin-12(0) = n941 
glp-1(0) = q46 
Bal = hT2[qIs48(myo-2p::gfp)] 
sel-10(0) = lon-3(e2175) sel-10(ar41) 
Ex[lin-12(+)] = arEx576 
Ex[gonad(-)] = arEx576 mosiac: no unc-122p::gfp expression in coelomocytes and no mir-84p::yfp 





Figure 12.  glp-1 does not show evidence for a role in β cell specification.  (A-C) Two 
different planes of focus of one early L2 worm show membrane-localized LAG-2-GFP 
lin-12(0 glp-1(0); cdh-3p::gfp;  
Ex[lin-12(+)] 
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fosmid expression the α and β cells merged with DIC (A,B) and without DIC (A’,B’).  
An early L3 worm shows LAG-2-GFP expression in the AC, the DTCs, and P6.p, which 
are all places that the transcriptional lag-2 reporters (arIs131, arIs222) show expression.  
The GFP channel is shown merged with DIC (C) and without DIC (C’).  (D-F) The GLP-
1-GFP fosmid does not show expression in an early L2 worm (D,D’).  In the L3, VUs 
divide and expression of GLP-1-GFP is observed in the VU daughters VU.x (E,E’) but 
not in the AC (F,F’).  (G) A lin-12(+) array rescues the 2AC defect of the lin-12(0) glp-
1(0) mutant, and nuclear YFP from the array is clearly observed in the AC and nearby 
gonadal cells.  cdh-3p::gfp marks the AC.  (H) When the array is lost in the somatic 
gonad, no nuclear YFP expression is observed, and the mutants have two ACs, as scored 
by cdh-3p::gfp (n=3).  Small arrowheads mark α and β cells, large arrowheads mark the 
AC, asterisks mark the distal tip cells (DTC), the bracket marks the 1° vulval precursor 
cell P6.p, and arrows mark the VU daughters.  Green indicates GFP(+) in that cell, and 


































Table 2.  Asymmetric GFP-POP-1 expression is observed, with higher levels in the α 




























Pathway Reporter Homolog Early L2 – mid L2 
Wnt GFP:-POP-1 TCF α > β  
(17/18) 
Insulin* DAF-16-GFP Foxo α = β,  OFF  (4/9)   (5/9) 
Dauer TGFβ** DAF-8-GFP Smad n.d. 
Sma/Mab TGFβ GFP-SMA-3 Smad OFF (10/10) 
Ras/MAPK YFP-LIN-45(aa281-480) Raf α = β,  OFF  (16/19)   (3/19) 
* Variable expression, often not visible 






Figure 13.   Maintenance of mir-61/250 expression in VUs requires LBSs, but initiation 
does not.  (A) A schematic of the mir-61 promoter shows two LAG-1 binding sites 
(LBSs) in the promoter (blue boxes).  Summary of expression:  Initially, mir-61p::yfp is 
expressed in the four α and β cells, as well as other gonadal cells.  After the AC/VU 
decision, expression is observed in the VUs and not in the AC.  (B) When the two LBSs 
are mutated (white boxes), mir-61(LBS-mut)p::yfp is expressed in the four α and β cells, 
as well as other gonadal cells.  After the AC/VU decision, expression is not observed in 
the VUs or the AC.  (C) A photomicrograph with YFP and DIC merged (C’ YFP only) of 
a late L2 worm expressing mir-61p::yfp shows no YFP expression in the AC and (D,D’) 
YFP expression in the VUs.  (E) A photomicrograph with YFP and DIC merged (E’ YFP 
only) of a late L2 worm expressing mir-61(LBS-mut)p::yfp shows no YFP expression in 
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Figure 14.   Genetic analysis does not conclusively find a role for mir-61/250 in the 
AC/VU decision.  (A) Schematic representation of the sel-11 and mir-61/250 locus and 
alleles used (adapted from Choi et al., 2010).  (B) I looked for enhancement of the 2AC 
defect of a lin-12 hypomorph.  The lin-12 temperature-sensitive (ts) allele n676n930 
causes a partially penetrant 2AC defect.  Both nDf59 and tm1743 suppress the 2AC 
defect.  nDf59 causes a significantly higher 2AC defect than tm1743 in a lin-12 
background, as determined by a one-tailed Fisher’s exact test.  Loss of alg-1 also 
significantly enhances the 2AC defect of lin-12, as determined by a one-tailed Fisher’s 
exact test.  In parentheses: number of 2AC worms / total worms scored.  (C) Left 
schematic: The microRNAs mir-61/250 were ectopically expressed in the AC using an 
hlh-2 promoter.  The microRNA lsy-6 was expressed and examined under the same 
conditions, serving as a negative control.  Right: Egg-laying defects (Egl) were scored for 
several independent lines. No Egl defects were observed in any of the transgenic lines. 





























Egl (no AC) 
p = 3x10-4 
p = 0.027 
